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ABSTRACT

MICHAEL LABRANCHE BERNARD. Structural and Functional Characterization of
the Activator of G-protein Signaling 3 (AGS3). (Under the direction of STEPHEN M.
LANIER)

AGS3 (Activator of G-protein Signaling 3) was isolated in yeast-based functional
screen for receptor-independent activators of heterotrimeric G-proteins. To examine the
role of AGS3 in mammalian signal processing, we defined the AGS3 sub domains
involved in G-protein interaction, its selectivity for G-proteins and its influence on the
activation state of G-protein.

AGS3 co-immunoprecipitated with Gia3 from tissue

lysates in a nucleotide dependent manner (GDP»GTPyS). The regions of AGS3 that
bound Gin were localized to 4 thirty amino acid repeats (GPR - G-protein regulatory
motif) in the carboxyl terminus (P463-S650), each of which were capable of binding Gin.
AGS3-GPR domains selectively interacted with Gin in tissue lysates and with purified
Gin/Gtn. The GPR domain of AGS3 containing four GPR motifs simultaneously bound
more than one Gia.

The AGS3-GPR domains competed with Gf3y for binding to

GtaGDP and blocked GTPyS binding to Gial. When added to reconstituted receptor/Gprotein complex, AGS3-GPR disrupted the high affinity state of the receptor.
From

N-terminus

to

C-terminus,

AGS3

contains

a

region

of seven

Tetratricopeptide repeats (TPRs), a one hundred amino acid linker region and the GPR
domain. Using the TPR and linker region as bait, screening a mouse II-day old
embryonic library using the yeast two-hybrid method yielded the C-terminal 107 amino

Xlll

acids (D330-Q436) of a serine/theronine kinase, S/TKII. A GST-S/TKII (D330-Q436)
fusion protein interacted with AGS3 from rat brain lysate.

Ga subunits were also

detected in this complex in a nucleotide dependent manner.
To uncover the role of AGS3 in the intact organism we analyzed the function and
expression profile of the AGS3 homolog in Caenorhabditus elegans. The pattern of
LacZ staining indicated a strictly neuronal expression pattern for AGS3-CE. The
expression in sub-adults appeared more widespread compared to that in adults. Using
double stranded RNA corresponding to the coding region of the predicted AGS3-CE we
performed RNA interference (RNAi). Injection of double stranded RNA into sub-adult
worms generated a phenotype with nearly 85% penetrance. Offspring of dsRNA injected
worms arrested in an early stage of embryogenesis.

XIV

CHAPTER!
INTRODUCTION

I. OVERVIEW

Heterotrimeric G-protein signaling systems are widely used in nature to convert
extracellular stimuli into intracellular responses.

The machinery of these ubiquitous

signaling systems consists of seven transmembrane span receptors, heterotrimeric
guanine nucleotide-binding proteins and their effectors. Throughout evolution, G-protein
coupled signaling systems transduce a great diversity of extracellular signals. What is
common to the specific signaling systems is the transfer of information from receptor to
G-protein to effector.

This mode of signal transduction is conserved from

Saccharomyces cerevisiae to Homo sapiens, yet higher organisms have developed very
complex G-protein mediated signaling pathways. This complexity can be explained by
an increase in the variety of receptors, G-proteins and effectors. However, it is apparent
that other factors beside receptor G-protein and effector can contribute to signaling
specificity. These factors known as accessory proteins can convert a generic G-protein
signaling cascade into a specific intracellular response. The understanding of how these
factor$ integrate into G-protein signaling pathways will greatly facilitate the
understanding of how specific responses to external stimuli are generated.
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II. HETEROTRIMERIC G-PROTEIN SIGNALING

A. DISCOVERY OF HETEROTRIMERIC G-PROTEIN SIGNALING
Discovery of G-proteins
The discovery of heterotrimeric G-proteins was the result of efforts to understand
the mechanisms of hormone-mediated modulations in intracellular cAMP. Using several
different hormone treatments, Sutherland demonstrated that cells responded by
modulating levels of cAMP.

He also discovered that an integral membrane protein,

which he termed adenylyl cyclase, was responsible for the conversion of ATP into cAMP
(1).

The discovery of adenylyl cyclase and cAMP as a "second messenger" earned

Sutherland the Nobel Prize in Medicine in 1971.
While trying to decipher the mechanism of cAMP regulation, Rodbell and coworkers learned that the hormones causing similar rises in cAMP levels did not act upon
the same cell surface receptor (2) and that the receptor was distinct from adenylyl cyclase
(3, 4). This body of data led Rodbell to hypothesize that a common "tranducer" linked
receptor stimulati'on and effector activation.

Rodbell and co-workers subsequently

discovered that guanine nucleotides could not only affect ligand receptor binding (5) but
that GTP was required for AC activation. He postulated that the transducer might be
regulated by guanine nucleotides (5).
In 1977 Gilman and co-workers demonstrated that a strain of S49 cells with
normal amounts of receptor but lacking adenylyl cyclase activity was not deficient in
aden yl yl cyclase itself.

They resolved the components of AC into a stimulatory

component and a catalytic component. They showed by reconstitution experiments that

3

the adenylyl cyclase catalytic component from cyc- S49 cells was not deficient in
activity. The deficiency was in the stimulatory component of adenylyl cyclase, a guanine
nucleotide binding protein called the GIF factor (6, 7). In 1980 Northrup and Sternweis,
working in the lab of Gilman, purified the GIF factor and named it Os for stimulatory
guanine nucleotide binding protein (8). Findings from the Gilman laboratory agreed with
the discovery by Rodbell that GTP was a requirement for receptor mediated AC
activation. The discovery of a guanine nucleotide binding protein acting as a stimulatory
factor advanced the concept of an intermediary between receptors and AC. Thus began
the paradigm of G-protein mediated signaling pathways: Receptor to G-protein to
Effector. Alfred Gilman and Martin Rodbell won the Nobel Prize in Medicine in 1996
for their work leading to the discovery of G-proteins.

G-proteins as heterotrimers
Other guanine nucleotide binding proteins were demonstrated to play a role in
signal transduction pathways. Sutherland noted inhibition of AC by certain hormones
(1).

Stimulation and inhibition of hormonal-mediated AC activity were blocked by

cholera toxin (9) and pertussis toxin (10), respectively, which modified different
substrates (11). The pertussis toxin substrate was purified simultaneously by Gilman's
(12) and Manclark's (13) groups as a guanine nucleotide binding protein, and was later
named Gi (14). Also present in the purification preparations of Gi was a 36 kDa protein
previously detected in the purification of Gs. This protein was considered a subunit of
the Gs/Gi complexes and named Gbeta

(G~);

the guanine nucleotide binding subunit was

termed Galpha (Ga). After eluding many scientists by running in the dye front, another

4

component of both Gs and Oi was discovered, a 7 kDa protein named G-gamma (Gy)
(15). Thus Os and Gi were subsequently known as heterotimeric G-proteins.

Signaling through heterotrimeric G-proteins: a common mechanism
In 1977 Wheeler, working with photo-transduction in the retina, separated a GTP
binding protein and demonstrated that it activated cyclic GMP phosphodiesterase (16,
17).

This finding led to the discovery of transducin, which was composed of three

subunits alpha, beta and gamma (18). The 41 kDa alpha subunit was the guanine
nucleotide binding component of transducin, shown to be the transducer of information in
the light-triggered signal cascade (19).

These findings also demonstrated that, upon

activation of the signaling cascade, the heterotrimer dissociates into the alpha subunit and
the beta-gamma heterodimer. This paradigm fit well with the proposed mechanism of
hormonal mediated cAMP regulation. Indeed, when the alpha subunits of transducin (Ot)
(20-22) and Gs (23, 24) were cloned, significant homology was found between the two
proteins.

This suggested a common mechanism of signal transduction mediated by

heterotrimeric G-proteins.

B. DIVERSITY OF HETEROTRIMERIC G-PROTEINS

Gasubunits
Heterotrimeric G-proteins consist of an alpha, beta and gamma subunit. The
number of reported alpha subunits in mammalian genomes range between 16 and 20 (2527). Results from the human genome project indicate as many as thirty Ga genes may
exist in the genome (28). Alpha subunits can be classified into 4 families: the Os, the Gi,

5

the Gq and the G 12 families (Table 1.1). The Os family consists of three members that
act by stimulating AC activity and/or regulating calcium channels (8, 27, 29). The Oi
family contains nine members that act upon various effectors. The Oq family contains
five members that act upon PLCJ3 (30). The most recently discovered family, 012/G13,
signals through a Rho GEF (31) and can modulate Na+lH+ exchange (26, 32).

C.

elegans and D. melanogaster genomes have members of each Ga. family, suggesting the
importance of the different Go. families throughout evolution (33).
The Gi family deserves special attention since AGS3 displays preference for this
class of alpha subunits.

Although sequence similarity and pertussis toxin sensitivity

group the nine Oi members into one family, there are distinct divisions among the
members. Of the nine, only three are called Gio. (Gia.1, 2, 3). Gia. proteins negatively
regulate AC and can mediate several effectors through their J3y subunits. The pair of Gta.
proteins is distinct due to their limited expression in the retina and their coupling to the
light triggered receptor rhodopsin (18).

Gustducin (Ggusta.) most closely resembles

transducin; however, its role is limited to another sensory system, taste (34). Of the two
Goa. proteins the Goa.1 subtype is more prevalent. Goa. is highly expressed in brain and
has been calculated to comprise up to 1% of brain membrane protein (14, 35). One of the
many mysteries of heterotrimeric G-protein signaling is the role of the copious amounts
of GOf;X.in mammalian brain tissue. Several effectors have been ascribed to activation by
Goa.; however, the mechanisms of action indicate that the effects are mediated through
the

~y

subunits (36). Gza. is distinguished from the rest of the Gi family by pertussis

toxin insensitivity, yet Gza. can inhibit AC activity (37-39). Gi represents the most

6

Ga

Ga

family

subtype

Gsa

Gsa-L
Gsa-S

Ca++ Channels

Golfa

AC

Gial
Gia2
Gia3

AC; K+, Ca++ Channels; PLCf3; PLA2

Giloa

Gtal
Gta2
Goal
Goa2

Effectors

AC; Na+ Channels

AC; K+, Ca++ Channels; PLCf3; PLA2
AC; K+, Ca++ Channels; PLCf3; PLA2
cGMP-PDE
cGMP-PDE

Ca++ channels
Ca++ channels

Ggusta

Gqa

G12/13a

Gqa
GIla
Gl4a
G15a
Gl6a

PLCf3
PLCB

GI2a

p115RhoGEF

G13a

pI 15RhoGEF

PLCf3
PLC(3
PLCf3

Table 1.1 Ga families and their effectors.
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diverse Oa family in mammals as well as in lower organisms. In C. elegans, 16 of the 20
alpha subunits can be classified as Gi subunits (33).

Gp subunits
There are 5

O~

subunits, as well as one splice variant of

0~5

containing a C-

terminal extension (27, 40). 0131-4 share -80% similarity, whereas 0135 is only 50%
similar to the others.

0135 also differs in its restriction to the CNS and its greater

likelihood to be localized to the cytosol (27). Initially, the beta subunit was not thought
to engage effectors; rather it was shown to be a required component of OPCR-mediated
GTP hydrolysis and a factor necessary for receptor-On interactions (41-43). Logothetis
(44) demonstrated that· Ol3y subunits could activate muscarinic K+ channels, opening up
new areas of research for the Ol3y subunit. Subsequently, the

O~y

subunit has been

implicated in the activation and/or inhibition of numerous effectors, such as certain AC
isoforms (45),

PLC~

and MAPK (40).

(46, 47) (48), PLA2 (49, 50), PI3 Kinase (51), GIRK channels (52)

In lower organisms such as Saccharomyces cerevisiae (53) and

Dictyostelium (54) the GJ3y subunit is the primary signal transducer. Recently, the beta
subunit in C. elegans was found to mediate mitotic spindle rotation in early
embryogenesis (55).

Gysubunits
Thirteen 0 gamma subunits have been identified (56), yet the functional roles of
these subunits have not been definitively resolved. By binding to the beta subunit, the
gamma subunits stabilize GJ3s.

Since

G~

8

is not modified by fatty acid, the lipid

modifications of the Gy subunit are thought to indirectly tether

GI3

to the plasma

membrane. Some evidence of Gy conferring receptor-effector specificity exists however
this may be a specialized function as opposed to a common rule (57).

The extensive

modifications of Gy subunits has led some to hypothesize that the thirteen y subunits and
all of the possible modified forms of those subunits play a role in signaling specificity
(57).

c. MECHANISMS OF G-PROTEIN SIGNALING
Receptor to G-protein to effector
The discovery of G-proteins provided proof for a direct link between extracellular
stimuli and intracellular responses.

Findings of various G-protein families and their

respective effectors, not to mention the myriad of cell surface receptors coupling to Gproteins, made it clear that this signaling motif was well-utilized by nature. Although
receptors, G-proteins and effectors can vary dramatically, the transduction of information
through G-protein signaling cascades uses many of the same core steps.

Generally,

activation of a cell surface receptor leads to nucleotide exchange on the alpha subunit,
thus activating the G-protein. Active G-proteins stimulate their effectors until GTPase
activity returns them to the inactive heterotrimer. Based on early G-protein research, the
emerging paradigm of G-protein signal transduction was that signaling information
transferred from receptors to G-proteins to effectors.

9

The ActivationIDeactivation Cycle of G-proteins
Measurements of the rates of G-protein activation were facilitated by the use of
guanine nucleotide analogs and radiolabeled probes (58-60). These studies allowed for a
detailed mechanism to be mapped for signal transduction through G-proteins (Figure
1.1). G-protein signaling is initiated by a stimulus dependent conformational change in a

G-protein coupled receptor (GPCR) (60). Some debate exists as to whether the G-protein
is pre-coupled to the un-stimulated receptor (61), or whether G-proteins are recruited to
activated receptors (62).

One receptor can activate multiple G-proteins (63, 64).

Regardless, the GPCR conformation change induces the inactive heterotrimer to undergo
nucleotide exchange. GDP bound to the alpha subunit dissociates leaving a temporary
empty state on the alpha subunit (65).

Since GTP is in vast excess over GDP, the

guanine nucleotide triphosphate that binds to the alpha subunit (66). Go. subunits bound
to GTP lose their affinity for receptor and for GJ3y heterodimers, and gain affinity for
their effectors (67, 68) GPy subunits do not undergo a change in conformation. Instead,
liberation from the heterotrimer allows GPy to engage effectors (69). Activation of Go.
effectors terminates when the intrinsic GTPase activity of the alpha subunit catalyzes
hydrolysis of the GTP gamma phosphate, thus returning Go. to the GDP bound state (6,
70, 71). The current model of GJ3y signaling suggests that when a free Ga.GDP complex
re-associates with GJ3y to form an inactive heterotrimer, the GJ3y signal is terminated (7072). Discrepancies in GTPase rates between purified G-proteins and membrane fractions
containing G-proteins were one of the first clues that other factors may be contributing to
signaling specificity.
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- - - - - - -.... GaGDPJiy

GPCR*
GaGTP + GJiy

t
Effectors

Figure 1.1 G-protein activation/deactivation cycle. Heterotrimeric G-proteins are activated
by agonist bound G-protein coupled receptors. Receptor stimulation of G-proteins causes the
alpha subunit to dissociate GOP from its nucleotide binding site, allowing for binding of GTP.
GTP-bound alpha subunits lose affinity for Gl3y heterodimers. Liberated Gl3r and GTP-bound
Go. act on effectors. The intrinsic GTPase activity of the alpha subunit hydrolyses the gamma
phosphate to return the alpha subunit to the GOP bound form. Gu-GOP and GPr then reassociate to form heterotrimers.
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III. ACCESSORY PROTEINS AND G-PROTEIN SIGNALING

Signals initiated by extracellular ligands often go through a tortuous path to
generate their specific cellular response.

In the case of G-protein mediated signals,

information is transferred from seven transmembrane span receptors to heterotrimeric Gproteins to effectors. Nature has employed this mode of transduction in many signaling
systems, using the myriad of GPCR, G-protein and effector combinations. However,
signaling specificity involves not only the selective activation of a particular effector. In
addition to selective effector activation, signaling specificity can be influenced by: 1) the
duration of signal, 2) the amplitude of signal, 3) the localization of signal and/or 4) the
cell-specific expression of signaling components.

While the many permutations of

receptor, G-protein and effector combinations confer a significant degree of specificity,
other factors beside the core components of G-protein signaling may be influencing
signaling specificity.

Thus, the identification and isolation of these factors tenned

accessory proteins has been a major area of interest in our laboratory.

A. DISCOVERY OF ACCESSORY PROTEINS

Early evidence for accessory proteins
Accessory proteins are factors other than receptor, G-protein or effector that can
modify signaling specificity of G-protein signaling pathways. Early reports of additional
factors influencing signaling specificity came from diverse areas of G-protein signaling.
Historically, accessory proteins to G-protein signaling were generally under-appreciated.
Their discovery was usually a serendipitous result of studies with G-protein signaling
12

systems. Benovic, working in Lefkowitz's laboratory, purified a protein that
phosphorylates f32-AR in the presence of agonist (73). This protein, BARK, is a member
of a family of six G-protein receptor kinases (GRKs) that act to initiate desensitization
and, in some cases, sequestration of most GPCRs. Another GPCR accessory protein, f3arrestin, was likewise discovered in the Lefkowitz laboratory (74).

Arrestins bind to

phosphorylated GPCRs, thereby uncoupling receptors from G-proteins and mediating
receptor sequestration (75).
Several alternate binding partners of G-proteins were discovered. Calmodulin
interacts with GJ3y and affects its regulation of AC (76). Enriched in growth cones of
neurons, neuromodulin or growth associated protein-43 (GAP-43) increases the rate of
GTPyS binding to the predominant G-protein in brain, Goa (77). In the retinal system,
phosducin negatively regulates signaling duration by sequestering Gf3y away from its
effector (78).

Another lead suggesting the existence of G-protein regulatory proteins

stemmed from observations of enhancement of Oa GTPase activity by PLC and cGMP
PDE (79, 80). Although both are known effectors, they provided the first evidence of
proteins that could affect the intrinsic GTPase rates of Ga subunits. One of the first
proteins known to affect the localization of G-protein signaling proteins was caveolin a
protein that forms subcellular structures in specialized cholesterol rich lipids (81, 82).
These lipid rafts are rich in a wide array of signaling proteins, including components of
G-protein signaling systems. Cross-linking studies from the Rodbell laboratory showed
that G-proteins interacted with F-actin and tubulin suggesting a link between the
cytoskeleton and heterotrimeric G-protein signaling (83). All these findings germinated
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the idea that G-protein signaling operated within the context of a complex of signaling
components that could determine signaling specificity.

The Search for Accessory Proteins
The numerous possible combinations afforded by the diversity of GPCRs, Gproteins and effectors imply that nature uses subtypes of the core signaling components
to generate signaling specificity. While this notion was implicit, Dr. Lanier's laboratory
was one of the earliest to examine factors that determine signaling specificity. This body
of work engendered the idea of accessory proteins to G-protein signaling.

Initially,

subtypes of the a.2-AR were examined for their ability to couple to different G-proteins
using Nlli-3T3 cells stably expressing a.2b, a,2c and a2d-ARs (84). Findings that a2cARs exhibited differential G-protein coupling and efficiency of signaling properties
compared with the other a.2-ARs (84) were complemented by the finding that the a2cAR preferentially coupled to Goa. subunits (85). The use of stable transfectants in both
studies as opposed to using reconstituted systems were in part prompted by the desire to
create a "natural environment model" (85). Lanier noted that cellular factors possibly
influencing receptor signaling might be lost in such reconstituted systems.
Continuing the investigation of factors contributing to signaling specificity, Duzic
and Lanier reported cell-specific coupling of a,2-ARs to adenylyl cyclase (86). NllI-3T3
and DDTI-MF2 cells expressing a.2-AR SUbtypes responded to epinephrine treatment
with AC inhibition. However, PC-12 cells expressing a,2-AR subtypes demonstrated a
dose-dependent increase of cAMP with epinephrine treatment. The calcium chelators
BAPTA and EGTA blocked a2-AR-niediated AC activation in PC-12 cells. Analysis
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indicated the expression of Ca++/CaM sensitive AC isoforms in PC-12 cells but not in
DDTl-:MF2 and NIH-3T3 cells. These findings suggested that one receptor sUbtype
could couple to different effectors.

Sato and co-workers generated a reconstitution

system using purified heterotrimeric G-proteins and membrane fractions from PC-12 and
NIH-3T3 stable transfectants (87).

G-protein activation was measured in membranes

from cells expressing the same receptor (a,2-AR) that were exposed to the same pool of
G-proteins. A 3-9 fold enhancement of pertussis toxin-sensitive G-protein activation was
found in PC-12 cells in comparison to the G-protein activation observed in NIH-3T3 cells
expressing the same receptor at the same receptor density. Speculating that PC-12 cells
contained an additional factor contributing to G-protein activation, Sato and co-workers
identified a detergent-soluble factor capable of stimulating GTPyS binding to G-proteins
that was present in PC-12 cells but not in NIH-3T3 cells. Thus, G-protein activation in
PC-12 cells could be modified by a non-receptor, non-G-protein factor. These findings
initiated the search for factors, termed "accessory proteins", distinct from receptor and Gproteins, that modify the transfer of signal from receptor to G-proteins or that modify Gproteins independent of receptor stimulation.

RGS Proteins
Regulators of G-protein Signaling (RGS) proteins are a family of Ga GTPase
Activating Protein or GAPs. Their presence and diversity throughout evolution suggests
that G-protein signaling is a favored motif that serves as a core upon which a complex set
of regulatory machinery is built. Their discovery ushered in a new understanding of how
signals through G-proteins are regulated, and confirmed the importance of accessory
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proteins. The first RGS proteins were discovered in the model organisms S. cerevisae and
C. elegans. Dohlman and co-workers found that SST2 (super sensitive to pheromone)
was a negative regulator of the G-protein mediated Saccharomyces cerevisiae pheromone
response cascade (88). In C. elegans, egl-10 was identified using a genetic screen as a
gene responsible for proper rate of egg laying (89). The suppressed rate of egg laying by

egl-10 mutants contrasted with the elevated levels of egg laying in Goa. (goa-l) mutants,
suggesting that egl-10 acted as a negative regulator of G-protein signaling (90, 91).
Analysis of the egl-10 sequence revealed significant similarity with portions of sst-2,
implying conservation of a protein domain responsible for G-protein regulation (89).
When GAIP, a mammalian protein identified as a Gia.3 interacting protein using the twohybrid method, was found to contain similarity to the shared regions of 'EGL-I0 and
SST2, a family of proteins was born (92).
The name regulator of G-protein signaling (RGS1) was given to a gene upregulated in lymphocytic leukemia. RGS 1 containied the 120 amino acid domain found
in GAIP, EGL-I0 and SST2 (93). The common domain became known as the RGS core
domain and was used a marker for putative G-protein regulators.

Currently 19

mammalian RGS proteins have been identified, largely based on the presence of the RGS
domain (94, 95).

Classification of accessory proteins
Accessory proteins refers to a collection of proteins distinct from receptor, Gprotein and effector that modify G-protein-mediated signaling events.

They can

generally be categorized into one or more of the following four groups: '1) receptor
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regulators, 2) signal propagators/integrators, 3) receptor binding proteins and 4) Gprotein binding proteins (Table 1.2). Receptor regulators are proteins that modify Gprotein-coupled receptors and in tum affect the signaling properties of the receptors.
Many of the receptor regulators are receptor kinases like GRKs (96), protein kinase AlC
(97) and casein kinase (98, 99). Another receptor regulator, arrestin, leads to
desensitization by binding to phosphorylated GPCRs (100). Other receptor regulators
include phosphatases (101) and the receptor transport and specificity co-factor RAMPs
(102).
The second group, signal propagators/integrators, contains proteins that either
confer specificity to signaling pathways or are required for the propagation of signal.
Two proteins, Calcyon and the CGRP component protein, represent signal-specifying
proteins.

Calcyon binding to the Dopamine D1 receptor can alter coupling of

downstream effectors (103). The CGRP component confers responsiveness to CGRP
(104). Signal propagators such as CRAC, Pianissimo, Rip3 and Aimless are required for
the transfer of signal between G-proteins and their effectors (105-108).
The third group contains a diverse set of proteins known to interact with Gprotein coupled receptors, although the purpose of some of the interactions has yet to be
determined. Some examples of receptor interacting proteins include calmodulin (109),
14-3-3 (110), endophilin (111) and spinophilin (112). Wu and co-workers discovered
that Gl3y binds to the third intracellular loop of m3 muscarinic receptors (113). AGS2, or
tctex1, interacts with the C-terminus of rhodopsin and mediate the trafficking of the
receptor (114).
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Group I Receptor Regulators
Arrestins
Casein Kinase
Coupling Cofactor
Phosphatases
Protein Kinase AlC
OPCR Kinases (ORKs)
RAMPs
Recoverin

Binds to phosphorylated receptor; signal termination
Phosphorylates M3 muscarinic receptor
Influences stability of receptor-O-protein complex
De-phosphorylate receptors
Phosphorylate selected receptors
Phosphorylate activated receptors
Regulate receptor traffickinglligand recognition
Inhibits rhodopsin kinase

Group
Aimless
Calc yon
CORP component
CRAC
ERK2
Homer
Inad
Pianissimo
RIP3
RSS

n Signal propagation/integration

Required for receptor coupling to AC (D. discoideum)
Binds to D 1 dopamine receptors; Ca signaling
Confers responsiveness to CGRP
Required for receptor coupling to AC (D. discoideum)
Required for receptor coupling to AC (D. discoideum)
Links IP3 receptor and metabotropic glutamate receptors
Rhodopsin; Multiple PDZ protein forms R-G-E complex
Required for receptor coupling to AC (D. discoideum)
Required for receptor coupling to AC (D. discoideum)
Enhances activity of 5HT2 receptors

Group ill Proteins that interact with receptor
14-3-3

a2AR-i3 loop; receptor localization

ABP280
ATRAP
Calmodulin
CortBPl
Endophilin

Crosslinks actin & D2 dopamine receptor i3 loop
AT1 receptor; interferes with PLC coupling
mGluR c-terminus and D2 dopamine receptor i3 loop
SSTR2 somatostatin receptor and actin binding protein
~1-AR; influences receptor internalization

O~y

i3 loop of M2R, M3R and a 2AR; C-terminus of mOluR

Orb2
Hsc73
Netrin
NHERF

D4 dopamine i3 loop; receptor internalization
Adenosine 1 receptor; interferes with R-G coupling
Adenosine 2b receptor ligand
J32AR c-terminus; mediates 132 control of H+/Na+ exchange

RhoA,ARF
Spinophilin
Shank
Tctex 1 (AGS2)

Co-immunoprecipitates with M3 muscarinic receptors
Crosslinks D2 dopamine receptor i3 loop, protein phosphatase 1
SSTR2 c-terminus; receptor localization
Rhodopsin c-tenninus; receptor trafficking

Table 1.2 Accessory Proteins for G-protein signaling.
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Group IV Proteins that interact with G.proteins
AGSI

Gia.; Increases GTPgS binding to Gi, Go

AGS2

GJ3y

AGS3

GilGt; GDI for Go. subunits

(3-app

Goa; C-terminus stimulates GTPyS binding to Goa.

BBP

Goa.; binds f3-app and mediates Goa activation

Bruton's tyrosine kinase

Gqa., G 12a., G(3y

Caveolin

Ga. subunits; N-tenninus inhibits GTPyS binding

Eya2

Gqa., Gia.

GAP-43

Goa.; stimulates GTPyS binding to Goa., enriched in growth cones

GRINl

Goa, Gza.; binds to activated Go. subunits

ORK2

Gqa., binds to activated Ga., contains RGS-like domain

LON

Gia.3, Gia.2, Goa; AGS3 family member

N uc1eobindin

Gia.3

P115RhoGEF

GI2a., GI3a.; Acts as effector and GAP

Pcp2

Gia.2 (ba.; GPR containing protein with GD I activity

Phosducin

GJ3y; impedes heterotrimer formation

PINS

Giloa; AGS3 family member, asymmetric cell divisions

PKC

Gza., GI2a.; phosphorylates Go. subunits

Presenilin -1

Goa.; C-terminus activates GTPyS binding to Goa.

Rap 1Gap

Goa, Gza., Gia.

RGS proteins

Gia, Gqa, GI2113a. families; Family of Ga. GAPs

Src

Gia, Gsa; activated by Ga. subunits

Syntaxin lA

G(3y

Tubulin

Gia.; Stimulates nucleotide exchange

Table 1.2 Accessory Proteins for G"protein signaling. (continued)
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The final group consists of G-protein interacting proteins. Some of these proteins
are only known to interact with G-protein subunits, but are not known to influence Gprotein activity. Proteins interacting with GJ3y include AGS2 (115), phosducin (78) and
syntaxin 1A (116). Compared to GJ3y binding proteins, Go; binding proteins are much
more prevalent. Proteins such as nucleobindin (117), eya2 (118) and Rap 1Gap (119)
interact with Go.; however, they are not known to influence the activation state of the
alpha subunit. The subset of proteins that can regulate the activation state of G-proteins
are classified as G-protein regulators.

The identification and characterization of G-

protein regulators is the major area of research in Dr. Lanier's laboratory and were the
focus of my efforts.

B. G-PROTEIN REGULATORS

G-protein regulators are the subset of accessory proteins that can influence the
activation-state of G-proteins independent of receptor stimulation. These proteins add
complexity by allowing non-receptor stimuli to influence G-protein signaling.
Monomeric G-proteins are predominantly regulated by proteins known as guanine
nucleotide exchange factors, GEFs, and GTPase activating proteins, GAPs (120). GEFs
generally activate monomeric G-proteins by inducing the formation of the GTP bound
state. GAPs act in contrast by catalyzing GTP hydrolysis, returning the monomeric Gprotein to the inactive or GDP bound state.

Therefore small G-protein activity is

regulated by opposing proteins, GEFs and GAPs.

Other factors such as guanine

nucleotide dissociation inhibitors (GDIs) have been described for small G-proteins (121).
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Heterotrimeric G-proteins are also regulated by GEFs and GAPs. Activated Gprotein coupled receptors act as GEFs for heterotrimeric G-protein. Ga subunits have
intrinsic GTPase activity, a feature not shared by small G-proteins. Therefore the alpha
subunit alone can act as a negative regulator of its own activity. However, another class
of proteins, the RGS family, functions as negative regulators of G-protein signaling.
They do not have GTPase activity, but can increase the rate of intrinsic GTPase activity.
Besides receptors, very few proteins have been shown to act as Ga GEFs. Likewise, few
proteins besides RGS or RGS-like proteins negatively regulate Ga activity.

The N-

terminus of caveolin 1 was reported to be a GD! for heterotrimeric G-protein, the first
such protein known (81); the corresponding region of caveolin 3 acts as a Ga GEF (82).

GTPase Activating Proteins- GAPS
Before the discovery of the RGS family, it was proposed that SST2 might act as a
Gpa1 GAP (88). Berman, working in Gilman's laboratory, demonstrated that GAIP and
RGS4 do not act as exchange factors but do stimulate the GTPase rates of purified Gia
subunits (122). The effect was not observed for Gsa. Subsequently, RGS proteins have
been shown to act as GAPs for Gqa (123), Gza (124, 125), Goa (89) and 012/130. (31).
A major physiological role of ROS proteins is speculated to be regulation of the
duration andlor amplitude of G-protein signaling cascades. Although the family of RGS
proteins contains a common 120 amino acid core domain, they can vary greatly outside
this region (Figure 1.2) (95).

Variation in RGS proteins likely generates specificity

among the family. RGS proteins such as SST2 and EGL-IO down-regulate G-protein
activity, but some RGS proteins in higher organisms are involved in fine-tuning of G-
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Figure 1.2 Mammalian RGS proteins. Left: A cladogram ,constructed from amino acid
sequence identities within the RGS domain defines five subfamilies RZ, R4, R7, R12, and RA.
The scale shows ,approximate amino acid identity calculated as 100% minus the sum of the
horizontal distance to and from the common branch point (e.g. 'axin and conductin are 64%
identical). All sequences are human except for RGS8 (rat), RGSZ2 (mouse)" and RET-RGSI
(bovine). Right: Most proteins within each subfamily are also ho~ologous in regions flanking
the RGS domain; homologies include definable functional domains shown as labeled blocks on
the diagrams of each protein's structure. Abbreviations: APC,. ~denomatous polyposis coli;
GGL, G-like; DEP, PDZ, and PTB, protein interaction domains; PP2A, protein phosphatase 2A.
Adapted from Ross, E.M. and Wilke, T. Annual Review of Biochemistry. 69: 795-827, 2000.
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protein signals. RGSS can accelerate not only the rate of GIRK channel activation, but
also the rate of inactivation, providing for a sharp response to GPCR agonists (126). A
sub-group of RGS proteins (RGS 6,7, 9, 11) can interact with

G~5

subunits through a

domain weakly similar to Gy subunits (127, 12S). Slepak and co-workers found that G~5
co-purified with RGS7 in cytosolic fractions of the retina (129). These findings were
supported when Siderovski and co-workers used computer ·prediction to find a domain
within RGS proteins containing similarity to Gy named the G-gamma like domain (GGL)
(12S). Proteins in this subgroup of RGS proteins form heterodimers with
thereby

raising

interesting

questions

about

signaling

through

G~5

subunits,

non-traditional

heterotrimers. RGS12 and RGS14 are the largest RGS proteins with several distinct
protein motifs including the GoLoco or GPR domain (115, 130). After the initial RGS
proteins were isolated, the remainder of the family was discovered based upon the
conserved RGS core domain. Lowering the stringency of search parameters, several
groups found RGS-like domains in some interesting proteins.

Non-RGS GAPS
G-proteins GAPs are not limited to the RGS family. Before the RGS proteins
were discovered, several factors were known to have GAP activity. Some of the earliest
known Ga. GAPS were in fact effectors. As mentioned before, the Gq effector PLC-13
and the Gta. effector cGMP PDE (79, SO) were described to have GAP activity. Recently
the Ga.12/13 effector p115RhoGEF was shown to have GAP activity for Ga.13 (31).
Closer inspection of both PLC-13 and p115RhoGEF sequences revealed regions
corresponding to Ga. binding domains with weak similarity to the RGS domain (31, 95).
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These domains have recently been dubbed RGS-like or RGL domains (95).

Other

proteins with this domain include GRK2, GRK3 (131, 132), axin (133) and conducin
(134); however, the latter two proteins do not have GAP activity for Ga subunits.
Neither GAP activity nor a RGL domain was detected in cGMP PDE.

The gamma

subunit of cGMP PDE stimulates the activity of a RGS9-GJ35 heterodimer thus indirectly
stimulating GTPase activity of Gta (135).

The existence of effectors having GAP

activity blurs the distinction between core signaling components and G-protein
regulators.

Effector-GAPs themselves provide a degree of signaling specificity by

regulating the conversion of signal from G-protein to effector.

In these signaling

pathways, one activated G-protein presumably activates one effector molecule and is then
inactivated, providing for rapid responses to signal termination.

Heterotrimeric G-protein GEFs, Guanine nucleotide exchange factors
Heterotrimeric G-protein GEFs stimulate the exchange of GDP for GTP on Ga
subunits. The most predominant group of Ga GEFs is agonist bound G-protein coupled
receptors. However, since they are core components of G-protein signaling, they do not
qualify as accessory proteins. Reports of non-receptor Ga. GEFs are relatively sporadic
as compared to those of Ga. GAPs,. A handful of proteins have been described as GEFs,
but do not share any sequence simllarity. The most well-known Oa GEF is GAP-43, or
neuromodulin.

OAP-43 co-localizes with and activates Goa. in neurons (77). The

cytoskeletal protein tubulin is a G-protein GEF for Gin (136, 137).

Two proteins

involved in familial Alzheimer's disease, J3-amyloid precursor protein (138) and
presenilin-l (139), are G-protein OEFs. The cytoplasmic tails of both proteins activate
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the major brain G-protein, Goa. Recently BBPs (f3-amyloid binding proteins), a family of
GEFs, were identified as cofactors in f3-APP-mediated activation of Goa.

Based on

homology searches, BBPs displayed significant similarity with the second intraceillar
loop of GPCRs (140).

Non-OPCR mediated extracellular signals acting through Ga

activating proteins could function through cross-talk with G-proteins. Signals initiated
within the cell might stimulate Go. GEFs, leading to G-protein cascades. G-proteins
activated by GEFs might behave or couple differently than those activated by G-proteincoupled receptors. GEFs might act in concert with GPCRs to provide a synergistic effect
of Ga activation. Basal G-protein activity might also be mediated by GEFs. These
intriguing possibilities, along with the relatively few numbers of OEFs reported in the
literature, stimulated the search for G-protein activators by our laboratory.

Our

development of a biochemical assay to detect G-protein activators facilitated the
discovery of a novel G-protein GEF, the NO-108 activator.

IV. IDENTIFICATION OF G-PROTEIN ACTIVATORS

A. BIOCHEMICAL SCREEN FOR G-PROTEIN ACTIVATORS
The discovery of G-protein regulators, and in particular non-receptor G-protein
activators, has been a major focus of study in Dr. Lanier's laboratory.

Initial

observations of G-protein activators came from work led by Sato describing a factor in
PC-12 membranes capable of stimulating GTPyS binding to G-proteins (87). Sato then
extended his search by analyzing membranes from several cell lines (141). Detergentsolubilized membranes from NG-108 cells were capable of stimulating GTPyS binding to
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brain O-proteins up to 4-fold. PC-12 membranes increased GTPyS binding by -1.5 fold.
Membranes from Nlli-3T3 and C6B4 cells did not show appreciable activation of OTPyS
binding.

Characterization of the NG-I08 activator revealed that it was distinct the

following G-protein OEFs: neuromodulin, tubulin, caveolin and f3-amyloid precursor
protein. The NG-I08 activator activated both Goa and purified bovine brain heterotrimer
with greater efficiency than Gin. Activity of the NO-I08 activator is pertussis toxininsensitive suggesting that it uses an alternate mechanism of O-protein activation
compared to O-protein coupled receptors (C. Ribas personal communication). Ribas
sought to purify the factor responsible for O-protein activation, but only resolved the
activity to 4-5 proteins.

Currently, efforts are underway to sequence protein bands

isolated from SDS-PAGE of the purified fractions.

Limited success with partial

purification of the NG-I08 activator led our group to search for alternative methods to
purify the protein responsible for G-protein activation.

B. YEAST EXPRESSION CLONING SCREEN
Takesono and Lanier initiated a collaboration with Cadus Pharmaceutical
Company in Tarrytown, New York in hopes of identifying the NO-I08 activator. Cadus
specialized in custom yeast strains designed for analysis of G-protein mediated signaling.
The knowledge of the yeast genome and the ease of genetic manipulation made

Saccharomyces cerevisiae an attractive model organism to use. In addition the O-protein
coupled pheromone response pathway in yeast is well-defined and relatively simple
(Figure 1.3). The goal was to screen a cDNA library from NO-lOS cells for entities that
could activate O-protein signaling pathways at the level of O-proteins. These proteins
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Figure 1.3 Pheromone response pathway and the Saccharomyces cereVlswe expression
cloning system. ' The above panel depicts the pheromone . response pathway ' used by
Saccharomyces cerevisiae. ' The bottom panel includes ' the modifications used to identify
receptor-independent activators of G-protein signaling. The strahl shown in the bottom. panel
lacks the pheromone receptor, and contains a modified mammalian' G-protein, Gia2Gpal(I-41),
in the place of the endogenous Gpal. Downstream activation of the pathway was altered by
knocking out the transcription factor Farl and introducing a FUSl::HIS3 transgene. Activation
of the pathway would therefore result in HIS3 production confering nutritional selection.
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also needed to able to activate G-proteins independent of receptor stimulation.

To

accomplish this goal, several modifications were made to components of the pheromone
response pathway (Figure 1.3) (142). The pheromone receptor and the endogenous Ga
protein, GPA-l, were knocked out. A mammalian-yeast chimeric G-protein containing
the first 41 amino acids of GPA-l and amino acids 42-351 of human Gia2 was
introduced. The chimera allowed a more efficient heterotrimer to form. Downstream
activation of the pathway normally stimulated growth arrest and mating preparation by
activating the transcription factor, Par-I. To tailor the system, a Fusl promoter-His3
transgene was introduced into farl- his3- yeast strains. Activation of the system would
therefore induce expression of His3 and confer activation-dependent selection. Thus,
activation of the pheromone response in the modified yeast system resulted in histidine
selective growth. The eDNA library vector, pYES2, contained a galactose-inducible
promoter to allow for induction of library expression.
Takesono and co-workers generated a eDNA library from NG-I08 cells and
transformed this into the modified yeast strain. After a series of selections and replica
plating, three clones were isolated: #34, #37 and #53.

Epistasis experiments were

performed to evaluate where these clones acted in the pheromone response pathway.
Clones #37 and #53, but not clone #34, were shown to activate the system at, or upstream
of, G-proteins (115). In a similar screen of a human liver eDNA library, a eDNA capable
of activating the system at, or upstream of, G-proteins was isolated (143). This protein
was named AGSI for Activator of G-protein Signaling 1. Clones #37 and #53 from the
NG-I08 screen were named AGS2 and AGS3, respectively.
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c. AGS PROTEINS
AGS proteins are a group of proteins isolated in a genetic screen selecting for
activators of G-protein signaling.

Analysis of AGS primary sequences revealed no

structural similarity among the three proteins; likewise further analysis using the yeast
system showed that each AOS protein utilized a distinct mechanism of G-protein
activation.

Using different On subunits in the initial screen, AGS1 and AOS3

preferentially activated Gin2 and Gin3 subunits, while AGS2 did not show any
preference for any particular On subunit (Figure 1.4). Since G-protein activation is
typically mediated through nucleotide exchange, a Gia2 mutant (G204A) incapable of
binding GTP was introduced into the system to determine if Gn activation was required
for each protein. Likewise, AGS activity was tested in strains over-expressing the Ou
GAP, ROS4, to verify the requirement of On activation.

Interestingly, only AOS1

activity was abolished in both the 0204A and RGS4 strains, suggesting that AOS2 and
AGS3 activated G-proteins by a mechanism distinct from nucleotide exchange (Figure

1.5, data not shown for AOS1) (115). Therefore, each AOS protein displayed a distinct
mechanism of action in the yeast system. AOS 1 activated Gia2 and Gia3 heterotrimers
and putatively activated the system by stimulating nucleotide exchange. AGS2 did not
have a preference for On activation, nor did AOS2 utilize nucleotide exchange for Gprotein activation.

AOS3 stimulated Gin2 and Gia3 subunits and did so without

requiring nucleotide exchange. When I entered the Lanier laboratory, this data had just
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Figure 1.5 Mechanisms of G-protein activation by AGS3. The expression cloning system was modified to test the effects of
RGS over-expression and a guanine nucleotide binding-deficient Gia2 (G204A) on AGS activity. Protein expression was
confirmed by immunoblotting. AGS2, AGS3 and empty vector pYes2 were evaluated in three yeast strains: WT, G204A Gia2,
RGS4. WT - wild type strain containing Gia2 as described for the original yeast screen. G204A Gia2: Yeast expression cloning
system expressing a nucleotide binding deficient Gia2 subunit. RGS4: yeast expression cloning system overexpressing RGS4.
Control plates represent growth on non-selective media. Selection plates are deficient in histidine. Expression of pYes2 inserts is
regulated by a galactose inducable promoter. Non-induced and induced are plates containing glucose and galactose respectively.
Similar results were obtained in three experiments.

been generated. Since AGS1 was discovered in a screen initiated by Cadus, I initially
focused upon characterization of AGS2 and AGS3 outside of the yeast system.

AGSI
AGS 1 was isolated in the yeast expression cloning system as a 843 nt cDNA.
Sequence analysis of AGSI revealed strong homology with the family of small GTPbinding proteins. AGS1 had previously been reported as Dex-Ras, a small G-protein upregulated by dexamethasone treatment (144). AGSI shared the PhosphatelMagnesium
(PM) and guanine nucleotide ring binding domains (G) of other small G-proteins, but
AGS 1 also contained unique sequences not detected in these related proteins. Cationic
inserts near the C-terminus and modifications in the PM! region distinguish AGS 1 from
other small G-proteins. The discovery of AGSI as a G-protein activator was significant
since no small G-protein had been described to interact with or directly influence Gprotein signaling. Cismowski and co-workers demonstrated that AGS 1 could directly
interact with Gia.2 subunits. Ribas contributed the finding that AGS 1 could increase
GTPyS binding to G-proteins. Therefore AGSI is a G-protein GEF, supporting the
hypothesis generated by the initial yeast data.

AGSI activates a GrYi-mediated MAP

kinase pathway in a pertussis toxin-sensitive manner, confinning the G-protein activating
activity of AGS1 (143). Recently, AGS1 was isolated in a yeast two-hybrid screen with
CAPON, a protein involved in nNOS signal transduction (145). Since NMDA-mediated
activation of MAPK is pertussis toxin-sensitive, AGS1 may be involved in cross-talk
between

NMDA

signaling

and G-protein

observations).
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AGS2
AGS2 was isolated as a 770 nt eDNA encoding a previously described protein,
tctex-l. Tctex-l was discovered in the mouse genome as a component of the t-complex,
a cluster of genes that when mutated cause sterility and sperm defects (146). Tctex-l and
its family member tctex-2 are light chains of the cytoplasmic motor protein dynein (147).
Tctex-l binds to the intermediate chain of dynein and plays an unknown role in dynein
function. AGS2 (tctex-l) was different from the other AGS proteins since it did not have
a preference for the type of Gu subunits used in the yeast system. This was explained by
interaction studies demonstrating binding of AGS2 to GJ3y subunits (115). The proposed
mechanism of AGS2 in the yeast system was speculated to involve subunit dissociation.
In this model, AGS2 would bind and liberate

G~y

subunits from Gn subunits without

initiating nucleotide exchange. Gl3y free from the alpha subunit could then activate the
pheromone response pathway despite the presence of AGS2. This mechanism was never
confirmed outside of the yeast system. AGS2 or Tctex-l was isolated in several yeast
two-hybrid screens. AGS2 was reported as a binding partner for Doc (148), Fyn (149)
and interestingly for the C-terminus of rhodopsin (150). The rhodopsin report describes
AGS2 as a facilitator of receptor trafficking within rod cells, classifying it as an
accessory protein acting at the level of receptor. Whether Gl3y was involved in this
process was not addressed.
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AGS3

AOS3 was discovered as a -1500 nucleotide cDNA encoding a novel protein.
Sequence analysis at the nucleotide level indicated that AGS3 was homologous to a
human cDNA, LON, and a mouse cDNA of unknown function, L23316. The C-terminal
735 nt of LGN were isolated in a two-hybrid screen using Gia2 as bait (151). Aya
Takesono demonstrated that the first 490 nucleotides of AGS3 retained activity in the
yeast system.

Before further characterizing AGS3, the protein product of AGS3

conferring activity in the yeast system needed to be identified since two potential reading
frames existed.

At this point, I began my work with AGS3.

Using site-directed

mutagenesis, silent mutations were engineered into the AGS3 sequence (Figure 1.6A).
Two frame one mutants, Silla (Q6-Stop) and Sillb (Q37-Stop), terminated frame one
prematurely but kept frame two intact.

Sil2, the frame two mutant (LIS-Stop),

terminated frame two prematurely but kept frame one intact. When analyzed in the yeast
system, the frame one mutants, but not the frame two mutant, lost activity (Figure 1.6B).
Therefore the active product of AGS3 was a 74 amino acid protein encoded by frame one
(255 bp). Analysis by immunblotting of protein products of wild type and frame two
mutants confirmed that AGS3-framel was being expressed (Figure 1.6C). AGS3 was
subcloned into a GST fusion protein vector.

The GST-AGS3 fusion protein was

produced in bacteria and purified. GST pull down assays performed with purified his
tagged Gia,2 demonstrated that AGS3 interacted with Ga. subunits, and that this
interaction was nucleotide-dependent (Figure 1.7) (115).
BLAST analysis of the AGS3 protein product revealed a group of proteins that
shared a common amino acid sequence motif with AGS3. Proteins in this group that
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Figure 1.6 Identification of the bioactive peptide encoded by AGS3. The original AGS3 cDNA isolated in the yeast screen was
truncated at its 3' end to generate AGS3-490. The 3' truncation of AGS3 did not alter the bioactivity of the cDNA. Site-directed
mutants were generated in the AGS3-490 construct. The frame 2 mutation T60A inserted a stop codon at L15 without altering the
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identify the bioactive peptide sequence. Extracts were prepared from yeast transformants and evaluated for expression of the frame
1 peptide by immunoblotting. Similar results were obtained in three experiments using different yeast extracts.
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Figure 1.7 Interaction of AGS3 with Ga subunits. AGS3-CT and AGS2 were generated as GST-fusion proteins in bacteria and
purified using a glutathione affinity matrix. GST -AGS3-CT and GST -AGS2 fusion proteins were incubated with G-protein
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detected on membrane transfers using anti -Xpress antisera (Invitrogen). Input refers to 20 J.lI of the incubation mixture. The
results presented are representative of four separate experiments. The GST -AGS3 fusion protein was functionally similar to the
original AGS3 isolate in terms of its ability to promote growth.

were not detected by the nucleotide homology search included a predicted C. elegans
protein, Pcp-2 (152), RGS12 (153), ROS14 (153) and Rap1-GAP (119). In addition to
LGN, RGS12 and RGS14 were known to interact with Go; subunits, suggesting a
conserved function for the shared motif, (153).

Also of interest was that LON and

L23316 contained four repeats of this motif whereas AGS3 contained amino acids
corresponding to parts of the third and the complete fourth repeat of both proteins. These
findings suggested that the AGS3 sequence isolated in the yeast system might represent
the carboxy terminus of a larger protein. Using cDNA library screening and 5'RACE, a 2
kb rat AGS3 cDNA was identified. These studies showed that the sequence isolated in
the yeast system was the 74 amino acid carboxy terminus of a 650 amino acid protein.
From this point I will refer to the 650 amino acid protein as AGS3, and to the 74 amino
acid protein (M577-S650) as AGS-CT (AGS3- Carboxy Terminus). The focus of my
dissertation will be the structural and functional characterization of AGS3.
Sequence analysis of AGS3 revealed two distinct protein repeats separated by a
100 amino acid linker (Figure 1.8). In the N-terminus, seven tetratricopeptide repeats
(TPRs) were detected. TPRs are 34 amino acid motifs found in over 400 proteins (154).
The TPR motif is highly degenerate with only eight of the thirty-four amino acids
defining the repeat (154). TPRs, which are involved in protein-protein interactions, are
generally found in tandem in copies ranging from 3 to 16 per protein. The

presenc~

of

TPRs in AGS3 did not suggest an interaction existed with any particular protein, but
rather that this region was a site for protein-protein interactions.

Four unclassified

repeats were detected in the C-terminus. For reasons to be described later, we named this
motif the G-protein regulatory (GPR) domain (115). GPRs were also discovered by
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Figure 1.8 Sequence alignment of AGS3 and related proteins. Full-length rat AGS3 (AAF08683) was aligned with the human
LGN protein (AAB40385), the D. melanogaster PINS protein (AAF36967) and the C. elegans protein (CE) (AAA81387) by
PILEUP (University of Wisconsin GCG program) and visual adjustment. Amino acid sequence similarity and identity are indicated
below the four sequences by + or residue, respectively. The shaded and lined sequences represent the tetratricopeptide repeat motifs
(TPR I-VII) and a repeated segment of amino acids (GPR I-IV). The amino terminus half of the AGS3 contains seven
tetratricopeptide repeats (TPRs). With the exception of PINS, each protein contains four GPR repeats in their C-terminus. PINS
contains three GPRs with highest homology to GPRs I, III, and IV of AGS3, LGN and CEo

computer search as the GoLoco domain and were speculated to function as exchange
factors for Giloa subunits in the D. melanogaster RGS protein, loco (130).

The

characterization of the GPR domain will be addressed at length in the following chapters.
AGS3 shares similarity with many proteins through its TPR and/or GPR domains.
Therefore, we classified AGS3 family members as those proteins with both N-terminal
TPRs and C-terminal GPRs (Figure 1.9). At the time of the discovery of AGS3, very
little was known about the function of AGS3 family members. My research was directed
at uncovering the structure/function relationship of AGS3 and, in particular, how AGS3
activated G-proteins. During the course of my study, the discovery of an AGS3 family
member in Drosophila melanogaster offered initial clues about this protein family.

v. ASSYMETRIC CELL DIVISION AND CELL POLARITY
During the course of my research, PINS, the AGS3 homolog in Drosophila

melanogaster, was functionally characterized. Each group reporting the discovery of
PINS identified it as a required component of a polarity/asymmetry complex in

Drosophila neuroblasts (155, 156). PINS, or Partner of Inscuteable, is associated with
Inscuteable in the apical membranes of delaminating neuroblasts. PINS, Inscuteable and
Bazooka are key interdependent components that set apica1/basal polarity and direct
asymmetric cell division in neuroblasts. Asymmetric divisions give rise to basal ganglion
mother cells (GMes) and to apical neuroblasts (157, 158). Neuroblasts can undergo
additional rounds. of asymmetric divisions to form more GMCs.

GMCs themselves

asymmetrically divide to generate a pair of distinct neurons. The co-localization of the
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Figure 1.9 AGS3 family members. AGS3 family members are proteins that contain both N-terminal TPRs (black) and Cterminal GPRs (gray). AGS3 (AFI07723) has two family members in the human genome, LGN (U54999; 66% overall
similarity) and Human AGS3 (AL543750, AI272212, 96% similarity). Human AGS3 is a predicted gene pieced together from
Genbank and Celera genome project entries. Genbank entries also predict family members in mouse (AGS3 homolog L23316
and others (-99%); LGN homolog AA543923 (-82%)), Japanese bony fish (AU168949), zebrafish (AI629073), puffer fish
(AL338846), chick (AL584215), pig (BF442904, BF079490), cow (BF655288, BF750988), fruit fly (PINS or Rapsynoid;
AF242203), nematode (AGS3-CE; U40409) and Xenopus (AW460360, BG234747) genomes.

Ga. binding protein PINS with polarity/asymmetry proteins has some interesting
implications for how the complex sets cell polarity. Recently, a flurry of reports has
added new proteins

to this complex.

The reports

also

indicate that the

polarity/asymmetry complex is highly conserved from C. elegans to D. melanogaster,
and to some extent in mammals. In C. elegans, heterotrimeric G-proteins were recently
shown to influence the proper rotation of the mitotic spindle in one- and two-cell
embryos. If the polarity/asymmetry complex is conserved throughout evolution, then
knowledge about PINS and its binding partners will help to define the function of AGS3.

A. DETERMINANTS OF CELL POLARITY AND ASSYMETRIC DIVISION
A fundamental question in the field of developmental biology is how asymmetric
cell divisions occur. Asymmetric division of a precursor cell generates two distinct cells,
leading to specialization and eventually differentiation.

For asymmetric divisions to

occur, proteins or RNA must themselves be asymmetrically localized.

When cell

divisions occur, the cytoskeleton must respond to cues from the opposing poles to
generate daughter cells of different sizes. The mitotic spindle must be properly oriented
to properly place asymmetric factors in the appropriate daughter cell. Model organisms
such as the fruit fly Drosophila melanogaster and the nematode Caenorhabditus elegans
have led the way in the study of development and therefore asymmetric cell divisions.
Since PINS is a determinant of cell polarity in the developing fruit fly nervous system,
the following section will focus on proteins involved in asymmetric divisions of

Drosophila neuroblasts.
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Bazooka
Bazooka was isolated as a gene required for maintaining polarized blastoderm
epithelium (159).

During neuroblast formation, a cell migrates out from the

neuroepithelial sheet to the basal surface of the neuroepithelium. As the cell leaves the
epithelial sheet, it buds out on the basal side. This process is known as delamination and
is illustrated in Figure 1.10. Bazooka is apically localized in the neuroepithelial layer
and maintains this localization as the· neuroblast delaminates.

Subsequent reports

revealed that Bazooka recruits Inscuteable to apical membranes of delaminating
neuroblasts (160-162). Bazooka therefore was designated an apical cue for Inscuteable
localization, suggesting that Bazooka acts upstream of Inscuteable (162). However, once
the neuroblast has delaminated, Bazooka localization is disrupted in Inscuteable and
PINS mutants (155, 156).
One purpose of maintaining cell polarity is to direct the proper orientation of the
mitotic spindle. In epithelial cell layers, cell division occurs in the plane of the sheet.
When neuroblasts delaminate, the mitotic spindle must be rotated by 90 degrees relative
to the axis of division of the epithelial sheet (157, 158). Cell division of neuroblasts
occurs along the apicallbasal axis. Bazooka mutants fail to rotate the mitotic spindle to
the proper orientation (160). Whether this effect is directly attributable to Bazooka, or
whether Bazooka acts on the mitotic spindle through proteins such as Inscuteable and
PINS, is unknown. Since Bazooka is present in both epithelial cells and in neuroblasts,
some have speculated that Bazooka sets polarity, but does not directly influence mitotic
spindle rotation (161, 162).
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Figure 1.10 Neuroblast delamination and asymmetric division . . The left panel depicts the localization of the BazookalPar6/aPKC complex (blue), inscuteable (yellow) and PINS (red) during delamination and cell division. As neuroblasts delaminate
out of the epithelial layer their apical membrane stays in contact with the basal surface of the epithelium. Before delamination the
Bazooka complex is apically localized whereas INSC and PINS are not. During early stages of delamination, inscuteable and
PINS are localized to the apical crescent. After the neuroblast has delaminated all three proteIns are interdependent .for proper
localizqtion to the apical crescent. In late stages of cell division, the amount of inscuteable and ' PINS at the apical .membrane is.
diminished. .Once the ganglion mother cell has divided, the neuroblast can undergo more asymmetric divisions. The right panel
shows the corresponding orientation of the mitotic spindle during those processes.

Inscuteable
Inscuteable was discovered as a gene that was up-regulated during periods of
neuroblast differentiation and migration (163). Analysis of Inscuteable expression and
sequence suggested that the protein was a putative cytoskeletal adapter. Five ankyrinlike repeats were detected, supporting this hypothesis. In the same year, Inscuteable was
implicated as a key determinant of asymmetric divisions in Drosophila neuroblasts (164).
Inscuteable mutants failed to properly orient the mitotic spindle during neuroblast
delamination. When Inscuteable was ectopically expressed in epithelial cells, the mitotic
spindle was re-oriented (164). Two proteins, Numb and Propero, normally localized to
basal membranes during delamination, were distributed throughout the cell in inscneuroblasts (164). Numb is a PTB protein possibly involved in setting basal polarity and
inhibiting Notch signaling (165). Pro spero , a homeo-domain containing transcription
factor, likely directs neuron-specific expression (165-167). Another protein, Miranda,
was also shown to be directed to basal crescents by Inscuteable (168-170). Miranda is an
adapter protein, linking Inscuteable to the localization of Prospero and Staufen (169).
Although Inscuteable mutants displayed mislocalization of asymmetrically distributed
proteins, there was no effect on cell size (171).
Bazooka provides the apical cue for Inscuteable localization (161, 162).
Inscuteable was not detected in the neuroepithelium, but was present during, or just after,
delamination (164, 172). Since Bazooka mutantions result in a cytosolic distribution of
Inscuteable, translocation of Inscuteable presumably initiates the basal localization of
downstream factors (162).

However, Inscuteable knockouts also display incorrect
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localization of Bazooka in neuroblasts (161). Some disagreement exists about the precise
relationship between Inscuteable and Bazooka. Generally Bazooka is thought to playa
polarity-setting role. Inscuteable, once at the membrane, appears to help in maintaining
polarity while directing the localization of several proteins.
Inscuteable is unique among polarity/asymmetry proteins since it does not have
any counterpart in the C. elegans or mammalian genomes. Sequence analysis detects five
regions with weak homology to ankyrin repeats; the rest of the sequence has no
homology to known proteins (163). Using deletion analysis, Knoblich localized a region
of Inscuteable capable of directing protein localization and maintaining cell polarity
(172). This region, which contained the five ankyrin repeats, was used to search for
Inscuteable binding partners.

PINS, partner of Inscuteable
Using a two-hybrid screen with the ankyrin repeat region of Inscuteable as bait
the AGS3 homolog Partner of Inscuteable (PINS) was discovered (156). Another group
found a 70-kDa protein, later identified as PINS, in a preparative immunoprecipitation
using the same asymmetry domain of Inscuteable (ISS). Two-hybrid screening with the
Drosophila Gin as bait yielded the discovery of "rapsynoid" (pINS) by a third group
(173). PINS was found in delaminated neuroblast apical crescents, consistent with the
distribution of Inscuteable and Bazooka. The phenotype of PINS mutants essentially
mimicked that of Inscuteable mutants. Loss of PINS function resulted in mislocalization
of Inscuteable and Bazooka during cell division. Bazooka localization was only affected
after the neuroblast delaminated (156). PINS mutants displayed the same spindle rotation
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defect found in Inscuteable mutants (155, 156). Proteins downstream of Inscuteable,
such as Miranda and PON, were mislocalized in PINS mutants (156). Yu and co-workers
noted that daughter neurons of GMCs in pins- animals were symmetric, as evidenced by
expression of Eve (156). In wild type animals Eve expression is limited to one daughter
neuron (174). Parmentier discovered that pins- neuroblasts divided symmetrically (173).
The proper hierarchy of polarity/asymmetry proteins is still debatable.

Both groups

contend that PINS acts downstream of Inscuteable based on genetic and expression
studies. To that hypothesis, Parmentier adds the possibility that PINS and Inscuteable
may simultaneously arrive at apical membranes to elicit asymmetric division and
asymmetric direction of proteins, respectively, but that they are independently required to
maintain cell polarity.
Two of the three groups studying PINS demonstrated that PINS interacts with
Giloa subunits (155, 173). Schaefer and co-workers localized the Gu binding domain to
the C-terminus of PINS, a region containing three GPRs. Both groups restricted the
Inscuteable-binding domain on PINS to the N-terminal TPRs (155, 156). The region of
Inscuteable responsible for PINS interactions is confined to the asymmetry domain or
ankyrin repeat domain.

Despite the preparative immunoprecipitation used to isolate

AGS3, all demonstrations of Gia interacting with polarity/asymmetry components were
performed in vitro.

Localization of heterotrimeric G-proteins during neuroblast

delamination was not evaluated. Both groups presented PINS as a mosaic protein linking
G-proteins to the polarity/asymmetry complex.

Each group also agreed that PINS,

Inscuteable and Bazooka become interdependent once neuroblasts enter prophase. Their
findings imply that Inscuteable has a dual function: a) directing basally localized proteins
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and b) recruiting PINS to apical membranes. If PINS requires only Inscuteable to get to
apical membranes, then some interesting issues arise. Inscuteable has no homologs in
any other organism whose genome has been completed (C. elegans, H sapiens, etc.), nor
does Inscuteable share homology with any sequences yet entered in the Genbank
database. If PINS homologs play similar roles in their respective organisms, then they
may utilize Inscuteable-independent mechanisms to arrive at apical membranes (173).
The mechanism by which PINS arrives at the membrane is still poorly
understood.

PINS is detected in the cytosol of neuro-epithelial cells, and arrives at

neuroblast apical crescent during prophase, after the neuroblast delaminates (155).
Bazooka is expressed at apical membranes before, during and after delamination.
Inscuteable is not detected in the neuroepithelium (161, 162). Inscuteable expression is
believed to be up-regulated at the time of delamination (163).

PINS distribution in

Inscuteable mutants is cytosolic, suggesting that translocation of PINS to the membrane
is triggered by expression of Inscuteable (156). Ectopic expression of Inscuteable in the
neuroepithelium leads to mitotic spindle rotation and asymmetric division (163),
supporting this hypothesis.

B. POLARITY/ASYMMETRY COMPLEX
Very soon after PINS was discovered, several more proteins were added to the
polarity/asymmetry complex. The new information has revealed a striking similarity
between D. melanogaster neuroblast division and divisions of the on- cell stage in C.

elegans. Some of the components play roles in setting mammalian epithelial polarity.
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Figure 1.11 depicts the polarity/asymmetry complex, and Table 1.3 summarizes polarity
and asymmetry determinants found in C. elegans, D. melanogaster and M. musculus.

BazookalaPKClPar-6
Bazooka transfers apical polarity from neuroepithelial cells to neuroblasts.
Recent findings suggest that two additional D. melanogaster proteins, atypical Protein
Kinase C (DaPKC) and DmPar-6, co-localize with Bazooka before, during and after
neuroblast delamination (175, 176). All three proteins are found in apical membranes of
epithelial cells and neuroblasts, where they are interdependent for apical localization
(158).

The complex at apical crescents is maintained from late interphase until late

anaphase .(157). When the neuroblast starts an additional round of division, the complex
is re-established at the apical pole. Bazooka homologs in C. elegans (par-3) and M.

musculus (ASIP) have been described.

Par-3 is one of six partitioning defect genes

identified as factors in the asymmetric division of one-cell embryos (177). Par-3 and Par6 are anteriorly localized in the one-cell embryo (177,178). Some Par proteins, such as
Par-4, are not anteriorly localized. Par-4 acts by affecting the localization of Par-3 and
Par-6 (179). The C. elegans homolog of DaPKe, PKC3, is also required for proper
asymmetric divisions of one-cell C. elegans embryos (180). As observed in Drosophila
neuroblasts, all three proteins are interdependent for proper polarity and division (179).
ASIP, atypical PKC isoform-specific interacting protein, was identified as a component
of tight junctions that interacted with atypical Protein Kinase C lambda (A) and zeta

(~)

(181). Also present in this complex is the mammalian homolog of Par-6, mPar-6 (182,
183). ASIP coordinates the complex by interacting with both mPar-6 and PKCA, which
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c. elegans

D. melanogaster

M. ·musculus
Figure 1.11 Polarity/asymmetry complex. Members of the polarity /complex from three
species ·are represented .in corresponding colors. Top- C. elegans, Middle- D. f!lel(,lnogaster,
Bottom: M. musculus. Proteins with bold borders have be'en showp. experimentally to function
in asymmetric divisions and/or maintaining polarity. In . different species, the' complex is
detected in different ·stages of development and/or cell type.' C. elegans- one cell stage; D.
melanogaster- neuroblast; M. musculus- epithelial cell tight junctions. Interactions between
proteins are noted by overlaps . . Question marks indicate that no homolog is detected for that
species in available databases.
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c. elegans

D. melanogaster

M. musculus

Function

Par-3

Bazooka

ASIP

Sets & maintains apical polarity

Par-6

dPar-6

mPar-6

Sets & maintains apical polarity

PKC3

aPKC

PKCIJ~

Sets & maintains apical polarity

CDC42

CDC42

CDC42

Sets & maintains apical polarity

No homolog in
genome

Inscuteable

No homolog in
genome

Directs basal localization; Rotates
mitotic spindle; Recruits PINS

AGS3-CE

PINS

AGS3

Similar to Insc; Maintains apical
polarity; Recruits Giloa

Gia

Gia

Gia

Recruited to apical complex
(Dm); Sets spindle in one cell
stage (Ce)

Gp

G~

G~

Directs spindle rotation in one
cell stage (Ce)

Table 1.3 Polarity/Asymmetry Determinants. Corresponding proteins from C. elegans,
D. melanogaster and M. musculus, as well as the known functions of those proteins, are
listed. Bold indicates experimental evidence for involvement in aspects of cell polarity
and/or asymmetric division in the following contexts: C. elegans- one-cell stage, D.
melanogaster- neuroblast delamination, M. musculus- epithelial cell tight junctions.
melanogaster- neuroblast delamination, M. musculus- epithelial cell tight junctions.
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do not interact with each other (181, 182). Another component identified in epithelial
cell tight junctions is CDC-42. CDC-42, a small G-protein implicated in actin regulation,
binds to and co-localizes with mPar-6 (182-185). CDC-42 has homologs in both the fly
and worm, but neither has been linked to cell polarity/asymmetric division (186).

InscuteableIPINS
" Inscuteable and PINS join the BazookalaPKClPar-6 trio during or just after
neuroblast delamination.

Thus, the Bazooka complex sets the apical pole in the

neuroepithelium to which Inscuteable and PINS localize once the neuroblast forms. Once
InscuteablelPINS join the other proteins at the apical crescent, they are required for
maintenance of the complex (156, 158).

Mammalian and insect epithelial cells

containing the Bazooka complex do not divide along the apical/basolateral axis. Ectopic
expression of Inscuteable in epithelial cells causes spindle rotation, while ectopic
expression of PINS in epithelial cells has no effect (156-158). These findings suggest
that Incuteable acts upstream of PINS. While Inscuteable has no homologs in any other
species, PINS is the fruit fly representative of the AGS3 family, which has a predicted
family member in C. elegans. If AGS3 function is conserved throughout evolution, then
AGS3IPINS proteins must require Inscuteable-independent mechanisms to arrive at
apical membranes.

C. HETEROTRIMERIC G-PROTEINS IN POLARITY/ASYMMETRY
Heterotrimeric G-proteins are linked to apical membranes by the GPR repeats of
PINS (155). Whether a similar mechanism occurs in C. elegans or in mammalian cells
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has yet to be determined. Initial studies of G-protein knockouts in the nematode did not
identify any embryonic phenotype, possibly because the maternal contribution of Gproteins was overlooked (187). Knocking out both the maternal and daughter sources of
GJ3 subunit resulted in early embryonic lethality characterized by abnormal mitotic
spindle orientation (188). Earlier this year, both Ga and GJ3 subunits in C. elegans were
implicated in control of mitotic spindle rotation of the one- and two-cell zygotes. Using a
series of RNAi (RNA interference) and knockout strains, the functional roles of Ga and
GJ3 subunits in early embryonic cell division were further characterized (55). G(3 RNAi
worms displayed random axis setting at the one-cell stage, suggesting that G(3 directly
influenced the mitotic spindle rotation.

A double knockout of early-expressed Go.

subunits, Goo.l and Gpal6, resulted in a phenotye consistent with G(3 overexpression.
The centrosomes did not migrate to opposite poles before the nuclear envelope broke
down. Also, the Ga knockout zygotes did not divide asymmetrically to form PI and AB
cells. In some of the resulting AB cells, the nuclei were misplaced. G(3 was not localized
to the membrane in Go. mutants, supporting the hypothesis that Go. depletion leads to
enhanced GJ3 function on the cytoskeleton.
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CHAPTER 2
FOCUS OF RESEARCH AND SPECIFIC AIMS
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As the core components of G-protein signaling became more completely
understood, factors modifying the transfer of signal from receptor to G-protein to effector
began to be appreciated. These factors provide specificity to G-protein signaling that
could not be achieved by the core components of receptor, G-protein and effector.
Efforts by our laboratory to define a signal transduction complex ultimately led to the
isolation of a putative G-protein activator, AGS3. Biochemical evidence indicated that a
factor in NG-108 membranes could activate G-proteins independent of receptor
stimulation. As an alternative to unsuccessful protein purification schemes, a functional
screen was employed to isolate proteins capable of activating G-proteins independent of
receptor stimulation.

Screening of a NO-108 cDNA library in the yeast expression

cloning system resulted in the isolation of a novel protein, AGS3.

As part of our

laboratory's goal to identify novel accessory proteins to G-protein, I was charged with
characterizing the G-protein activator, AGS3.
At the time when I entered the lab, AGS3 and its family members were not
completely characterized with respect to function. An AGS3 family member in humans,
LGN, was shown to interact with G-proteins in a yeast two-hybrid screen (151).
Common to both AGS3 and LGN are four uncharacterized repeats in the C-terminus.
The fragment of AGS3 isolated in the yeast system contained one partial and one
complete repeat. These domains were also present in two members of the RGS family
suggesting that AGS3 contained a novel Go. interaction domain.
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Since AGS3 was

isolated in a screen designed to select for G-protein activators, we developed our first
hypothesis about AGS3.

This hypothesis is that AGS3 is a G-protein regulator, a

protein that can 1) influence the transfer of signal from receptor to G-protein
and/or 2) influence the activation state of G-proteins independent of receptor
stimulation. Because AGS3 was·a novel protein and a possible G-protein regulator, my
initial research focused upon the interactions of AGS3 with G-proteins.
Another aspect of AGS3 function revolves around the distinct protein repeat
structure. AGS3 contains seven tandem N-tenninal TPRs, a protein motif found in over
400 proteins implicated in protein-protein interactions (154). While the C-tenninus of
AGS3 appeared to bind G-proteins, the AOS3-TPR region did not have an apparent
function. TPRs are such degenerate motifs that very little can be gleaned from their
presence alone. Our best clue came from a protein named rapsyn, which contains similar
number and spacing of TPRs in its N-terminus (189).

Rapsyn is localized to post-

synaptic membranes via its TPR domain. If the TPRs of AGS3 have a similar function,
they may localize AGS3 to particular subcellular domains.

Alternatively, the TPR

domain might regulate the function of the C-terminus. Our hypothesis concerning the
AGS3 N-terminus is as follows: The AGS3 TPR domain binding partner(s) regulate

the localization and/or function of AGS3. Our goal was to utilize a yeast two-hybrid
screen with the TPR domain as bait to identify potential binding partners. With insight
and advise from Tim McQuinn and Mary Cismowski, we settled upon using a yeast strain
pre-transformed with a rat brain eDNA library as our source of prey sequences. During
the course of our research, we initiated another screen using a mouse 11 day-old
embryonic library.
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At the inception of my dissertation research, very little was known about the
function of AGS3 family members. Genbank BLAST searches of the C. elegans genome
turned up an AGS3 homolog that I will refer to as AGS3-CE (cosmid name F32A6.4).
AGS3-CE has five predicted N-terminal TPRs and four C-terminal GPRs~ with an overall
homology of 42% with AGS3. As an initial approach to define the function of AGS3, we
sought to characterize the function of AGS3-CE. The completion of the C. elegans
genome and the depth of knowledge about cell fate in this organism facilitated analysis of
gene function. Recent technological advances have allowed for the easy generation of
knockout animals in the nematode. Fire developed the RNA-interference method (RNAi)
in 1998 to generate knockout animals (190). He demonstrated that double-stranded RNA
(dsRNA) injected into parental wonns could selectively suppress expression of the
encoded protein in Fl worms. Operating under the hypothesis that AGS3 influences G-

protein function in the intact animal, we sought to initiate experiments with AGS3-CE.
These studies were initiated in collaboration with Dr. Guy Benian at Emory University.
My overall goal was to structurally and functionally characterize the Activator of
G-protein Signaling 3, AGS3. Since AGS3 was a founding member of a novel protein
family, I had the unique opportunity to characterize a new class of G-protein regulators.
Armed with a sequence and a link to G-protein function, I began my efforts to ultimately
learn the role of AGS3 function. To accomplish my goals I developed the following
specific aims:

Specific Aim1: Identify and characterize the domains of AGS3 involved in Gprotein subunit interactions

56

A) Does AGS3 interact with Ga subunits?
B) Which domains of AGS3 are involved in G-protein interactions?
C) Characterization of the AGS3 domains responsible for Ga interactions.
D) Is the GPR domain required for Ga interactions?

Specific Aim 2: Define the specificity of the AGS3-Ga interaction.
A) Does AGS3 interact with specific Ga subtypes?
B) Does AGS3 interact with specific members of the Giloa family?
C) Does AGS3 interact with multiple Ga subunits?

Specific Aim 3: Define the mechanism by which AGS3 activates G-protein signaling.
A) Can AGS3 influence G-protein subunit interactions?
B) How does AGS3 influence the activation state of G-proteins?
C) Can AGS3 influence the transfer of signal from receptor to G-proteins?

Specific Aim 4: Identify binding partners of the AGS3-TPR region.
A) Screen a mammalian cDNA library for potential TPR binding partners.
B) Identify and characterize candidate positive clones.
C) Verify protein-protein interactions outside of the yeast screen.

Specific Aim 5: Define the function of AGS3 in the intact organism.
A) Analyze the expression pattern of the C. elegans homolog of AGS3.
B) Characterize the knockout phenotype of AGS3 in C. elegans.
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CHAPTER 3

EXPERIMENTAL MATERIALS AND METHODS
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MATERIALS

General materials
[35 S]GTPyS

(1250 Ci/mmol) was purchased from DupontINEN (Boston, MA).

Tissue culture supplies were obtained from JRH Bioscience (Lenexa, KS). Acryl amide ,
bis-acrylamide, protein assay kits and sodium dodecyl sulfate were purchased from BioRad (Hercules, CA). Ecoscint A was purchased from National Diagnostics (Manville,
NJ). Guanosine diphosphate, guanosine triphosphate, and Thesit (polyoxyethylene-9lauryl

ether)

were

obtained

from

Boehringer-Mannheim

(Indianapolis,

IN).

Polyvinylidene difluoride membranes were obtained from Pall Gelman Sciences (Ann
Arbor, MI).

Gammabind G Sepharose was obtained from Amersham-Pharmacia

(piscataway, NJ) and nitrocellulose BASS filters were purchased from Schleicher and
Shuell (Keene, NH).

Purified bovine brain G-protein and antisera to the carboxyl-

terminal 10 amino acids of G~1," which recognizes G~1-4, were kindly provided by Dr.
John Hildebrandt (Department of Pharmacology, Medical University of South Carolina)
(191, 192).

Gia.1-3 and Goa were purified from Sf9 insect cells infected with

recombinant virus as described (193) and kindly provided by Dr. Stephen Graber (West
Virginia University School of Medicine). Gsa. and Gqa., similarly expressed in Sf9 insect
cells, were kindly provided by Dr. Elliott Ross (University of Texas Southwestern
Medical Center) (194). Purified Gta and Gt~y were kindly provided by Dr. Heidi Hamm
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(Northwestern University Medical School) (195). Polyclonal Gia3 antisera generated
against the carboxyl-terminal 10 amino acids was kindly provided by Dr. Thomas W.
Gettys (Department of Medicine, Medical University of South Carolina) (196). Purified
GA antibody, which selectively recognizes Gi/Goa, was kindly provided by Drs. Paul
Goldsmith, Andrew Shenkar and Allen Spiegel (197). All other materials were obtained
as described elsewhere (115, 198).

Materials for Saccharomyces cerevisiae two-hybrid screening
Yeast strains pre-transformed with prey eDNA libraries, Anti c-Myc monoclonal
antisera and KC-8 chemically competent cells were obtained from Clontech. Bait vector
pGBKTI and yeast strains Y187 and AHI09 were kindly provided by Dr. Tim McQuinn
(Medical University of South Carolina).
obtained from Sigma.

Amino acids and J3-mercaptoethanolwere

Technical agar was purchased from Difco.

reagents and supplies were obtained from Fischer.

All other media

The pGEX5X2 vector, BL-21

competent cells and Glutathione Sepharose 4B were purchased from Pharmacia Biotech.
PVDF membranes were obtained from Pall Gelman Sciences (Ann Arbor, MI). X-Gal
was bought from Boehringer Manheim. All other materials were obtained as described
elsewhere (198).

c. elegans materials
C. elegans genomic DNA and vector pD96.04 were kindly provided by Dr. Guy

Benian (Emory University).

T7 and T3 mRNA synthesis kits were purchased from
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Gibco. High Fidelity PCR reagents were obtained from Boehringer. All other C. elegans
reagents were provided by Dr. Benian's laboratory.

METHODS

General methods
Generation of AGS3 subdomains AGS3 subdomains were generated as glutathione fusion
proteins by polymerase chain reaction (PCR) using the full length cDNA of AGS3 as a
template. Primers were designed to add BamHI and BeoRI sites to the 5' and 3' ends,
respectively, of AGS3 subdomains to fuse the AGS3 open reading frame with the reading
frame of glutathione-S-transferase contained in the pGEX4Tl vector. The PCR reactions
were generally performed using 250 nM primers and 125 pM template DNA in a total
volume of 50

JJL.

Cycles were 1 x 3 minutes at 94°C; 30 x 1.5 minutes at 94 °c, 1

minute at 60°C, and 2 minutes at 72 °C; 1 x 10 minutes at 72°C. Primers used to
generate specific constructs:
TPR (MI-I462)
5'- GGGGATCCATGGAGGCCTCCTGTCTGG
3'- GCGATITCTCAGATACCCGTGCGAGGCACCTG
GPR (P463-S650)
5'- CGGGATCCACCATGGCCCCGTCCTCT
3'- GGGAATTCTfAGCTGGCACCTGGCGGACA.
AGS3-CT (M577-S650)
5'- CGGGATCCACCATGACCGCGTATGCA
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3'- GGGAATTCTTAGCTGGCACCTGGCGGACA.
GPRI (I463-E501)
5'- CGGGATCCACCATGGCCCCGTCCTCT
3'- CGGAATTCTTACTCAGCAGCCCCAGCCTG
GPRll (S516-L555)
5'- CGGGATCCTCTGTAACAGCTTCACCA
3'- CGGAATTCTfAGAGGGTGATGCGAAGCCC
GPRm (G563-T602)
5'- CGGGATCCGGCGACGGGGACCCCCAG
3'- CGGAATTCTfAGGTGGGGCCTCGGGGCAG
GPRIV (T602-S650)
5'- CGGGATCCACCATGCCTGATGAGGATTTC
3'- GGGAATTCTTAGCTGGCACCTGGCGGACA.

GST fusion protein purification Overnight cultures of transformed BL-21 bacteria were

diluted (1:50) into fresh 2XYTA media (lL: 16 g Tryptone, 10 g Yesat Extract, 5 g NaCI,
pH 7.0) and incubated with 250 rpm shaking at 37°C for 2 hours. After inducing protein
expression by the addition of 100 mM !PTG (1000X), the culture was incubated at 30°C
for an additional 3 hours. Pellets from 5,000 x g spins at 4 °c were resuspended (50 m1
FP bufferlL culture volume) in Fusion Protein buffer (10 mM Na2HP04, 1.8 mM
KH2P04, 2.7 mM KCI, 140 mM NaCI, 1 mM EDTA plus protease inhibitors) and
sonicated using a Branson Sonifier 250 (output setting 2, constant sonication) for 30
seconds. Lysates from 12,000 x g spins were incubated with 50% Glutahtione Sepharose
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4B slurry in FP buffer (2 mL slurry/L culture volume) for 30 minutes at 4°C. Packed
resins from 1,000 x g spins were washed sequentially with 10 mL of FP buffer, 10 mL of
FP buffer plus 250 mM NaCI and 10 mL of FP buffer plus 500 mM NaCl. Washed resins
were transferred to fresh 1.5 m1 tubes using FP buffer. Fusion protein was eluted from
packed resins by incubation with elution buffer (10 mM reduced Glutathione in 50 mM
Tris pH 8.0) overnight at 4 °c (2: 1, elution buffer to packed resin). After removal of the
first elution fraction, an additional elution was performed as described except at room
temperature for two hours.

Eluted fractions were concentrated and desalted by

ultracentrifugation using Centricon molecular weight cutoff 3 kDa filter tubes. After the
fractions were spun at 6,000 x g for one hour at 4°C, the concentrated protein was
washed with 3 applications of 300 f..tl of 20 mM Tris pH7.5. Between each wash, the
concentrate was spun at 6,000 x g for one hour at 4°C. Concentrated fusion proteins
were evaluated by Bio-Rad protein assays and by coomassie blue staining of SDS-PAGE
gels.

Preparation of celVtissue lysates DDTI-MF2 cells were grown as previously described
(87). Rat brain was homogenized in 3 ml buffer/gram tissue of lysis buffer (50 mM Tris
pH 8.0,150 mM NaCI, 5 mM EDTA, 1% NP-40) and then incubated at 4 °c for 2 hours
with rotation. Confluent 100 rom dishes of cells were washed with cell washing solution
(137 mM NaCI, 2.6 mM KCI, 1.8 mM KH2P04, 10 mM Na2HP04) and then resuspended
in 1 mlIdish of lysis buffer by homogenization. Cell homogenates were incubated for one
hour on ice. Tissue/cell homogenates were centrifuged at 27,000 x g for 30 minutes.
Supernatants were collected and spun at 100,000 x g for one hour to generate a detergent-
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soluble fraction. The supernatant was immediately processed. for immunoblotting or
immunoprecipitation. Protein concentrations were determined by a Bio-Rad protein
assay.

Protein interaction assays The interaction of AGS3 with G-proteins was assessed by both
co-immunoprecipitation and protein interaction experiments using tissue/cell lysates or
purified G-proteins. For immunoprecipitation from mammalian cells, cell/tissue lysates
(1-3 mg of protein in .5 -1 ml) were pre-cleared by rotating incubation with Gammabind
G Sepharose (12.5

~l

packed resin equilibrated in lysis buffer) for 30 min at 4°C.

Following centrifugation, Gia3 antisera (1 :250 dilution) was added to pre-cleared lysates
and incubation continued overnight at 4°C. Protein complexes were captured by adding
Gammabind G Sepharose (12.5 J..lI packed volume) and continuing the incubation for 30
min at 4°C. The mixture was then microfuged at 4°C and the pellets washed (3 x 500

~l

of incubation buffer) and resuspended in 2 x Laernmli buffer. Resuspended samples were
placed in a boiling water bath for 5 min and microfuged for 10 min prior to loading on
denaturing 10% polyacrylamide gels. Proteins were transferred to PVDF membranes for
immunoblotting.
For analysis of the interaction of AGS3-GPR with multiple G-protein subunits,
Gia.2 (200 nM) was incubated with Gia3 (50 nM) in the presence or absence of the
AGS3-GPR GST-fusion protein (250 nM) in 250 at buffer A (20 mM Tris pH 7.5, 70
mM NaCI, 1 mM dithiothreitol, 0.6 mM EDTA, 0.01 % Thesit) for one hour at 4°C. Gia.3

antisera (1 : 500) was added and the incubation was continued for 3 hours at 4°C. Protein
complexes were isolated and evaluated by immunoblotting as described above.
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Protein interaction assays using purified G-protein subunits were conducted as
previously described (198). All purified G-proteins used in these studies were isolated in
the GDP-bound form. Unless indicated otherwise, all G-protein interaction assays
contained 10

JlM GOP. The AGS3-GST fusion proteins were expressed in and purified

from bacteria using a glutathione affinity matrix. The AGS3-GST fusion proteins were
eluted from the matrix with glutathione and desalted by centrifugation (Centricon YM-3;
Millipore - Bedford, MA). For interaction assays with cell/tissue lysates, the AGS3-GST
fusion protein (100-300 nM) was incubated with purified G-protein (50-100 nM) or
cell/tissue lysate (-4 mg proteinlml) for 1 hr at 24°C in a total volume of 250 f.1L. 12.5

J.11 of packed glutathione-sepharose slurry was added and the mixture rotated at 4 °C for
20 min, after which the affinity matrix was pelleted and washed three times with 500 f.11
of incubation buffer.

Proteins retained on the matrix were solubilized in 2 x Laemmli

loading buffer and separated by electrophoresis on denaturing, 10% polyacrylamide gels.
Proteins were transferred to PVDF membranes for immunoblotting. Each blot was
checked by amido-black staining to verify equal loading of fusion proteins.

PVDF membrane transfers After applying samples to SOS polyacrylamide gel
electrophoresis, protein was transferred to PVDF membrane as described below. After
electrophoresis SOS gels were placed in ice-cold transfer buffer (20% methanol, mM Tris
and mM Glycine) and allowed to soak for 5-10 minutes. A transfer sandwich was made
onto the base of a Bio-Rad semi-Dry transfer apparatus from bottom to top: whatman
paper (soaked in transfer buffer), PVDF membrane (soaked in methanol), SDS gel,
whatman paper (soaked in transfer buffer). Transfer onto PVDF membranes occurred
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using constant amperage (.4-.5 Amps) with variable volts «=20 V). Time of transfer
ranged from 60-100 minutes depending upon membrane size.

Membranes were

immediately processed for immunoblotting.

Immunoblotting PVOF membrane transfers were blocked in blocking solution (7% milk,
0.2% tween, 20 mM Tris pH 7.6, 150 mM NaCI) for one hour at room temperature with
gentle rocking. Membranes were washed twice for 15 minutes each in wash solution
(0.2% tween, 20 mM Tris pH 7.6, 150 mM NaCl). Membranes were then exposed to
primary antibody diluted in wash solution for one hour. After two 15 minute washes in
wash solution, conjugated secondary antibody of the appropriate dilution and species
(diluted in wash solution) was applied to membranes for 20-30 minutes. Membranes
were then washed twice for 15 minutes each and prepared for chemmiluminescence.
Washed membranes were blotted dry and added to ECL reagent (NEN). Membranes
shaken in ECL for one minute were blotted dry and exposed to film.

For storage,

membranes were washed for ten minutes to remove ECL and placed in plastic wrap and
kept at 4 oC. For further re-probing, membranes were washed for ten minutes and then
subjected to the stripping procedure.

Nucleotide binding assays.. Nucleotide binding assays were conducted by a modification
of a previously described techniques (141, 199). G-proteins (100 nM) were preincubated
with varying amounts of AGS3 subdomain proteins or GST controls for 15 minutes at
24°C (binding buffer = 50 mM Hepes-HCI pH 7.5, 1 mM EDTA, 2 mM MgClz, 1 mM
dithiothreitol, 50 J.lM adenosine triphosphate, 10 J,lglml bovine serum albumin) prior to
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addition of 0.5-1 f,LM GTPyS (4.0 x 104 dpm/pmol); the final incubation volume was 50
J.1L. Samples were incubated with GTPyS at 24°C for 30 min. Incubated reactions were
terminated by rapid filtration through nitrocellulose filters (S&S BA85) with 4 x 4 ml
washes of stop buffer (50 mM Tris-Hel, 5 mM MgCI2 , 1 mM "EDTA, pH 7.4, 4°C).
Radioactivity bound to the filters was detennined by liquid scintillation counting.

High affinity agonist binding- Sf9 cell membranes expressing 5-HTIA receptors were
reconstituted with GaJ3y, and high affinity agonist binding was measured with 3H-5-HT
as described previously (200). Membrane aliquots (100 J.1g of membrane protein, 85 nM
receptor) were preincubated for 15 min at 25°C with G-proteins (2125 nM GaJ3y) with
or without AGS3 fusion proteins in a total volume of 17 J...lI (reconstitution buffer, 5 mM
NaHEPES, 100 mM NaCI, 5 mM MgCI2, 1 mM EDTA, 500 nM GDP, 0.04% CHAPS,
pH 7.5). The reconstitution mixtures were then diluted 10-fold with binding buffer (50
mM Tris-HCI, 5 mM MgCI 2, 0.5 mM EDTA, pH 7.5), and 50 J.1I were added to binding

tubes (total volume = 150 J.11) containing 2 nM 3H-5-HT. The final concentrations of
receptor, G-protein, and fusion protein in the binding tubes were 2.8 nM, 70.8 nM, and
13 J,1M, respectively. Nonspecific binding was determined in the presence of 100

J.LM 5-

HT. Binding reactions were incubated at 25°C for 1.5 h and terminated by filtration over
Whatman GF/C FP200 filters using a Brandel cell harvester. The filters were rinsed thrice
with 4 ml of ice-cold washing buffer (50 mM Tris-CI, 5 mM MgCI2, 0.5 mM EDTA,
0.01 % sodium azide, pH 7.5, at 4°C), placed in 4.5 ml of CytoScint, and counted to
constant error in a scintillation counter.
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Stripping and re-probing of PVDF membranes- For reprobing of membrane transfers, the
membranes were washed with immunoblot wash buffer (20 mM Tris-HCI pH 7.6, 140

mM NaCI, 0.2 % Tween) and then incubated with pre-heated stripping buffer (62.5 mM
Tris-HCL pH 6.8, 2% SDS, 100 mM J3-mercaptoethanol) for 20 minutes in a 55°C water
bath with gentle shaking. The membrane was then washed with buffer A and processed
for immunoblotting.

Coomassie blue staining- Gels were incubated in 100 m1 staining buffer (0.25 %
Coomassie blue in 45 % methanol, 45 % H20, 10 % glacial acetic acid) for 30 minutes at
room temperature. Stained gels were then washed in 100 ml of destain solution (45 %
methanol, 45 % H20, 10 % glacial acetic acid) and incubated for 30 minutes. Gels were
then washed in fresh destain solution every 30 minutes until protein bands were visible.

Additional methods-

DDTl-~2

cells were stably transfected with pcDNA3.AGS3 by

DNA/calcium phosphate coprecipitation (84). For antipeptide antisera, AGS3 peptides
(P-32

T306~I436,

P-22 D528-G550 and 9808 V625-S650) were synthesized and

conjugated for generation of rabbit polyclonal antisera using the Peptide Synthesis and
Antibody Production Facility at the Medical University of South Carolina. Each of the
three antisera specifically recognized GST-AGS3 at reasonable dilutions (1:500 to
1:2,000) of serum and were affinity purified.
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Yeast two-hybrid methods
Generation of Bait Constructs- AGS3-TPR constructs TPRLong (Met 1-lle462) and

TPRShort (Met 1_Gly337) were generated ~y PCR. Restriction digested PCR products
were subcloned into pGBKT7 to generate the TPRL and TPRS bait constructs. TPRL,
TPRS and empty pGBKT7 vector were transformed into AHI09 by the lithium acetate
method (201). Positive transformants from SD -TRP plates were re-streaked onto fresh
SD- TRP plates and stored at 4°C. Protein extracts of pGBKT7-TPRL, pGBKTI-TPRS
and pGBKTI AHI09 strains were obtained by the UrealSDS method (202). Expression
of bait fusion proteins was confirmed by immunblotting with Anti c-Myc. Basal activity
of bait strains was assayed by nutritional selection.

Yeast two-hybrid screening- AHI09 yeast strain expressing a Gal4BD-TRPL fusion as

bait were mated with Y187 yeast strains expressing fusion proteins of mouse 11 day old
embryo cDNAs and Gal4AD by following the manufacturer's protocol. The mated yeast
culture was plated onto 120 QDO (SD -TRP, -LEU, -HIS, -ADE) plates which were then
incubated at 30°C for 7 days. Ten colonies from each plate were re-streaked onto QDO
plates and allowed to grow for 3 days. Colony-lift J3-gal assays were performed on the
master plates as described (203). Clones were scored based upon the time required to
demonstrate J3-gal activity. The top ten percent (120 colonies) based on this scoring
system were re-streaked onto QDO plates and were assayed again by the colony lift J3-gal
assay. Yeast plasmid DNA was isolated from the top sixteen colonies and subsequently
transformed into chemically competent KC-8 cells. Transformants containing the prey
vector containing the LEU2 reporter gene were selected by plating onto M9 -LEU plates.
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Bacterial plasmids isolated from KC-8 transformants were transformed into XLI-Blue
cells for large-scale production.

Re-streaking of yeast colonies Yeast colonies of 2-3 rom were picked with sterilized
toothpicks and vortexed in 100

J.1L

of sterile water. 2.5 J.1L of the re-suspended yeast

were placed upon the appropriate yeast media plates. For most applications a 5 x 5 grid
was used as a template to spot yeast upon 100 mm plates.

/3-Gal colony lift assay 75 mm diameter circular whatman filter lifts of yeast colonies
were flash frozen in liquid nitrogen and were placed in a 100 mM dish atop another 75
mm diameter filter pre-soaked in 2.5 mL Z-buffer with X-gal (Z-buffer: 100 mM

NaHP04 pH 7.0, 10 mM KCI, 1 mM MgS0 4 ; Z-buffer wI X-Gal: 100 mL Z-buffer, 0.27
mL f3-mercapoethanol, 1.67 mL 20 mglmL X-gal in DMF). Time zero was set as the
time the colony filters were placed in contact with Z-buffer.

The earliest colonies

(including the positive control) turned bluebetween 30 and 60 minutes. Clones were
scored based on the time it took them to tum blue. Colonies turning blue after two hours
were not included as positive clones.

Secondary two-hybrid screening- Bait constructs in pGBKT7 were co-transformed with
candidate prey constructs in pACT2 into yeast strain AH109 using the Lithium acetate
method (201). Transformed yeast cultures were plated onto SD -TRP, -LEU plates to
select for uptake of both plasmids. Five positive clones from each plate were re-streaked
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onto QDO plates and allowed to grow for 3 days at 30°C. Colony lift b-gal assays were
performed as described above.

Protein interaction assays- The fragment of SITKII coding sequence isolated in the twohybrid screen was obtained by digesting the pACT2-SfTKll construct with Bco RI and
Xho I.

The purified fragment was subcloned into the pGEX5X2 vector such that the

SlrKll reading frame was aligned with the GST reading frame. The pGEX5X2-SITKll
construct was transformed into BL-21 competent cells. GST-SfTKII fusion protein was
purified as described.
Protein interaction assays were performed as described.

Tissue lysates were

generated using NP-40 lysis buffer as described above. Brain lysate (2.5 mg in 250 Jl.L)
treated for 30 minutes with either 30 J.1M GDP or 30 uM GTPyS plus 10 mM MgCl 2 was
incubated with GST or GST-SITKII (500 nM) for one hour at room temperature.
Protein complexes were captured by incubating the lysate-fusion protein mixture with 25
uL 1:1 Glutahtione Sepharose 4B for 30 minutes at room temperature. The pelleted
sepharose beads were washed 3 times with 500 J.lL NP-40 lysis buffer. After sample
buffer was added to washed beads the mixture was boiled for 3 minutes and loaded onto
SDS-PAGE gels. Immunoblotting was performed as described.

AGS3-CE methods
Promoter expression assay The 3 kb region upstream of the predicted start methionine of
AGS3-CE, the first exon, first intron and part of the second exon were PCRed from
genomic C. elegans DNA provided by Dr. Guy Benian. The PCR product was subcloned
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into the pD96.04 vector such that the frame of the second exon matched with the frame of
LacZ and GFP coding regions in the pD96.04 vector. This construct was co-injected with
the rol-6 marker construct into 40 sub-adult C. elegans hermaphrodites using a microinjector (injection buffer: 20 mM KP04, 3 mM KCitrate, 2%PEG 6000, 100J,lglml
plasmid DNA) (204).

After recovery, the worms were placed on bacterial lawns and

were left at room temperature for 20 hours. The injected parental worms were moved to
a fresh plate and left at room temperature for 24 hours, during which time they laid eggs
of transgenic offspring. From 20 plates containing -100 worms each we detected 12
worms with the roller phenotype indicative of the uptake of plasmid rol-6.

These

individuals were analyzed for GFP using a fluorescent microscope. The worms were also
assayed for LacZ activity using X-gal staining. Pictures of mounted worms were taken at
40X magnification.

X-gal staining olC. elegans Transgenic worms were washed with acetone and air-dried at
room temperature on glass slides. 25 J.tl of staining solution (0.2 mM NaHP04 pH 7.5, 1
mM MgCI2, 0.004% SDS, 10 mM FeCN, 7.S J.tglml kanomycin, 0.0025% X-Gal) was

added and coverslips were sealed on top of the worms (205). After a 20 hour incubation
at room temperature, GFP and LacZ staining was observed.

RNAi Full length AGS3-CE in the pSK+ vector was obtained from the C. elegans est

database of Yuji Kohara. AGS3-CE -GPR and AGS3-CE -TPR were isolated from the
full length sequence and subcloned into the pSK+ vector. The AGS3-CE constructs were
linearized by restriction enzyme digestion at their 5' and 3' ends. Single stranded RNA
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was generated by using the Gibco T7 and T3 roMessage roMachine kits. Single stranded
RNA representing the sense and antisense strands were mixed together, incubated at 100

°c and brought to room temperature. Annealed, double stranded RNA (dsRNA) was
distributed into aliquots and stored at -20°C.
DsRNA of AGS3-CE was injected into the gonad syncitia of 30 sub adult wonns
(injection buffer: 20 roM KP04, 3 roM KCitrate, 2%PEG 6000, 50J.1g/ml dsRNA) (190).
After recovery, the worms were placed on bacterial lawns and left at room temperature
for 20 hours. The injected parental worms were moved to a fresh plate apd left at room
temperature for 24 hours, during which time they laid eggs of affected "RNAi" offspring.
The parent was moved off of the plate containing the affected progeny. The RNAi
offspring were evaluated by light microscope.
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CHAPTER 4
SPECIFIC AIM 1
Identify and characterize the domains of AGS3 that interact with Go; subunits.
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Introduction

The identification and

characteri~ation

major focus of interest in our laboratory.

of novel G-protein regulators has been a
Using a functional screen for receptor-

independent activators of heterotrimeric G-protein signaling systems three AGS
(Activators of G-protein Signaling), proteins were isolated. At the time when I entered
the lab, these proteins'had not been shown to functionally interact with G-proteins outside
of the yeast system. After generating initial data indicating that the C-terminal 74 amino
acids of AGS3 could interact with purified G-proteins, I began to focus my efforts on
AGS3. The discovery of a novel protein, AGS3, possibly acting as a G-protein regulator,
left us with many questions to answer.

Paramount among these was the potential

association of AGS3 and G-proteins in endogenous tissue. A common method used to
determine if proteins associate in cells or tissue is co-immunoprecipitation.
availability

of AOS3

and G-protein

antisera,

together

with

The

successful co-

immunoprecipitation protocols in our laboratory, allowed these experiments to proceed.
Sequence analysis of AGS3 revealed two distinct protein repeat domains, an Nterminal TPR domain and a C-terminal region containing repeats that were termed GPRs
based on data gathered in this aim. The region of AGS isolated in the yeast expression
cloning system that was subsequently shown to interact with G-proteins contained one
partial and one complete GPR. Initial BLAST results using AGS3 generated several
proteins that were known to interact with G-proteins such as RGS12, RGS14 and LON.
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The C-terminus of LGN containing four GPRs was isolated in a yeast-two hybrid screen
using Gia2 as bait (151). Based on these-data, we hypothesized that the region of AGS3
responsible for this interaction was the GPR domain. Since the GST pull-down assay had
been used successfully by our laboratory, our approach was to use this technique to
analyze protein-protein interactions of various AGS3 fragments.
If our hypothesis about the GPR repeat was correct, then the domain constituted a
novel Ga interacting domain. Aside from the RGS domain, no other accessory protein
domain had been indicated as such. Thus we were afforded the opportunity to define this
domain and report it as a signature Ga.-binding motif. With the advice and aid of Starr
Hazard ill, our approach was to use computer algorithms to define the consensus repeat
and then use this repeat to search for other proteins containing this domain.

These

searches would allow for 1) the discovery of other GPR containing proteins, 2) a
consensus motif upon which to design mutants and 3) a platform upon which to design a
peptide for further research.

Results
Does AGS3 interact with Ga subunits?
Initial studies indicated that the carboxyl-terminal 74 amino acid fragment of
AGS3 was active in the yeast functional screen and that this peptide fragment directly
bound to Gia'(llS). We thus asked if full length AGS3 was complexed with Gia3 in
lysates of rat brain or DDTl-:rvtF2 cells stably transfected with AGS3. As AGS3
preferentially regulated GiaZ and Gia3 in the yeast functional assay (115), we first
approached this issue by immunoprecipitation of Gia.3. Approximately 30% of brain
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lysate Gia3 was immunoprecipated with a Gia.3 carboxyl terminus antibody.
Immunoblots of membrane transfers containing Gia.3 immunoprecipitates indicated that
AGS3 co-immunoprecipitated with Gia, in a nucleotide-dependent manner (Figure 4.1).
The absence of Gf3 in the GTPyS treated samples provided internal controls for G-protein
activation and subunit dissociation by added GTPySlMg2+.

Immunoprecipitation

experiments were also conducted with the AGS3 antisera P-32 raised againt the linker
region (T406-I436). Although AGS3 was effectively immunoprecipitated by the P-32
antisera in each cell/tissue extract, co--immunoprecipitation of Gia.3 was variable, which
may reflect lower immunoprecipitation efficiency for P-32 and/or a masking of the P-32
epitope in the AGS3-Ga, complex (data not shown). Nevertheless, these data indicated
that a subpopulation of Gia3 and AGS3 exists as a complex in the cell and that this
interaction is regulated by nucleotide binding to Ga..

Which domains of AGS3 are involved in G-protein interactions?
The interaction between AGS3 and G-proteins was further explored in in vitro
binding assays to define the regions of AGS3 actually involved in binding to Ga. We
generated the amino terminal half of AGS3 (AGS3-TPR, MI-I462) and the carboxyl
terminal half of AGS3 (AGS3-GPR, P463-S650) as GST fusion proteins (Figure 4.2).
The AGS3-TPR, AGS3-GPR and the 74 amino acid carboxyl terminus (AGS3-CT,
M577- S650) isolated in the original yeast functional screen were incubated with DDT 1MF2 cell lysates.

Proteins bound to the AGS3 subdomains were identified by

immunoblotting of gel transfers. The Gia,1/2 binding domains of AGS3 were found in the
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Figure 4.1 Co-immunoprecipitation of AGS3 with Gia3. A) Rat brain (2.5 mg) and B) DDT-AGS3 cell (1.25 mg) lysates
were preincubated with 30 ~M GDP or 30 ~M GTPyS/25 mM MgCl 2 at 24°C for 30 minutes. Lysates were then precleared and
Gia3 immunoprecipitated. Membrane transfers were first blotted with AGS3 P-32 antisera and then stripped and sequentially
reprobed with Gia and G~ antisera. The data are representative of 2-4 experiments. The input lane contains 1/10 of the lysate
volume used for immunoprecipitation. IP - immunoprecipitation. IB - immunoblot. P-32 antisera was used for immunoblotting
at a concentration of 1.0 111?;/ml. DDT-AGS3 - DDTcMF2 cells stably transfected with rat AGS3.
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Figure 4.2 Subdomains of AGS3 that interact with G-proteins. Subdomains of AGS3 A) were generated as glutathione-Stransferase (GST) fusion proteins and purified following expression in bacteria for protein interaction studies. (B) Lysates were
prepared from DDTcMF2 cells and 1 mg of lysate protein was incubated with 300 nM GST-AGS3 fusion proteins. Membrane
transfers of bound proteins were probed with G-protein subunit antisera. B) TPR M1-I462, GPR P463-S650, CT M577-S650.
Similar results were obtained in 3-5 individual experiments using different batches of lysate. The input lane contains 1/10 of the
lysate volume used in each individual interaction assay.

carboxyl terminal half of the protein (Figure 4.2). The TPR domain of AGS3 did not
interact with Gial/2 or G~y (Figure 4.2).
Within the C-terminal region of AGS3 that binds to Ga, there are four GPR
motifs. Previous data indicated that the 74 amino acid at the carboxyl terminus of AGS3,
containing one full and one partial GPR, was functional in the yeast functional screen.
We then asked if each GPR domain was indeed capable of binding Ga. Each GPR motif
was generated as a GST-fusion protein (Figure 4 . 3) and evaluated in protein interaction
assays using DDTl-1VlF2 lysates (Figure 4..3). Each GPR motif bound Gial/2, although
GPR I, at least in this context, bound less Go. than did GPR II-IV (Figure 4.3). These
data suggest that interaction of AGS3 with Gia3 observed by coimmunoprecipitation
experiments (Figure 4.1) reflects interaction of Gia3 with the GPR domains in AGS3.

Characterization of the AGS3 domains responsible for Ga interactions.
The core of the C-terminal GPRs of AGS3 exhibit 80-85% homology: GPR I E470 to R489, GPR II - E524 to R542, GPR ill - D572 to R590, GPR IV - D606 to R624.
Four repeated GPR domains are also found in human LGN and the predicted C. elegans
protein, AGS3-CE. The Drosophila protein PINS contains three GPRs in its C-terminus.
Based upon computer projections, each of the repeated domains can exist as an
amphipathic helix.

GPR domains I-IV in AGS3, human LGN and AGS3-CE were

evaluated by MAST (Motif Alignment and Search Tool) to determine their existence in
other proteins in the databases.

Initial searches returned four additional proteins that

contained GPRs, two of which were members of the RGS family (Figure 4 . 4). The other
two proteins were shown to interact with G-proteins during the course of my research.
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Figure 4.3 Individual AGS3 GPR domains interacting with G-proteins. Subdomains of AGS3 A) were generated as
glutathione-S-transferase (GST) fusion proteins and purified following expression in bacteria for protein interaction studies. (B)
Lysates were prepared from DDTI-MF2 cells and 1 mg of lysate protein was incubated with 300 nM GST-AGS3 fusion proteins.
The roman numbers correspond to the GPR domains in (A): GPR-I P463-E501, GPR-II S516-L555, GPR-III G563-T602,
GPR-IV T602-S650. Similar results were obtained in 3-5 individual experiments using different batches of lysate. The input
lane contains 1/10 of the lysate volume used in each individual interaction assay.
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Figure 4.4 Consens~s sequence for G-protein regulators. The four repeat domains in the carboxyl terminus half of AGS3,
human LGN, the predicted C. elegans protein (AGS3-CE) were aligned and used to fonn a consensus sequence. Related
sequences identified by the motif search program MEME are shown below the consensus. Red amino acids represent 'consensus
residues and .blue amino acids represent proline residues. Asterixes over the sequence correspond.to positions of site-directed
mutagenesis.

PcpL7 (PQ0109) (pcp2) was recently isolated in a yeast two-hybrid screen using Goa as
"bait" and may act as a guanine nucleotide exchange factor (152). Rap1GAP (P47736) is
a GTPase activating protein for the small G-protein Rap-1A and was also identified in a
yeast two-hybrid screen using Goa as "bait" (119). RGS12 (AF035151) and RGS14
(0087737) are members of the RGS family (153) and have been a focus in the Siderovski
laboratory. Presence of the motif in the RGS12IRGS14 Drosophila homolog Loco, a
protein known to influence the activity of Goa, prompted the report of the repeat as the
GoLoco domain (130). Based upon available reports they speculated that the GoLoco
domain behaved as a Giloa GEF.

Artemyev and colleagues recently re-visited the

influence of these proteins on G-protein activity (206).

Is the GPR domain required for Ga interactions?
Analysis of GPRs I-IV in AGS3, human LGN, the predicted C. elegans protein
and the motifs in PcpL7, RGSI2, RGS14 and Rap 1GAP indicated a consensus sequence
of FlDEXFILFDIEUMI.IIXRIKXQS/GXRMILDDQR.

Other groups have labeled the

repeat as GoLoco (130) and the LGN motif (207). We used AGS3-CT containing one
complete GPR motif as a base for our mutagenesis studies. Substitution of phenylalanine
at position eight with an arginine (F8R) was designed to break up the N-terminal
hydrophobic patch by introducing a long, bulky, charged amino acid where the aromatic
ring had been.

Conversely, we introduced a phenylalanine at position twenty-three

(R23F) to disrupt a conserved, charged position. The invariant glutamine at position 15
was changed to an alanine to test its requirement for G-protein interactions (GI5A).
Introduction these mutations into the AGS3-CT GPR motif eliminated interaction of
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AGS3 with Gia2 and Gia.3 in crude cell extracts (Figure 4.5). The same fusion proteins
were inactive in the yeast assay system (Data not shown). Of the three mutants, Q15A
showed some binding to Ga. subunits.

G18.1b
The previous data indicates that the GPR motif may be diagnostic of protein function.
Sequences entered into the database from genome sequencing projects may be analyzed
for the presence of GPR domains, an indicator of G-protein regulatory activity. As stated
""~

above, based upon the presence of GPR domains, both PcpL7 and RaplGAP were
identified during the course of this study as putative G-protein regulators prior to the
recent publications providing experimental evidence supporting this hypothesis (119,
152). Screening of recently released sequences revealed another GPR containing protein,
G18.lb.

Indeed, when made as a GST-fusion protein, G18.1b was demonstrated to

interact with purified Ginl (Figure 4.6).

GPR Proteins
Screens of the database for the GPR domain identified 10 protein groups, each
representing a distinct gene. Including species homologs, the number of non-redundant
GPR containing proteins is 26. Figure 4.7 depicts the domain structure of GPR proteins.
Families include the AGS3 family, the pcp-2 family, the G18.lb family the RGS12/14
family and the Rap 1Gap family. The AGS3 family can be sub-divided into the AGS3
and LGN sub-families. RGS12 and RGS14 constitute distinct proteins of the RGS12/14
family.

Likewise RaplGAP and RaplGAPll are distinct proteins.
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Figure 4.5 Interaction of wild type and mutant AGS3 with G-proteins. The AGS3 cDNA isolated in the yeast screen and
shown to interact with Ga subunits (Figure 1.7) was modified by site-directed mutagenesis to disrupt conserved residues within
the GPR motif defined in Figure 4.4. GST fusion proteins were generated in bacteria. The number of the amino acids altered in
the mutant constructs (F8R, Q15A and R23F) refers to their position in the sequence found in Figure 4.4. The GST -AGS3 fusion
proteins were then added to DDTI-MF2 cell lysates containing 30 f..tM GDP and processed to determine interaction with
endogenous mammalian Gia2 or Gia3. Equal loading of individual samples was verified by amido black staining or
immunoblotting with the AGS3 specific antisera (lower panel). This experiment was repeated twice with similar results. The
lysate lane contains 10 f..tl of the 250 f..tl sample incubated with the fusion proteins.

-\!;

30'

1

--- EE- FFDL L- K- QS - RMD
D.
EM I ' R .G ·L

CONSENSUS

"

G18.1b-I (Ss9)
G18.1b-II (L100)
G18.1b-III (P130)

Input

DQR ~---~~-

.

SLQTELLLDL VAEAQSRRLE EQRATFYTPQ
LEDREQLYST I LSHQCQRME AQRSEPPLPP
PGGQELLELL LRVQGGGRME
EQRSRPPTHT
.
. . .
..
..

GST

GST

GST

GPR

G18.1b

00

0\

Gial

~

Figure 4.6 Interaction of predicted protein G18.1b with G-protein subunits. G18.1b cDNA (AJ243937) was obtained from
the IMAGE Consortium est database (image.llnl.gov) and used to 'generate ,a GST-G18~lb fusion protein. Purified GST, GSTGPR and GST-G18.1b (300 nM) were incubated with 100 nM purified Gia1 in the presence of 10 f..lM GDP. Protein complexes
Isolated by precipitation with glutathione-sepharose were analyzed by immunoblotting. The data presented are the results of two '
experiments. The input lane represents 10% of the G-protein used in each interaction assay.

RatAGS3
LGN
AGS3-Short
Pcp-2

,--

RaplGAP
RGS12
00

-......l

I

RGS14
G18.1b

I PDZ I

I

PTB

-I

I

Rap GAP

I

RGS

I

I

RGS

I

I RBD II RBD I

•

I

IIII

CG 13789 (Dm)
YSOF7A.l (Ce)
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proteins from lower organisms, C.elelgans Y50F7 A.l and D.melanogaster CG 13789, fall
into neither category and contain single copies of weak: GPRs.

Disscussion
Demonstration that AGS3 could interact with G-proteins not only helped to
validate the yeast expression cloning system, but it supported the hypothesis that AGS3 is
a G-protein regulator. Co-immunoprecipitation experiments suggested that AGS3 and
Go. subunits are complexed within mammalian cells and tissue and that their interaction
is dependent upon the activation-state of the alpha subunit. Subsequent analysis of AGS3
localized its Go. binding domain to a region in the carboxy terminus containing four
previously unknown repeats which we termed GPR (G-protein regulatory) domains.
With the exception of a weak interaction between GPRI and Go., individual GPR
repeats readily bind Ga..

Moreover, mutations of the GPR disrupted protein-protein

interactions with Ga. and abolished activity in the yeast expression cloning system.
Using the GPR domains of AGS3 family members, a consensus sequence was obtained
by computer algorithms. Searches with this domain revealed the presence of GPRs in
known G-protein regulators as well as in predicted proteins.

The interaction of an

unknown GPR containing protein, GI8.1b, with Go. supported our claim that the GPR is
diagnostic of a G-protein regulator. The GPR is found in over 10 proteins, most of which
have been linked to G-protein function.
The data gathered in this aim has been the foundation for many of my other
studies as well as a basis for new projects and collaborations. Our discovery that AGS3
can interact with G-proteins not only introduced a novel G-protein regulator, but the
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additional finding of a Gu binding motif introduced a novel signaling motif, the GPR
domain. Most of the data presented in this aim were published in two

me papers (115,

198). Data gathered on G18.1b has not been submitted for publication. Methods used in
this aim to define Ga binding domains have been submitted for publication in Methods in
Enzymology (208). Some of the constructs used in this aim, most notably the GST-GPR

fragment, have been used in collaboration with Dr. Stephen Graber of West Virginia
University and Dr. Nickoli Artemyev of the University of Iowa.

Natochin and co-

workers used the GPR domain in his publication characterizing the biochemical
properties of AGS3 (209). Peterson has headed efforts to characterize the properties a
peptide derived from the AGS3-GPR repeat. Using variations of the assays presented in
this aim, he was able to show that the GPR peptide can block protein-protein interactions
(210).

Based upon characterization of GPR mutants, he was also able to duplicate

findings that OPR mutant peptides do not interact with G-proteins (210).
The discovery of the GPR domain has not only been a foundation for our
laboratory, but it has added an additional motif to the well-studied field of G-proteins.
Beside receptor, GJ3y and effectors only one protein family is known to interact with On
subunits, the RGS family. The ROS domain and the GPR domain do not share any
similarity nor are their functions shared. RGS proteins contain one copy of the RGS
domain, giving the protein its GAP activity.

GPR-containing proteins, which are

otherwise unrelated, contain from one to four copies of the domain. Our data indicate
that one domain is capable of binding to Ga., suggesting that the GPR domain serves as a
Ga. anchor. For proteins such as ROS12 and RGS14, the

presen~e

of a GPR domain may

provide an additional Ga binding surface working in concert with the RGS domain.

89

the protein (119). In this regard, the GPR is a Ga anchor on an "effector" molecule,
Rap 1GAP. The Rap 1GAP family member RaplGAPll is a mediator of Gia stimulation
of ERK (211). Initial studies with Pcp-2 suggested that Pcp-2 acted as a GEF for Goa
subunits (152). The influence of Pcp-2 on Gn function has since been re-examined
calling these data into question (206). The hypothesis that the GPR is a Ga anchor is not
completely solid since some proteins such as the AGS3 splice variant expressed in the
heart contain little more than GPR domains (212). Such proteins imply that the GPR
regulates the function of Oa subunits. Our efforts to characterize the effects of the OPR
domain on Ga function are presented in chapter 6.
. Another distinguishing feature of the GPR domain is its size. The Gn binding site
on RGS proteins is a 120 amino acid region known as the ROS domain. The GPR repeat
is a smaller domain, whose core is less than twenty amino acids. Therefore, in addition
to being a signature Gc:x binding motif, the GPR may also be developed as a biological
tool.

Subsequent aims will demonstrate that the function of the domain has been

determined. Currently studies are underway to develop the GPR peptide as a method of
delineating signaling pathways and possibly as a template for the development of an
organic compound.
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CHAPTERS
SPECIFIC AIM 2
Determine if AGS3 specifically interacts with G-protein subunits
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Introduction
Heterotrimeric G-proteins are a diverse set of signaling proteins involved in a
wide array of biological pathways. As mentioned in the literature review, diversity of Gprotein subunits contributes to the generation of signaling specificity.

Different Oa

families are distinguished not only by sequence, but also by the class of effectors that
they engage. In addition, some classes of Ga subunits seem to signal through their GJ3y
subunits with relatively higher frequency_

G-protein regulators generally act upon a

specific Ga family and therefore affect a subset of signaling systems. The RGS family
contains GAPs for the Gin, Gqa and Gl2/13a families but not the Gsa class. In fact,
most G-protein regulators act upon the Gia family whereas few Gsa regulators have been
described. Since the NG-108 activator was shown to activate brain G-protein, which
contains mostly Gia family members, the initial expression cloning screen used a
modified Gia2 subunit to identify G-protein activators. Therefore we initially focused
our AGS3 protein-protein interaction studies upon the Gia class. To further characterize
the novel G-protein regulator, we sought to determine if AGS3 interacted specifically
with G-protein subunits.
Based upon the yeast expreSSIon cloning system, the activity of AGS3 was
selective for Gia2 and Gia3 heterotrimers.

AGS3 did not activate heterotrimers

containing Gsa, Gl6a or the endogenous yeast Ga, GPAI (Figure 1.4). The initial
motivation for this aim was to verify if AGS3 selectively interacted with Gia subunits.
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The previous aim clearly demonstrated that AGS3 interacts with Ga. subunits in coimmunoprecipitation and GST pulldown experiments.

We used these techniques to

assess the preference of AGS3 for Ga. subunits. Two sources of G-proteins were used: 1)
G-proteins as components of cell/tissue lysates, 2) purified G-protein subunits. Through
a long-tenn collaboration with Dr. Hildebrandt we were generously provided with
specific G-protein antisera.

Our collaboration with Dr. Graber of West Virginia

University was the source of purified Gia.1-3 and Goa. subunits. Gsa. and Gqa. were
kindly provided by Dr. Ross of the University of Texas Southwestern.

Transducin

subunits and heterotrimers were gifts of Dr. Hamm of Northwestern University. Using
cell/tissue lysates as our source of G-protein, the preference of AGS3 for Ga. subunits
could be determined.

With the purified subunits, a more standardized comparison

between affinities of AGS3 for Ga. subunits could be made.
The discovery reported in the previous aim that each GPR repeat could
independently bind to Ga. raised additional questions about the AGS3-Ga interaction.
Specifically, we wanted to know if AGS3 could simultaneously interact with mUltiple Ga.
subunits.

We designed a co-immunoprecipitation experiment such that multiple Ga.

interactions could be tested. Immunoprecipitates from a mixture of Gia.2 and Gia.3 using
Gia3 antisera were evaluated in the presence and absence of AOS3-GPR.

Our

hypothesis was that, in the presence of AGS3, Gia2 would be present in Gia.3
immunoprecipitates. This experiment also assessed whether AGS3 could simultaneously
interact with different Ga. subunits.

This approach is limited in that a rigorous

determination of AGS3-Ga. stoichiometry could not be determined.
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Results
Does AGS3 interact with specific Ga subtypes?
The preceding aim clearly established the interaction of AGS3 with Ga within the
cell and defined the regions of AOS3 involved in G-protein binding. We then asked if the
interaction of AGS3 with Oa was selective for different O-protein families. We
approached this question using crude tissue/celllysates and purified Oa subunits. The
AOS3-GPR GST fusion protein was incubated with rat brain lysate and bound proteins
identified by immunoblotting with Oa specific antisera. AOS3-GPR effectively bound
Gial-3, but not Gsa, Goa, Gqa. or GJ3y (Figure 5.1). Based upon the comparison of the
signal intensity in the input versus sample lane, it is estimated that AGS3-GPR binds
-20-% of the total Gia protein in the lysate sample. Similar results were obtained in

DDT}-:MF2 cell lysates. Each of the protein interaction experiments in the tissue/cell
lysates was done in the presence of GDP, which would stabilize heterotrimeric

Ga.~y;

however, immunoblotting with G-protein a. subunit antisera indicated that AGS3 was
complexed with Giain the absence of Gf3y (Figure 5.1).

Does AGS3 interact with specific members of the Giloa family?
The selectivity of AGS3 for different G-proteins within the Gilo family was also
observed using purified Ga. subunits. AGS3 bound to Gial-3 and purified Gta., but it did
not interact with Gsa. and weakly bound Oqa. and Goa. (Figure 5.2). A similar profile of
AGS3 selectivity for Ga. subunits was observed in a yeast functional assay (115).
Comparison of the relative intensities of the bound Ga. versus input Ga. for Goa, Gqa
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Figure 5.1 Selective interaction of AGS3 with G-proteins from brain lysates. One milligram of lysate protein from rat brain
was incubated with 300 nM GST -AGS3 fusion (TPR MI-I462, GPR P463-S650, CT M577 -S650). Membrane transfers of bound
proteins were probed with the indicated antisera. The input lanes represent one tenth of the G-protein used in each interaction
assay. Membrane transfers of bound proteins were probed with the indicated antisera with intervening stripping of the blot as
described in the methods section. The Gia3 antibody exhibits some cross reactivity with Goa that likely accounts for the broad
immunoreactive band observed in the input lane. Similar results were obtained in 2-3 separate experiments.
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Figure 5.2 Selective interaction of AGS3 with purified G-proteins. Recombinant Ga (100 nM) or purified Gta (100 nM) were
incubated with 300 nM GST or AGS3-GPR. All interactions were done in the presence of 10 JlM GDP. The input lanes represent
one tenth of the G-protein used in each interaction assay. Membrane transfers of bound proteins were probed with the indicated
antisera. Similar results were obtained in 2-3 separate experiments.

and Gia (Figure 5.2) indicated a higher apparent affinity of AGS3 for Gi versus Go/Gq,
which may account for the inability of AGS3 to interact with Gqaf3y and GoaJ3y in brain
lysates (Figure 5.1).

Does AGS3 interact with multiple Ga subunits?
The interaction between individual GPRs and Ga subunits suggested that AGS3
is capable of binding mUltiple Gia subunits. To address this issue, we asked if a GSTAGS3 fusion protein containing GPRs I-IV indeed bound more than one Gia. at the same
time. A GST-AGS3 fusion protein containing GPRs I-IV was incubated with a mixture of
Gia3 and Gia2. Samples were then immunoprecipitated with antisera directed against
the carboxyl terminus of Gia.3. In the presence of AGS3, Gia2 was also found in the
Gia.3

immunoprecipitate

(Figure

5.3).

Gia2

was

not

found

in

the

Gia.3

immunoprecipitate in the absence of AGS3 (Figure 5.3). These data clearly indicate that
AGS3 is capable of binding more than one Gin subunit consistent with a putative role of
AGS3 as a scaffolding protein within a larger signal transduction complex.

Discussion
The results of experiments performed in this rum demonstrated a specific
interaction between AGS3 and Gial-3. Additionally, AGS3 was shown to be capable of
interacting with multiple Go. subunits. G-protein interaction assays using rat brain lysate
revealed that AGS3 selectively pulled down Gia subunits. The finding that AGS3 does
not interact with Goa is surprising, given the expression of both proteins and the high
percent homology between Goa and Gia. Goa represents up to 1% of particulate protein
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Figure 5.3 Interaction of AGS3 with multiple Gia subunits. Gia2 (200 nM) was incubated with Gia3 (50 nM) in the
presence or absence of the AGS3-GPR GST -fusion protein (250 nM). Samples were immunoprecipitated with Gia3 antisera
and processed for SDS-PAGE as described in the methods section. Membrane transfers were immunoblotted with the indicated
antisera. The arrows to the left indicate the migration of the indicated proteins. Similar amounts of Gia3 antisera were pelleted
in each lane as indicated by detection with secondary antibody. Input lanes represent one tenth of the the sample processed for
immunoprecipitation. This experiment is representative of 3 such experiments.

in the brain (14, 35) and AGS3 expression is enriched in brain (198, 212). Experiments
using purified Oa subunits confirmed what was observed in lysate experiments.
Comparing the relative amounts of G-protein in the input lane to the amount bound by
AGS3-GPR, the selectivity of AGS3 for Gial-3 is apparent. Experiments validating that
AGS3 can bind to multiple Oa subunits also confinned that the binding of one type of
Ga subunit does not exclude the binding of another.

Another degree of specificity

discovered in a previous aim is the preference of AOS3 for GDP-bound Ga subunits
(Figure 4.1). Collectively these experiments suggest that AGS3 specifically influences
Gia signaling pathways and that AGS3 is functioning through

multiple~

simultaneous

interactions with GDP-bound subunits.
The data presented in this chapter give us better resolution of the nature of the
AGS3-Ga interaction. Again, the results of these experiments validate the data obtained
from the expression cloning system. By knowing which O-protein signaling pathways
are being

affected~

the function of AGS3 can be more efficiently examined.

Demonstration that AGS3 interacts with multiple Ga. subunits suggests that AGS3 might
serve a role as a Ga. scaffolding protein. The absence of Gl3v from GST-GPR pulldowns
in the presence of GDP stimulated a series of work to assess if AOS3 influenced Gprotein subunit interactions. Data gathered in this aim were published in the Journal of
Biological Chemistry (198).
Compared with published reports of other proteins containing GPRs, the
selectivity of AGS3 for Gia subunits is relatively limited. Whereas our data restricts
AGS3 binding to Gia.I-3 and transducin, DeVries reported that AGS3 interacted with
Goa. in the context of a two-hybrid screen (213). LON, which was originally isolated in a
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yeast two-hybrid screen with Gia2 (151), has also been isolated in yeast two-hybrid
screens with Gia.3 and Goa. (152). Both pcp-2 (152) and Rap 1Gap (119) were identified
by yeast-two hybrid screening as Goa interacting proteins. Pcp-2 also interacted with
Gia but not Gsa in GST pulldown experiments (152). RaplGap was also identified as a
GZ(l (214) and Gicx.2 (119) interacting protein, but was not found to interact with Gsa. or
Gqa. (206).

Discovery of the GoLoco domain stemmed from observations that the

RGS12 homolog in D. melanogaster, loco, could regulate the function of Goa.
Mammalian RGS12 and RGS14 serve as GAPs for Gia. and Goa. but not for Gqa. and
Gsa. (215). The variability existing between GPR proteins can be explained by variations
in the repeat amino acids. In the case of RapIGAP, the most promiscuous GPR protein,
the GPR repeat begins at amino acid 10 leaving out a hydrophobic, aromatic region
conserved in most GPRs.

AGS3 (115, 198), LGN (151) and RaplGAP (119) each

showed preference for the inactive state of Ga. subunits whereas Pcp-2 did not display
any selectivity for GDP vs. GTPyS bound Ga. (152). RGS proteins nonnally prefer the
transition state of Ga. subunits. No comparisons have been made between RGS12/14
selectivity and other RGS protein selectivity for Ga. activation states.
The suggestion that AGS3 selectively interacts with Gia. subunits over Goa. is
remarkable considering the expression profile for AGS3.

Not only is the interaction

specific for SUbtype, but it is specific for the conformation of the alpha subunit. AGS3
binds to the GDP-bound conformation of Gia. subunits, the same confonnation that GJ3y
interacts with. Interestingly no

G~y

was found in protein complexes anchored by AGS3-

GPR. Either AGS3 is accessing a pool of free Oia. subunits or Oa. bound to AGS3 no
longer are able to bind to OJ3y. As stated above, this finding led us to the hypothesis that
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AGS3 might influence G-protein subunit interactions.

Most G-protein effectors and

regulators only have a single G-protein binding domain therefore making the mUltiple Gu
binding domains on AGS3 family members unique.

The phenomenon is not

characteristic of GPR-containing proteins since most have only a single repeat. If the
GPR domain can regulate G-proteins, then AGS3 might be involved in rapid regulation
of G-protein signaling. An unlikely scenario is that G-proteins act upon AGS3 in sets of
four to exert biological function.
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CHAPTER 6
SPECIFIC AIM 3
Determine the mechanism by which AGS3 activates G-protein signaling.
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Introduction
The yeast expression cloning system was designed to isolate the NG-108 activator
(141) and any other putative G-protein activators.

All known G-protein activators,

including the factor isolated from NG-108 membranes, were Gn GEFs, guanine
nucleotide exchange factors. AGS proteins were isolated based upon their ability to
activate the pheromone response pathway, a Gf3y mediated pathway. Therefore these
proteins were each able to liberate G~y, allowing it to engage effectors. Manipulations of
the yeast system indicated that each AGS protein was using a distinct mechanism to
release Gf3y. Efforts to determine if AGS proteins were GEFs led to the surprising
finding that AGS3 could activate the yeast expression cloning system without requiring
nucleotide exchange. Moreover, the activity of AGS3 was not antagonized by overexpression of an RGS protein (Figure 1.5).

Since AGS3 was not a GEF, it likely

represented a novel class of G-protein activators. Therefore the purpose of this aim was
to determine the mechanism by which AGS3 activated G-proteins.
One hypothesis concerning AGS3 function was that AGS3 might be influencing
heterotrimeric G-protein subunit interactions. Figure 6.1 depicts our notion that AGS3
could bypass the formation of GaGTP and liberate Gf3y by stimulating subunit
dissociation. Such a mechanism of activation had not been described in the literature for
heterotrimeric G-proteins.

Our approach was to use protein-protein interaction

techniques to determine if AGS3 was influencing G-protein subunit interactions. We
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Figure 6.1 AGS3 and the activation/deactivation cycle. G-proteins are regulated by activating proteins known as GEFS and
negative regulators known as GAPS. GEFs and GAPs control the available pool of GaGTP in a given signaling system. AGS3
was not abolished in yeast strains expressing a Gia2 mutant incapable of binding to GTP. Therefore AGS3 was not likely
acting as a GEF. Over-expression of a GAP, RGS4, did not antagonaze AGS3 activity also suggesting that AGS3 did not
require the formation of GaGTP. AGS3 was possibly acting at the level of subunit dissociation

designed our GST pulldown and immunoprecipitation assays to analyze AGS3-G-protein
complexes.

If AGS3 was influencing G-protein subunit interactions then protein

complexes anchored by AGS3 would contain only Ga and not GPy in the presence of
GDP. H this hypothesis was correct then AGS3 and Gfiy would- be expected to compete
for binding to Ga. We could test this hypothesis by using GST-pulldown experiments.
Modifications of the original yeast screen suggested that AGS3 was not a OEF.
Outside of the yeast system, the influence of AGS3 on the nucleotide binding state of Gproteins had not been determined. As an approach to determine if AGS3 influenced the
activation-state of G-proteins, we used GTPyS binding assays. In the presence of the
non-hydrolyzable analog of GTP, GTPyS, Ga subunits bound to GDP will undergo
nucleotide exchange. This process of nucleotide exchange can be monitored by using
GTpt5S. GTPyS binding assays were well-established in our laboratory, where they had
been used to detect activators (141). Early experiments by Catalina Ribas showed that
AGS3-CT did not stimulate GTPyS binding to Ga subunits but those experiments used
low total binding to Ga subunits. We altered the system to detect if AGS3 was inhibiting
GTPyS binding by raising the level of total binding. Through our collaboration with Dr.
Graber we obtained purified Ga subunits used in the nucleotide binding assays.
G-protein regulators can influence the transfer of signal from receptor to Gprotein andlor they can influence the activation state of G-proteins independent of
receptor. GTPyS binding experiments with AGS3 addressed the latter, but we had no
data concerning the former. Most of our experiments involved purified G-proteins or Gproteins in the context of a cell or tissue lysate.

The influence of AGS3 on the

receptor/G-protein complex was yet to be addressed. Our discussions with Dr. Graber
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engendered the idea that we could test the influence of AGS3 on receptor/G-protein
signal transfer with high affinity agonist binding assays. In the absence of G-proteins,
receptors adopt a low affinity for agonist and in the presence of heterotrimers adopt a
high affinity for agonist. Since Dr. Graber's laboratory had an established system to
study high affinity agonist binding, we asked them to test the influence of AGS3 on the
formation of the high affinity state of G-protein coupled receptors. If our hypothesis was
correct concerning the ability of AGS3 to dissociate heterotrimers, then the high afinity
state would be disrupted.

Results
Can AGS3 influence G-protein subunit interactions?
The ability of AGS3 to dissociate heterotrimers was addressed by comparing
Ga.GDP pulled down with GST-AGS3 with GaGDP subunits immunoprecipitated from
the same batch of lysate.

AOS3-CT preferentially interacted with GaGDP versus

Ga.GTPyS in pulldown assays with crude cell lysate (Figure 6.2). Despite the presence of
GDP, which would stabilize the G-protein heterotrimer, the AGS3-GaGDP complex
from the mammalian cell lysate did not contain GJ3y. In contrast, Gf3y subunits were
readily detected when GaGDP was isolated from the same cell extract by
immunoprecipitation with a Ga subunit antibody (Figure 6.2). In a reciprocal experiment
N-terminally His6 tagged Gia2 was used as an anchor to pull down protein complexes.
HiS6-

Gia2GDP and bovine brain GJ3y were incubated in the presence and absence of

GST and GST-AGS3-CT. Using a nickel resin, protein complexes were captured and
analyzed by immunoblotting. Heterotrimer formation as indicated by the presence of
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Figure 6.2 Absence of GJ3y in AGS3-Ga protein complexes. 225 J.!l of lysate containing GDP (30 J.!M) or GTPyS (30 J.!M)
were incubated with GST or GST-AGS3 (300 nM) for 30 minutes at 24°C. 25 J.!l of a 50% slurry of glutathione-sepharose was
added to bring down protein complexes. Bound proteins were solublized and processed for SDSIP AGE. Gia3 was
immunoprecipitated as described in the Methods section. The input refers to 10 J.!l of the incubation mixture used for either the
interaction or immunoprecipitation experiments. Bound proteins were solublized and processed for SDS/PAGE and
immunoblotting of membrane transfers. Gia subunits were detected with the Gia3 antibody and GJ3 was detected with an
amino terminus antibody. Experiments were repeated four times with similar results.

Gj3y was observed for the control and GST treated samples, but not for the samples
treated with GST-AGS3-CT (data not shown). These data support the hypothesis that
AGS3 activates G-protein signaling by influencing subunit interactions. Alternatively, it
is possible that AGS3 is selectively interacting with a population of Ga in the cell that
exists independent of Of3y and sub serves unexpected functional roles.
As both AGS3 and GJ3y interact with the GDP-bound conformation of Ga, the
two proteins may actually compete with each other for interaction with Ga and thus
AGS3 would essentially promote subunit dissociation in the absence of nucleotide
~\:

exchange. This issue was addressed by determining the influence of G(3y on the
interaction of AGS3 with Gta. We first compared the ability of AGS3 to interact with
purified Gta. versus heterotrimeric Gt (Figure 6.3). At equimolar concentrations of
purified Gta. and heterotrimeric Gt, AGS3 bound equivalent amounts of Gta.

As

observed with the AGS3-Gia complex isolated from tissue/cell lysates, Gj3y was not
present in the AGS3-Gta. complex isolated from purified heterotrimeric Gt, indicating
that AGS3 effectively dissociated Gt from GJ3y. We thus asked if GJ3y would interfere
with formation of the AGS3-Gta. complex. In these experiments, Gta. was first incubated
with equimolar or excess O(3y to generate heterotrimeric Gt prior to exposure of the
complex to AGS3.

The interaction of AGS3 with Ga was not altered by GJ3y at

concentrations equivalent to Gu, as observed in the experiments using heterotrimeric Gt

(Figure 6.4).

However, the interaction was completely blocked by lO-fold higher

concentrations of G(3y (Figure 6.4), indicating that AOS3 and Gfiy are effectively
competing with each other for binding to GaGDP.

108

$-

,~~

(j~

~~
~(j

(;"

~

$-

,~~

(j~

~~
~(j
(;"

~

Gta - .

~

o

\0

G~

-.

Gta

Gta~y

Figure 6.3 Influence of G~y on the interaction of AGS3 with Gta. AGS3-GPR (300 nM) was incubated with purified Gta
or Gta~y (100 nM) and processed for protein interaction studies. The data presented are representative of five individual
experiments with Gta and two experiments with Gta~y using different batches of fusion proteins. The blot was first probed
with the Ga antisera and then stripped for reprobing with the G~ antisera. The input lane contains 1/10 of the lysate volume
used in each interaction assay.

Gt~y

$

"'~~
Gta

50

500

[oM]

50

500

-+

~
~

o

GST

AGS3-GPR

Figure 6.4 Competition ofG~y with AGS3 for Gta binding. AGS3-GPR (100 nM) was added to tubes containing Gta (50
nM) that had been preincubated with G~y (50 or 500 nM) and samples processed for protein interaction assays. Similar data
were obtained in two experiments. The input lane contains 1/5 of the lysate volume used in each interaction assay.

How does AGS3 influence the activation state of G-proteins?
AGS3 and GJ3y compete for binding to GaGDP. Since GJ3y is known to inhibit
GDP dissociation from the Ga. subunit, we hypothesized that AGS3 might act in a similar
manner to regulate the activation state of Ga.. To address this issue, we asked if AGS3
influenced the guanine nucleotide binding properties of Gia.. AGS3-GPR blocked the
binding of GTPyS to Gia.l (ICso -- 0.1 J.1M) (Figure 6.5). We had previously identified
key amino acid residues in GPR-IV that disrupted binding of AGS3-CT to Gia. We next
examined the effect of this series of AGS3-CT mutants on GTPyS to Gia,l. The AGS3CT peptides containing GPR mutations that resulted in a loss of binding to Gia. in protein
interaction assays (F609R, R624F) (115) were also ineffective at inhibiting GTPyS
binding to Gia.l (Figure 6.5).

These data, along with the results obtained in protein

interaction experiments where AGS3 preferentially binds GaGDP versus Ga.GTPyS,
suggest that AGS3 actually stabilizes the GaGDP or nucleotide-free conformation and
functions as an inhibitor of guanine nucleotide exchange on Ga. These biochemical data
are consistent with the functional properties of AGS3.in S. cerevisiae in that the action of
AGS3 did not require the generation of GaGTP, and was not antagonized by overexpression of the GTPase activating protein RGS4 (115).

Can AGS3 influence the transfer of signal from receptor to G-proteins?
The AGS3-GPR motif can influence subunit interactions by interfering with GJ3y
binding to Gia and can inhibit nucleotide exchange on Gia. The influence of the AGS3-
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two experiments.

GPR domain on subunit interactions and nucleotide exchange would have significant
implications for signal processing. First, interaction of the AGS3-GPR motif with Ga
would release Gl3y for regulation of downstream signaling events, while stabilizing
GaGDP (115). A second implication of stabilization of GaGDP by a GPR domain is
related to receptor G-protein coupling. We addressed this issue experimentally using a
membrane assay system where receptor-G-protein coupling is reflected as high affinity
binding of agonists. The high affinity binding of agonist observed upon reconstitution of
the membrane-bound 5-HT1A receptor with Oi was inhibited by addition of GST-GPR
but not GST alone (Figure 6.6). These data confirm that AGS3 can disrupt heterotrimer
formation in the presence of G-protein coupled receptors.

Discussion
The results of experiments in this aim defined the mechanisms by which AGS3
activates G-protein signaling. Protein interaction experiments comparing Ga bound to
AGS3 and Gu immunoprecipitated from cell lysates reveal that the Ga interacting with
AGS3 does not interact with Gl3y despite the presence of GDP. When presented with
purified heterotrimeric Gt, AGS3 only brings down Ota but not Ol3y subunits. Using
increasing amounts of Gl3y, the interaction between AOS3 and Gta can be abolished
confirming that AGS3 and Gf3y compete with one another for Ga subunits. AGS3 not
only binds to Go:GDP, but it stabilizes Go: in its GDP bound form . AGS3-GPR, in a dose
dependent manner, blocks the conversion of Go:GDP to Go:GTPyS.

Mutant AGS3

proteins that do not interact with G-proteins do not influence their nucleotide binding
properties. Therefore AGS3 can regulate the activation state of G-proteins independent

113

12.5

I

-

.~

10.01

......

~

Il:/;,-I-i

Membranes
Membranes & af3y
Membranes & a

0

~

'-'"

.-e

7.

=
0

~

~

5.

==
In
~
~

2.

~

o.

~

~

v~~

~

~~

(jc;

~

~#

(j~

~

~

v~~

~

~~

(jc;

~

~#

(j~

~

~
v~

~

~~

(jc;

~

~#

(j~

~
~
~
Figure 6.6 Influence of AGS3-GPR on receptor/G-protein coupling. Sf9 cell membranes expressing 5-HTIA receptors were
reconstituted with G-proteins in the presence and absence of GPR peptides as described in the Methods section. The final
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affinity, guanosine 5'-(,-imido)triphosphate-sensitive binding site. The control bar indicates the amount of agonist binding
observed in the absence of added G-protein. Data are presented as the mean ± S.E. from four independent experiments.

of receptor stimulation.

When placed into a reconstituted receptor/G-protein system,

AGS3-GPR abolished the high affinity state suggesting that AGS3 disrupted heterotrimer
formation and thereby influenced the transfer of signal from receptor to G-protein.
The findings resulting from this aim delineate the mechanism by which AGS3
activates G-protein signaling and distinguish AGS3 from other known G-protein
regulators. Beside the discovery that the N-terminus of caveolin can inhibit nucleotide
exchange of G-proteins (81), this is the only protein known to act as a heterotrimeric Gprotein GDI, guanine nucleotide dissociation inhibitor.

With the exception of the

receptor reconstitution experiment performed in Dr. Graber's laboratory, the data
presented in this aim were published in the Journal of Biological Chemistry (115, 198).
The ODI property of AGS3 was also subsequently verified by two other groups led by
Artemyev and Devries (209, 213). Natochin and co-workers used our fusion protein
constructs in assays

similar to those described in this chapter but in the

rhodopsinltransducin system (209). DeVries and co-workers isolated AGS3 in a yeast
two-hybrid screen with Gia3 and characterized its properties using Biacore plasmon
resonance and nucleotide binding assays (213). Simultaneous with the discovery that
AGS3-GPR could inhibit GTPyS binding to Ga. subunits, Peterson discovered that a
peptide derived from AGS3-GPRIV had the same effect (210).

Subsequent studies

demonstrated that the GPR peptide stabilized the GOP-bound state of Oa. in a "GDP-off'
experiment and that the Ga. bound to AGS3-GPR contained GDP. In the same receptor
reconstitution assays used in Figure 6.6, the GPR peptide was also effective in
uncoupling receptors from G-proteins (210).

Additional data about the GPR

structuraVfunctional relationship has been obtained using a series of mutant GPRs. We
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have also sent GST-GPR constructs to Dr. Stephen Sprang of the University of Texas
Southwestern to initiate efforts to co-crystalize AGS3 with Ga. Currently, as part of our
collaboration with Dr. Graber, the selectivity of individual GPR repeats to disrupt Gprotein heterotrimers and whether the repeats have differential effects on the formation of
the high affinity state are currently being investigated.
Through our efforts to characterize AGS3, a new Gn binding domain, the Gprotein regulatory domain, was defined.

The results from this aim complete our

characterization of the GPR as a Gia binding domain with guanine nucleotide
dissociation inhibitory properties.

The presence of the GPR in a protein not only

suggests an interaction with GiaGDP, but also suggests that the protein is a
heterotrimeric G-protein GDI. Recently, the Artemyev laboratory reported the effects of
several GPR proteins on Ga guanine nucleotide binding (206). Each of the proteins
tested (LON, Pcp-2 and RaplOap) was demonstrated to be a ODI. Their findings conflict
with the report that Pcp-2 is a ODS, guanine nucleotide dissociation stimulator, for Ooa
(152). The presence of a ODI domain in Gn GAPs ROS12 and RGS14 suggest that the
two proteins may have unique influences on O-protein signaling. Through the GAP
domain RGS12 and RGS14 could terminate a Ga signal, and through the GDI domain
keep the Oa subunit from being re-incorporated into a heterotrimeric G-protein signaling
cascade. A summary of the properties of GPR proteins is included in Table 6.1.
AGS3 acting as a heterotrimeric G-protein GDI adds an unexpected dimension to
field of G-protein signaling.

AGS3 is also distinguished as a protein capable of

dissociating heterotrimeric G-proteins without requiring nucleotide exchange.

This

activity likely accounts for the isolation of AGS3 as a G-protein activator in the yeast
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Gilo (Scaefer 2000)

?
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protein
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RGS12

GO,Gi

GAP
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GO,Oi
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G18.1b
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Table 6.1. GPR Proteins
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expression cloning system and may be suggestive of AGS3 function. AOS3 releases G~y
from heterotrimers allowing it to activate the pheromone response pathway. In a similar
manner, AGS3 may be a receptor independent activator of Ol3y pathways in mammalian
signaling systems.

However AGS3 is not a receptor independent activator of Gu

subunits since it stabilizes the GDP-bound state of Gin, the inactive state. In addition
Gin subunits bound to AGS3 cannot be recognized by G-protein coupled receptors. The
overall

effect

of

AGS3

IS

to

remove

Ga

subunits

from

their

typical

activation/deactivation cycle. The AGS3-GinGDP complex may therefore be a reservoir
~.

of Gin that can be tapped by GPy competition. In this capacity, AGS3 could desensitize
G-protein signaling pathways at the level of G-proteins. An alternate role for the AGS3GiaGDP complex may be in heterotrimer-independent signaling systems. An unknown
signaling regulator could stimulate nucleotide exchange selectively on the AGS3-Gia
complex and couple the two proteins to unique effectors (Figure 6.7). In such a pathway,
Ga. subunits could re-enter the normal G-protein cycle after termination of its signal.
GPR containing proteins represent a class of heterotrimeric G-protein GDIs. The
effects of these proteins reside in the newly described GPR domain. The AGS3 family is
distinguished from other GPR proteins since its proteins contain multiple GPR domains.
Since one of the repeats is capable of eliciting an effect, some questions arise regarding
the presence of four repeats with presumably similar capabilities in one protein. Multiple
GPRs may confer greater ODI activity to AOS3 compared with single OPR containing
proteins. Alternatively, multiple GPRs may suggest a distinct role for the AGS3 family.
AGS3 family members by binding to 3-4 Ou subunits could function to cluster Go. in
specific cell subdomains.

AGS3 would therefore be a G-protein regulator and a
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Figure 6.7 Functions of the AGS3·GiaGDP complex. The formation of AGS3-GiaGDP may have several consequences.
AGS3 can remove GiaGDP from the G-protein activation/deactivation cycle by preventing it from interacting with G~y, and
therefore receptor, thus causing desensitization at the level of G-proteins. AGS3- GiaGDP may also fonn as a means to affect
the subcellular localization of Gia. AGS3- GiaGDP may be activated by undefined exchange factors, causing the formation of
free AGS3 and GiaGTP possibly leading to the activation of unique effectors.

scaffolding protein for Ga. Strengthening this hypothesis is the presence of conserved
repeats in the N-terminus of AGS3 family members known to be involved in proteinprotein interactions, the TPR domain.
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CHAFfER 7
SPECIFIC AIM 4
Determine the functional role of the AGS3 TPR region.
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Introduction
The discovery of Activator of G-protein Signaling 3 (AOS3) was the result of a
long-term goal to identify G-protein regulators. AGS3 was first implicated as a Gn
regulatory protein based upon the activity of the carboxyl terminal 74 amino acids in a
functional screen designed to isolate receptor independent activators of G-protein
.;\~~

signaling. AGS3-CT could activate the pheromone response pathway in yeast strains
lacking the pheromone receptor. This activation was also independent of nucleotide
exchange on the Gn subunit. Analysis of full-length AGS3 revealed the presence of
distinct protein repeats in the N-terminus and C-terminus (Figure 1.10). The N-terminal
repeats are tetratricopeptide repeats (TPRs), degenerate domains involved in proteinprotein interactions. The C-terminus of AGS3 contains four GPR or GoLoco repeats
which have been sho.wn to bind to and stabilize the GOP-bound form of Gia subunits. In
addition, the GPR domain dissociated Gn from GJ3y and thus was thought to be
responsible for G-protein activation in the Saccharomyces cerevisiae expression cloning
system. The N-terminal TPRs and C-terminal GPRs are connected by a 100 amino acid
linker sequence with little homology to proteins in the GenBank database.
Although function has been ascribed to the C-terminus of AGS3 little is known
about the function of the TPR and linker domains of AGS3. TPRs, or TetratricoPeptide
Repeats, are 34 amino acid repeats of which only eight residues are conserved. Therfore,
there exists a high degree of variability in function among TPR containing proteins.
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TPRs are detected in over 450 proteins from bacteria to humans and function in various
cellular roles (154). The TPR domain in the AGS3 D. melanogaster homolog PINS is
responsible for interacting with Inscuteable (155 Yu, 2000 #368); however there is no
homolog of Inscuteable yet detected in either the C. elegans genome or in mammalian
genomes. PINS binds to a region of five ankyrin-like repeats in the Inscuteable sequence
which do not generate database hits when used in BLAST searches.

Through this

interaction, PINS gets recruited to apical membranes where it helps to stabilize the
polarity/asymmetry complex. Outside the AGS3 family, the TPR structure of AGS3 is
most closely matched by rapsyn- receptor associated protein of the synapse (Figure 7.1).
Nicotinic acetylcholine receptors in rapsyn knockout mice fail to cluster at post-synaptic
membranes (216).

The receptor binding domain of rapsyn was localized to the C-

terminus and the portion responsible for cluster receptors was found to be the TPR region
(189). Although not yet demonstrated, rapsyn is suggested to interact with dystrophin at
post-synaptic membranes to anchor its clusters (217). In both PINS and Rapsyn, the TPR
domains were involved in sub-cellular localization. Our hypothesis was that the TPR
domain served as regulatory domain for AGS3 by influencing its sub-cellular
localization. Since no binding partners of the AGS3TPR domain have yet been detected,
we performed a yeast two-hybrid screen using an N-terminal AGS3 construct as bait.
The focus of this aim was the screening of a mammalian cDNA library and identification
of candidate TPR binding partners.
With advice from Dr. Tim McQuinn and Mary Cismowski, we decided to use
Clontech Pretransformed Matchmaker Libraries as our source of prey sequences. In
constrast to co-transfection of bait and prey plasmids, Matchmaker two-hybrid systems
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Figure 7.1 TPR domains of AGS3 and related proteins. The domain structure of AGS3, PINS and rapsyn are schematically
depicted. Black boxes- TPR; Gray Boxes- GPR; nAR-BD- nicotininc Acetylcholine receptor binding domain. Underneath the
TPR domains are their functions and binding partners.

utilize mating of two haploid strains to generate yeast strains expressing both bait and
prey proteins (Figure 7.2). A positive interaction between bait and prey proteins induces
the expression of up to four reporter genes, two of which are nutritional. Two additional
nutritional markers are incorporated in plasmids of both bait and prey.

One of the

inducible reporter genes is LacZ affording the use of various f3-Galactosidase assays. To
initiate two-hybrid screening, our task was to generate bait strains and verify that they did
not cause basal activation of reporter genes. These strains would then be used to screen
mammalian cDNA libraries for candidate positive interacting proteins. Candidate clones
isolated by selection and/or reporter gene assays would be isolated and re-transformed to
confirm their activity. Using sequence analysis, positive clones could be restricted for
those clones that were in the proper open reading frame with respect to the prey vector.
This pool could also be narrowed by eliminating DNA binding proteins and extracellular
matrix proteins whose distribution is strictly outside the cell. From this analysis we
sought to identify candidate clones with which to further our studies with AGS3. The
first steps in characterizing these clones would be to perform interaction assays outside of
the yeast system to confirm the association between the clones and AGS3.

Results
Generation and characterization of bait strains.
Two N-terminal domains were used in two-hybrid screerung experiments:
TPRLong (TPRL) and TPRShort (TPRS) (Figure 7.3A).

AGS3-TPRL (M1-1462)

contains the TPR domain and the linker region whereas TPRS (M1-G337) contains only
the TPR domain. Each of these constructs was subcloned in the bait vector pGBKT7 and
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Figure 7.2 Yeast two-hybrid screens. Positive protein-protein interactions can be detected by nutritional selection as shown in
the cartoon. Yeast expressing two hybrid proteins, Gal4AD-prey (cDNA library) and Gal4BD-bait (AGS3-TPR), can be
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Figure 7.3 Analysis of AGS3-TPR bait strains. A) AGS3 fragments used as bait in the yeast two-hybrid screen: TPRL- Ml1462, TPRS- MI-G337. B) Y187 "and AHI09 yeast strains containing empty vector, TPRL, TPRS and p53 (bait positive
control) were plated onto selective media indicating the uptake of plasmid (SD -TRP). After 3 days growth 5 colonies were
picked from each plate and re-streaked upon various selective media: SD-TRP, SD -LEU, SD -ADE, SD -HIS. Pictures were
taken after 3 days growth. Shown are representative plates. Small spots indicate pen marking to indicate the location of colony
streaks.

transformed into yeast strain AHI09 to generate bait strains. In our initial analysis, the
constructs were also transformed into the Y187 strain. Non-transformed yeast and yeast
transformed with empty vector, TPRL and TPRS were plated onto selective media
(Figure 7.3D). Growth was only detected on SD -rrp plates as expected. Compared
with a positive control, no basal LacZ activity was detected.

To verify if the TPR

constructs were expressed, protein extracts from AHI09-TPR strains were obtained and
analyzed by immunoblotting. Proteins migrating at the appropriate molecular weight
were detected by a monoclonal Anti-myc antibody (data not shown).

These data

confirmed that AGS3-TPR did not basally activate reporter gene expression in the
matchmaker system and that the AGS3-TPR fusion protein was expressed in the bait
strains.

Screen mammalian libraries for AGS3-TPR binding partners.
We performed three yeast two-hybrid screens with the AGS3-TPRL as bait. The
first two screens were of a rat brain cDNA library; a mouse 11 day-old embryonic cDNA
library was used in the third screen. Although the first screen was a technical disaster, we
learned enough from our mistakes to perform the second screen with sufficient expertise.
The results from the first two screens are not included. The focus of this chapter will be
on the results of the third screen. Despite the lack of evidence demonstrating expression
of AGS3 in mammalian embryos, the series of reports about PINS suggested that an
AGS3-TPR binding partner might be found in embryonic libraries. Each screen utilized
the same mating protocol, but the method to identify candidate clones differed. In the
first screen the mating culture was initially plated upon TDO (triple dropout: ""Trp, -Leu, -
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His) media, and candidate clones were selected by selective growth on QDO (quadruple
dropout: lrp, -Leu, -His, -Ade) media. In the second and third screens, initial plating was
upon QDO media and selection of candidate clones was achieved by f3-Gal assays
(Figure 7.4). Yeast plasmids from positive colonies were isolated and transfonned into
bacteria to amplify the plasmids for sequencing and retransfonnation. Sequence analysis
of each screen is listed in Appendix A. A summary of the candidate clones isolated from
each screen and the method used in each screen are listed in Table 7.1.

c:,:,~

Identify potential N-terminal regulatory partners of AGS3.
A yeast two-hybrid screen of a mouse II-day old embryonic library using AOS3-

TPRL (MI-1462) as bait yielded the identification of several AGS3 binding partners.
Four of these proteins are involved in aspects of asymmetric division and/or cell polarity
and were therefore became the focus of our efforts. The candidate TPR binding partners
are MACF- microtubule actin crosslinking factor, MRP- MARCKS related protein,
SrrKl1- Serineffhreonine Kinase 11 and the mouse homolog of Robo. Due to various
circumstances each candidate did not receive equal attention. In the last few months of
my laboratory work I

focus~d

upon SffKll and that work is described below. Before the

studies with StrKll are addressed, I will describe what is known about the three other
candidate proteins.

MACF- Microtubule Actin Crosslinking Factor
MACF is a member of a recently recognized family of giant cytoskeletal
crosslinking proteins, the plakins (218). MACF, isolated as ACF7, is a -5,500 amino
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Figure 7.4 Selection of positive clones. The mating c~lture ' was plated upon 120 QDO
plates·. . Ten colonies from each plate were selected and re-streaked onto QDO plates after 3
days of.growth . .Colony lift B-Gal assays resulted in 120 positive clones (10%) . . The ·120
colonies were re-streaked onto QDO plates (max 25 colonies per plate ) and allowed to grow
for 3 days. Colony lift assays on the 120 colonies resulted in the identification' of 16 colonies
that displayed strong B·-gal activity. Yeast plasmids were isola~ed from culture of the 16
positive clones and transfo.rmed in chemically competent KC-8 cells for amplification and
sequencing. Each positive clone was re-introduced into yeast strains to verify activity. 13 out
of 16 were positive in subsequent B-gal colony lift assays.
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Table 7.1 Yeast two-hybrid screening summary.

MACF (Kakapo)
SrrKll (Par-4)
Robo
MRP

acid protein with N-terminal actin binding domains, a microtubule binding domain,
twenty-three dystrophin-like spectrin domains, a calcium binding EF-hand repeat and
another microtubule binding domain related to Gas2 (Figure 7.5). MACF has related
proteins in the fruit fly genome collectively known as kakapo. The region of MACF
isolated in the two-hybrid screen (3560-4160) encompasses 5 dystrophin-like spectrin
repeats. MACF and kakapo direct microtubule formation from integrin-rich sites at cellcell boundaries and regulate the actin-microtubule interface (219, 220). Kakapo, named
for a wingless parrot, was discovered as a protein important for wing formation in D.
melanogaster (221).

Kakapo was also isolated as a gene important for dendritic

outgrowth and branching of developing neurons (222). Kakapo has been reported as
short stop since axons fail to grow to normal lengths in short stop mutant flies (223).

MRP- MARCKS Related Protein
MRP is a distant relative of MARCKS (Myristolated Alanine-Rich protein Kinase
C Substrate) sharing the N-terminal myristolation site, a MARCKS homology 2 (MH2)
site and a PKC sensitive CalCalmodulin binding site that also binds to actin (Figure 7.5)
(224, 225). MRP is also known as MacMARCKS and MLP (MARCKS-Like Protein) in
the Genbank database and in the literature. As yet, no homologs or MRP or MARCKS
have been detected in lower organisms.

Of the 204 total amino acids, the fragment

isolated in two-hybrid screening represents the last 175 amino acids of MRP containing
most of the functional domains except for the myristolation site at the N-terminus. MRP
is involved in general aspects of cell trafficking and morphogenesis during embryonic
development likely through its binding to and regulation of phospholipid vesicles (226,
227).

One report describes MRP as a basolateral determinant of epithelial cells and
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Figure 7.5 Yeast two-hybrid positive candidates. Schematics of whole proteins whose fragments were isolated in the two-hybrid
screen include protein domains as predicted from database searches and from publications. Underneath each protein is the region
isolated in the screen. Protein domains, amino acid length and other pertinent information are included. Protein domain
abbreviations are as follows: AD- actin binding domain, CAAX- C-terminal fatty acid modification site, ED- effector domain (ac tin
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homology domain 2, MT - microtubule binding domain, Myr- N-terminal site of myristolation, P- PKC phosphorylation sites, grey
bar- calcium binding domain, black bar- transmembrane domain.

is found basally localized in the neuro-epithelium. :MRP knockout mice fail to obtain
proper cranial neurulation likely through abnormal cell morphogenesis during neural tube
formation (228). Basal localization is mediated through a PKC dependent mechanism
and involves the actin binding domain in the C-terminus (229, 230).

Robo
Another positive clone represented the mouse homolog of the D. melanogaster
protein roundabout, or robo (231, 232). Robo regulates crossing of the CNS midline by
growing axons (231-234). Mammalian family members of robo have been reported in
the literature with similar function (235, 236). The C. elegans homolog, sax-3, has been
implicated in axon growth, guidance and maintanence in the developing nervous system
(237). Robo contains several IG-like domains in its extracellular N-terminus, a single
membrane span region and a cytoplasmic tail of roughly 400 amino acids. The fragment
of mRobo obtained in the screen represents the C-terminal 406 amino acids comprising
of the entire predicted cytoplasmic domain (Figure 7.5). Robo is a cell surface receptor
for the midline repellant Slit (238). In Robo mutants, axons that normally cross the CNS
midline once are found to cross numerous times (239). Robo is enriched in growth cones
during axon guidance and is up-regulated after axons cross the midline (234). While the
ligand for Robo is known, the downstream signaling events have not been characterized.

StrKll
One of the candidate clones contained the coding region of the C-terminal 107
amino acids of serine/threonine kinase 11 (SfTKl1). StrKl1, also known as LKB 1, is a
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product of a gene implicated in Peutz-Jeghers Syndrome, a condition manifested by
neoplasia of the GI tract (240). Mutations in SfTKl1 that inactivate the kinase domain
lead to increased risk of GI tract cancer suggesting a potential role as a tumor suppressor
(240, 241). The only identified protein domains in SffKll are the 180 amino acid kinase
domain (K44-P314) and a C-tenninal CAAX box, a site for fatty acid modification
(Figure 7.5). The region of SITKII interacting with AGS3 has no function ascribed to it,
yet it is -90% conserved between mouse and human. StrKl1 is also the mammalian
counterpart to the partitioning defect gene, Par-4, in C. elegans (242).

Par-4 was

discovered in a genetic screen looking for improper partitioning of cytoplasm of the onecell stage of C. elegans embryos (177).

Par-4 knockouts were initially reported to

generate arrest in early stages of development and to prevent the start of intestinal
development (243). Par-4 was recently identified as a serine/threonine kinase that directs
the proper localization of asymmetry determinants par-3 and par-6 in the one-cell stage of
C. elegans embryos (179, 242).
Re-screening of SffK11 and AGS3 constructs TPRL (MI-I462) and TPRS (Ml0337) using the two-hybrid method revealed selective binding of StrKll to AGS3TPRL (Figure 7.6). Compared to TPRS, TPRL contains an additional -120 amino acid
region that links the N-terminal TPR domains to the C-terminal OPR domains. This
domain is conserved between mice and humans, however it is not conserved in AGS3
family member LON nor is it conserved in AOS3 homologs in lower species. There are
no predicted protein domains or consensus phosphorylation sites within the linker region.
The bait construct TRPL does contain a consensus tyrosine kinase phosphorylation site
(Y226) as well as several PKC and Casein Kinase IT sites.
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Figure 7.6 Secondary screen of StrKll and MACF. Prey plasmids bearing clones 15B (MACF) and 741 (STKll) were cotransfected into yeast strain AHI09 with empty vector, TPRL and TPRS. Transformants selected upon SD -TRP, -LEU plates
were re-streaked onto QDO plates and allowed to grow for 3 days. If present, yeast growth spots were analyzed for (i-gal by
colony lift assay. Plus (+) indicated selective growth on QDO plates and positive LacZ activity. Minus (-) indicates no growth
onto selecti ve media~

Confirm interaction of AGS3 with potential binding partners.
To verify the interaction of SrrKll with AGS3, in vitro protein-protein
interaction studies were perfonned. GST-SrrKII (D330-Q436) was able to pull down
endogenous, full length AGS3 out of a rat brain lysate treated with either GDP or GTPyS
(Figure 7.7). Previous data indicate that AGS3 and Gin can exist in a protein complex,
therefore protein complexes were also probed for the presence of Gin subunits. Indeed,
Gin was present in protein complexes isolated from GDP-treated lysates, but not in
protein complexes isolated from GTPyS treated lysates. The selective presence of Gin in
GDP treated but not GTPyS treated lysates mirrors previous observations that the
interaction between AGS3 and Gia is enhanced in the presence of GDP.

Discussion
Using an II-day old mouse embryo library as prey we isolated several clones, one
of which corresponded to the carboxyl terminal 107 amino acids of serine/threonine
kinase 11 (SffKll). Other proteins isolated in two-hybrid screening with AGS3-TPRL
are involved in aspects of cell polarity/asymmetry.

SrrKll, also known as LKBI

(LKBl), is implicated in Puetz-Jeghers Syndrome, a condition characterized by
neoplasms of the GI tract. The downstream targets of SffKll kinase activity have yet to
be identified. SlrKl1 is also the mammalian counterpart of the C. elegans gene Par-4, a
member of a group of genes that display partitioning defects in early embryogenesis
when mutated. The region of SrrKl1 isolated in the two-hybrid screen begins just after
the kinase domain and ends at the C-terminus of the native protein. In subsequent two-
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Figure 7.7 Interaction of SffKll with AGS3. Rat brain (2 mg) lysates were preincubated with 30 nM GDP or 30 nM
GTPyS/25 mM MgCl 2 at 24°C for 30 minutes. Lysates were then incubated with 500 nM GST or GST -STK11(330-436) for one
hour at room temperature. Protein complexes captured by glutathione sepharose beads were analyzed by immunblotting.
Membrane transfers were first blotted with AGS3 P-32 antisera and then stripped and with Gia antisera. The data are
representative of2 experiments. The input lane contains 1/10 of the lysate volume used for each interaction assay.

hybrid analysis, the C-terminal fragment of SffKll interacted with an AGS3 fragment
containing the TPR domain and the linker, but it did not interact with the AGS3-TPR
region alone. When generated as a GST fusion protein, the SffKll CT was able to pull
down AGS3 from rat brain lysate.

Also present in this complex was Gia; subunits;

however Gia; was only present in protein complexes captured from GDP versus GTPflyS
treated 1ysates.
The results of two-hybrid screens described in this aIm have identified four
candidate proteins that bind to the N-terminal TPRs of AGS3. The data concerning the
interaction of AGS3 with SffKll serve as the foundation of a manuscript being prepared
for submission. Currently, Blumer working in Dr. Lanier's laboratory at the LSD Health
Science Center is continuing the work with the candidate interacting proteins.

If a

functional association between AGS3 and SffKll can be demonstrated, it would be the
first such finding that a mammalian AGS3 family member is linked to a determinent of
cell polarity.

Also, Dr. Lanier's laboratory is in the early stages of establishing

collaborations with laboratories that work on MACF, MRP and Robo. Each of these
proteins deserves their due attention as possible AGS3 interacting proteins (Figure 7.8).
AGS3 contains two distinct protein repeat domains; N-terminal Tetratrico-Peptide
Repeats (TPRs) and C-terminal G-Protein Regulatory (GPR) repeats. The TPR domain is
thought to serve a regulatory role in AGS3 function while the GPR domain serves a
catalytic role by activating G-proteins.

It is unclear if the GPR domain affects the

activity of the TPR domain; however the TPR does not affect the ability of the GPR to
interact with Ga; subunits. Based on studies with the AGS3 homolog in D. melanogaster
PINS, the TPR domain apparently regulates the function of AGS3 by interacting with
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Inscuteable (155, 156). PINS translocates to apical membranes of neuroblasts as they
delaminate from the neuro-epithelium. At the apical membrane, PINS forms a complex
with Inscuteable, Bazooka, dPar-6 and daPKC3 (244). The translocation of PINS and the
maintenance of PINS in that complex might be independent (173).

Modification of

AGS3 once it arrives at the apical membrane may anchor it in the complex until the
neuroblast divides and the complex dissolves.

SffK11 homolog Par-4 has been

demonstrated to direct the localization of asymmetry-determining proteins in C.

elegan~

(179). Worms expressing mutated forms of par-4 exhibit wide distributions of par-3
,~~~~

(homolog of Bazooka) and par-6 (homolog of DmPar-6) at the membrane distinct from
the specific localization found in wild type worms.

The interaction of AGS3 with

SffKl1 suggests a conserved functional role for SffKl1 in regulating components of the
asymmetry-determining complex.
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CHAPTER 8

SPECIFIC AIM 5
Determine the function of AGS3 in the intact organism.
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Introduction
At the inception of this project, the functional role of the AGS3 family was
unclear. Most of the work on AGS3 family members at that point had focused upon the
I

Gu binding domains in the C-terminus. An obvious question at the time concerned the
functional role of AGS3 and if AGS3 influenced G-protein signaling pathways. In 1998,
{~~

Fire developed a technique known as RNA interlerence that could quickly generate
knockout animals in the nematode C. elegans (190). Database searches indicated that the
AGS3 family had a member in the C. elegans genome containing five N-terminal TPRs
and four C-terminal GPRs. Overall homology between this protein and AGS3 was -42%
with most of the similarity in the GPR domain and to a lesser degree in the TPR domain

(Figure 8.1). After talking with several C. elegans researchers, we set up a collaboration
with Dr. Guy Benian of Emory University in Atlanta, GA. With Dr. Benian's help we
sought to generate RNA interference (RNAi) knockouts of the AGS3 homolog in C.
elegans, AGS3-CE. Simultaneously, we sought to map the distribution of AGS3-CE in
the whole animal.

This chapter describes our efforts to obtain preliminary data

concerning the function of AGS3-CE in the intact animal.
In 1998 the genome of C. elegans was completed and made public thus
representing the first finished genome of a multicellular organism (245). The release of
this data allowed us to analyze the gene structure of AGS3-CE and use it for our
purposes. With the promoter and initial coding regions of a gene, the expression of that
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Figure 8.1 Comparison of the AGS3 and AGS3-CE protein domains. AGS3 and AGS33-CE domains are indicated as
follows: Black (TPR); Gray (GPR). The predicted homolog of AGS3 was detected by BLAST searches as U40409. AGS3-CE
was the fourth gene contained on cosmid F32A6, thus it is also referred to as F32A6.4. Five entries into the est database of Yuji
Kohara (DNA database of Japan, www.ddbj.nig.ac.jp) contain the full length coding region of AGS3-CE: yk283d6, yk391f5,
yk404g12,yk432h7,yk469f8.

gene could be mapped out with the use of reporter genes. With vectors made available
by the Fire lab, we could generate these constructs and use them in expression mapping
experiments. Dr. Benian provided us with both reporter vector (pD96.04) and genomic
DNA from which to begin our studies. Our role was to make the constructs and bring
them to his laboratory to perform the microinjections.
RNAi is a method by which double stranded RNA of a coding region can repress
the protein expression of the encoded protein (190). Injection of dsRNA into the gonad
syncytia of a subadult worm results in the birth of a whole generation of knockout
animals. The effect is highly penetrant and is relatively expedient compared with other
knockout techniques (246, 247). RNAi can be easily duplicated and controled. We
obtained the AGS3-CE cDNA from the est repository of the DNA Databank of Japan
(www.ddbj.nig.ac.jp).

We manipulated this cDNA to make several RNAi templates.

Double stranded RNA was produced in our laboratory and brought to the lab of Dr.
Benian where the injections occurred. We hypothesized that AGS3-CE RNAi worms
would show phenotypes similar to those observed in G-protein mutants.

G-protein

function in C. elegans had been well documented and numerous genetic studies had been
reported (33, 55, 188).

Results
Determine the tissue distribution of AGS3-CE in C. elegans.
Using genomic sequence information, PCR primers were designed to amplify
I

regions of the AGS3-CE gene. Five prime primers, containing a Hind III site, were
positioned roughly 3 kb upstream of the start methionine of AGS3-CE. Three prime
primers, positioned in the second ex on of AGS3-CE, contained a BamHI site engineered
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to maintain the open reading frame of AGS3-CE and the coding regions of LacZ: :GFP in
the pD96.04 vector (Figure 8.2). PCR fragments were subcloned into the Hind III and
Bam III sites of pD96.04 and plasmid DNA was amplified in bacteria.
Sub-adult worms were co-injected with pD96.04-AGS3-CE promoter and a
marker gene, rol-6. Uptake of the rol-6 marker is characterized by abnormal "rolling"
motion and movement in circular patterns. Of over 40 worms injected with the AGS3CE promoter recombinant DNA, eleven of their progeny were detected that displayed the
roller phenotype. Progeny of injected wonns displaying the "roller" phenotype were
~~~

analyzed for LacZ and GFP expression. One adult worm exhibited GFP expression in the
chemosensory area near the head. The other ten did not display any GFP expression. In
adult worms, staining with X-gal revealed a consistent pattern of staining to that observed
in the GFP expressing worm (Figure 8.3A). Several sub-adults showed staining in the
chemosensory region and additional staining down the body of the worms (Figure 8.3B).
The pattern of expression is consistent with the C. elegans nervous system.

Define the knockout phenotype of AGS3 homolog AGS3-CE in C. elegans.
Double stranded RNA generated from an AGS3-CE full-length template was used
to generate RNAi worms. Injection of two sets of worms with AGS3-CE full-length
dsRNA gave vastly different results. A set of worms very close to adulthood did not give
birth to progeny displaying any noticeable RNAi phenotype. However a set of worms at
a more optimal stage for microinjection gave birth to a generation of progeny displaying
a distinct phenotype. AGS3-CE RNAi worms were arrested at a very early stage of
embryogenesis. They were also in clusters of 4-12, unlike the normal pattern of zygote
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Figure 8.3 Expression of AGS3 in the adult and sub adult Transgenic worms displaying the roller phenotype were stained for
the expres·sion of LacZ as described in the methods section. LacZ staining of A) an adult and B) a subadult worm containing the
AGS3 promoter-LacZ fusion vector. The adult worm (only head shown) is representative .of 7 such worms out a total of 11
rollers. The .sub adult (head-tail:right-Ieft) is representative of 2 such worms. Images were taken .with a camera mounted light
microscope (40X power).

distribution.

This effect was highly penetrant, displayed In over 80% of the Fl

generation (Table 8.1).

Discussion
AGS3-CE constructs for expresslon mapping studies and RNA interference
experiments were generated. AGS3-CE promoter constructs were injected into sub-adult
worms resulting in a somewhat similar staining in eleven worms. The expression profile
was consistent with that of the C. elegans nervous system. Although the sample size was
~t;J

small, there was the indication that the expression of AGS3-CE is developmentally
regulated. Staining patterns in younger worms were stronger than that observed in adult
Adult worms consistently displayed expression of AGS3-CE in the

worms.

chemosensory neurons. AGS3-CE RNAi worms were arrested at a very early stage of
embryogenesis, possibly in the one-cell stage, and were unusually clustered.

Each

embryo was of similar size in the groups of 4-12. The RNAi phenotype was highly
penetrant.
The preliminary microinjection experiments discussed in this aim were conducted
over the span of one week in the laboratory of Guy Benian at Emory University. During
this time, we were able to map the expression of AGS3-CE and generate a RNAi
phenotype. Unfortunately, we were not able to continue our collaboration after the initial
experiments were performed. Regardless, these experiments serve as a foundation for
future studies with AGS3-CE. We have sent our materials to the laboratory of Dr. Ohno
in Japan to initiate a collaboration. They are planning to continue the RNAi experiments
with AGS3-CE.
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Plate

Numbers

1

21/25

84%

2

48/51

95%

3

43/53

81%

4

13/17

76%

5

26/31

84%

6

28/35

80%

7

6/14

43%

8

55158

95%

9

18/19

95%

10

45/45

100%

11

53/68

78%

12

12125

48%

13

35/46

76%

14

34/34

100%

15

41/44

93%

Total

478/565

84.6%

Percentaee

.......
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o

Table 8.1 Analysis of AGS3-CE RNAi phenotype. Raw numbers and percentages of worms displaying the AOS3-CE RNAi
phenotype as displayed. Individual zygotes were counted, not zygote clusters.

The studies with AGS3-CE were conducted just prior to the discovery of PINS in
the fruit fly. With the additional flurry of reports about the polarity/asymmetry complex,
our AGS3-CE data need to be re-examined (Figure 1.11). If the protein complex used for
'establishing polarity or generating asymmetry is conserved from the nematode one-cell
stage to the fly neuroblast, our AGS3-CE RNAi results may have merit. Members of the
polarity/asymmetry complex PKC3 and Par-6 have a similar RNAi phenotype, embryos
in an amorphous cell mass (179). If we discount that AGS3-CE RNAi zygotes were
clustered, and re-interpret them as the results of abnormal embryonic division the AGS3CE RNAi phenotype is consistent with that of other polarity determinants. A recently
published manuscript implicated both Ga and GJ3 in the proper divisions of early
embryos, supporting the case that a heterotrimeric G-protein regulator is involved in
these processes (55). The authors concluded that the liberation of GJ3y is the primary
trigger of spindle rotation and asymmetric cell division.

Release of GJ3y is the

mechanism by which AGS3 activates G-proteins in mammalian systems. Expression of
AGS3-CE in the nervous system of C. elegans is consistent with expression patterns
observed across species. The apparent increase of expression in development correlates
with studies in the developing fly, in which PINS expression is highest during the early
stages of development (156).
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CHAPTER 9
DISSCUSSION AND CONCLUSIONS
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AGS3 was discovered as part of an effort to identify novel G-protein regulators.
Through biochemical, genetic and functional assays the work presented in this
dissertation has characterized the properties of AGS3 and has laid the ground work for
future discoveries.

AOS3 interacted with On subunits through its C-terminal GPR

domain, a novel signature motif for G-protein interacting proteins. This interaction is
specific for the Gia family, and AGS3 seems to prefer the GDP bound state of Gin
subunits.

Through its multiple GPR domains, AGS3 binds to as many as four On

subunits simultaneously. While bound to AGS3, Gn subunits neither undergo nucleotide
exchange nor can they be recognized by G-protein coupled receptors. AGS3 activity in
the original yeast expression cloning system can be explained by its ability to compete
with G(3y for binding to GaGDP.

The N-terrninus of AGS3 contributes to overall

function by its possible interactions with several proteins known to playa role in neural
development. AGS3 interacts with STKl1, the mouse homolog of a polarity detenninant
in C. elegans. When we knock out the AGS3 homolog in C. elegans, we generate a
phenotype not inconsistent with those observed with other polarity/asymmetry
determinants.

AGS3 as an activator

The yeast expression cloning system used to isolate AGS3 was orignially
designed to clone the NO-108 activator, a GnGEF. AGS3 was discounted as a GEF
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since its activity did not require the fonnation of GaGTP. Further biochemical analysis
of AGS3 indicated that AGS3 actually stabilized the GDP-bound, or inactive, form of
Ga. Regardless, AGS3 was named an activator of G-protein signaling since it could
stimulate the Gpy-mediated pheromone response pathway. In mammalian systems, both
Go. and

G~y

can transduce signals. Thus, we are presented with a paradox. AGS3

stabilizes the inactive form of Gia subunits and liberates a Gf3y molecule. By disrupting
heterotrimer formation AGS3 is also preventing receptor access to G-proteins thereby
uncoupling Gia signaling from external stimuli. AGS3 is therefore acting more as an
",C

activator of GPY signaling than of G-protein signaling.

This assumes that AGS3 is

disrupting heterotrimers and not finding free GaGDP subunits.

The physiological

consequences of AGS3 activity would be selective activation of GPy signaling not
initiated by a receptor. This raises the interesting possibility of GPy released by AGS3
behaving differently than GPy released by receptor-mediated activation of Ga.

AGS3 as an accessory protein

Accessory proteins are defined as proteins that can 1) regulate the transfer of
signal from receptor to G-protein to effector or 2) regulate the activation-state of Gproteins independent of receptor stimulation.

AGS3 was identified as a G-protein

activator in a genetic screen, but as mentioned above has some unique mechanisms of
activation. AGS3 does meet the definitions of an accessory protein because it regulates
the transfer of signal from receptor to G-proteins (Figure 6.6), and influences the
activation-state of G-proteins independent of receptor (Figure 6.5). What has yet to be
determined is whether AGS3 has these capabilities in the context of mammalian G-
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protein signaling. What makes AGS3 unique among the class of G-protein regulators is
the presence of multiple Ga binding sites. Most G-protein regulators, such as the RGS
family of GAPs, contain one domain capable of influencing Ga activity. AGS3 with its
four GPRs may also be included in another class of accessory proteins, the scaffolding
proteins.

By interacting with multiple Ga subunits, AGS3 might function either to

seqeuster G-proteins or to localize them to distinct cellular sub-domains. If AGS3 TPRs
can self-associate as do the Rapsyn TPRs, then AGS3 could effectively cluster GaGDP
subunits (248). Alternatively, the role of AGS3 may be to regulate the pool of GaGDP
available for receptor coupled signaling. Thus, AGS3 could cause desensitization of
GPCR signaling at the level of G-proteins.
At this point, little is known about the circumstances necessary for AGS3 to
engage G-proteins. Most of our sub-cellular fractionation and immunohistochemistry
data indicate that AGS3 is localized to the cytosol (198). In rat brain AGS3 is found in
the 100,000 x g supernatant which agrees with the pattern of immunohistochemical
staining observed in primary cultures of hippocampal neurons (J. Blumer unpublished
observations). Therefore, AGS3 must either translocate to the membrane, or interact with
GiaGDP in the cytosol, to regulate G-protein activity. The former is the most likely the
mechanism given the dynamic localization of PINS in neuroblasts. PINS is cytosolically
distributed until the neuroblast begins its delamination, when AGS3 is recruited to apical
membranes (155, 156).

This localization is thought to require a protein-protein

interaction between Inscuteable and the TPR domain of PINS.

If PINS function is

conserved, then AGS3 would be translocated to the membrane via its TPR domain, a
likely candidate for such a function. If AGS3 is acting outside of a developmental role
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then its activity might be regulated by signaling events. RGS proteins are translocated to
the membrane after a signaling stimulus (249), and in yeast have been implicated in a
negative feedback loop (250). AGS3 could alternatively be activated by a non-GPCR
signal to stimulate the selective release of G~y. Such non-traditional signal crosstalk has
been reported. IGFII receptor immunoprecipitation complexes contain Gi heterotrimers,
but upon receptor activation GPy is absent from these protein complexes (251, 252).

AGS3, outside the R-G-E paradigm
,,;:

Heterotrimeric G-protein activity is positively regulated by GEFs and negatively
regulated by GAPs.

However, both types of regulators propel the G-protein

activation/deactivation cycle in the same direction (Figure 6.7). AGS3 is unique among
these proteins in that it can disrupt the normal progression of G-proteins through their
usual stages of activation. By preventing heterotrimer formation, AGS3 stimulates Gf3y
mediated signaling but keeps Oa dormant. The function of the AGS3-GiaGDP complex
may be to allow for a temporary burst of free GJ3y. However, AOS3 may function as an
alternate signaling binding partner for GiaGDP. Therefore AGS3-GiaGDP could be
considered a heterodimer under control of unique regulators that acts upon unique
effectors. In such a scenario, activation of the AOS3-GiaGDP complex would require an
exchange factor distinct from G-protein coupled receptors. Activated Ga subunits would
undergo hydrolysis of GTP to terminate their signals and regenerate GaGDP. At that
stage, GaGDP could either enter the normal cycle, or enter a heterotrimer-independent
signaling pathway by partnering with AGS3.
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The AGS3-GiaGDP complex has the

p~tential

to self-aggregate or to localize to

-

unique regions of the cell. AGS3 can potentially bind up to four Gn subunits at a time
through the GPR domain suggesting a role as a scaffolding protein. H the TPR domain
dictates the localization of AGS3, then the domain also dictates where Ga subunits are
localized. The binding and subsequent concentration of GaGDP might be involved in Gprotein oligomerization.

Rodbell hypothesized that G-proteins, especially the Go.

subunit, evolved from cytoskeletal origins (62). Also, in contrast to crystallization of the
GTPyS bound On subunit, GaGDP crystals tend to form oligomers with much higher
frequency (253). As mentioned above, the clustering of GiaGDP might also playa role
in regulating the pool of available OiaGDP. However, in the context of asymmetric
division, sequestration of Gia to one pole of a dividing cell could have a significant
effect upon the fates of the daughter cells. Given the selectivity of AGS3 for Gia versus
Goa, the apical daughter cell of an asymmetric neuroblast division would receive more
Gin than its basal counterpart. This postulation is premature, since the identity of the Gprotein found in the INSCIPINS complex is currently unclear (155).

Function of AGS3 in development
The fly counterpart of AGS3, PINS, is a critical determinant of neuroblast cell
polarity, spindle rotation and asymmetric division. PINS is but one of a handful of
proteins implicated as required components of an apically localized complex in the
neuroblast. Looking across species, homologs of some of the required proteins have been
suggested to play similar roles but in other cell types (Figure 1.11). Asi.de from PINS,
there are no reports of other AGS3 family members being directly linked to
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corresponding protein complexes in mammalian cells. Our preliminary data indicate that
AGS3-CE might be involved in aspects of early embryogenesis. The discovery of the
Par-4 homolog, SrrKll, in a yeast two-hybrid screen suggests that AGS3 is linked to the
polarity/asymmetry complex in mammalian systems. AGS3 is highly expressed in brain,
but we do not know if its expression is developmentally regulated or if AGS3 is
expressed in mammalian neuroblasts. A critical future study would be to localize AGS3
with mammalian counterparts of the polarity/asymmetry complexat apical membranes in
developing mammalian neuroblasts.
In my view, the purpose of PINS in the polarity/asymmetry complex has yet to be
completely determined. Each manuscript reporting the discovery of PINS concluded that
PINS is required to maintain the apical complex after it arrives via its interaction with
Inscuteable.

However, only one paper commented upon the potential of a G-protein

signaling event emanating from the complex (155). PINS is apparently tethered to the
polarity/asymmetry complex via an interaction with Inscuteable (156). While the TPR
domain mediates this interaction, the GPR domains interact with Gi/oa (155). With our
demonstration that the AGS3-GPR domain can dissociate heterotrimer and therefore
liberate Gf3y, the function of PINS may be to initiate a receptor-independent G-protein
signaling cascade that requires Gf3y as the primary signal transducer. As an example of a
situation in which Ol3y alone transduces a signal is in early stages of C. elegans
embryogenesis. Through RNAi studies of both Gf3y and Ga, it was concluded that Gf3y
directly affects spindle rotation of the first few cell divisions (55). This function would
match quite well in the Drosophila neuroblast.

Recruitment of PINS to apical

membranes would cause a localized release of Ol3y that would induce the required 90°

158

spindle rotation to occur (Figure 9.1).

The presence of BazookalPar-6/aPKC alone

cannot cause the mitotic spindle to rotate in epithelial cells. However, expression of
INSC and PINS can cause the mitotic spindle of epithelial cells to properly rotate (156).
As mentioned in the introduction, the Bazooka/Par-6/aPKC complex likely functions to
set the apica1/basal poles upon which INSCIPINS translocates in order to initiate spindle
rotation and asymmetric division.
If PINS requires Inscuteable alone to be recruited to apical membranes, then
AGS3 might have an Inscuteable-independent mechanism to undergo translocation. One
of the authors reporting the discovery of PINS mentioned that PINS could be acting
independent of Inscuteable, on the basis of subtle differences in their knockout
phenotypes (173). However, there is strong evidence for a functional interaction between
the ankyrin repeat region of Inscuteable and the TPR domains of PINS. When analyzed
by BLAST, Inscuteable does not generate any significant database hits using wither
nucleotide or protein sequences. Similarly, analysis of translated sequences from EST
databases does not reveal the existence of Inscuteable homologs. Although there is the
remote possibility that Inscuteable homlogs in both C. elegans and H. Sapiens genomes
have yet to be entered, Inscuteable likely represents an insect-specific gene. The ankyrin
repeat region used to isolate PINS is our best clue to the potential mammalian binding
partners for AGS3.

However, there is another possible site of interaction.

Low

stringency BLAST searches reveal very weak homology between Inscuteable and Gprotein coupled receptors. Schaefer and colleagues mentioned, but did not show, weak:
interaction data between Inscuteable and Gi/oa (155). Therefore, in mammalian systems,
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Figure 9.1 AGS3 mechanism'. Recruitment of AGS3 to an apical , complex governing cell
polarity and asymmetric divisions might initiate a receptor independent G-protein signaling
cascade. Selective activation of G~ effectors would then generate mitotic s piIidle rotation and
possibly asymmetric cell division.
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two different proteins could be interacting with AGS3 at apical membranes, one with an
ankyrin-rich region and another with GPCR-like domains indirectly binding through Ga.

Function of AGS3 in the adult
AGS3 protein expression is detected in adult rat brain, implying that AGS3 may
serve a function outside of development. If neuroblasts are present in the adult brain,
then AGS3 could play the same role that it plays in the embryo. If not, there are several
possibilities for its adult function. First, AGS3 might function exclusively as a signal
regulator. As mentioned above, AGS3 has the potential to affect G-protein signaling by
selectively activating GJ3y signals, controlling the population of Gia available for
signaling and desensitizing Gia signaling at the level of G-proteins. The possibility also
exists for signals to transducer selectively through the AGS3-GiaGDP complex. Second,
AGS3 could playa role in maintaining cell polarity in neurons. The polarity/asymmetry
complex or components thereof could localize to specific subdomains of neurons to
maintain an axis of polarity.

Third, AGS3 could direct microtubule formation from

specific regions of the plasma membrane by initiating a GJ3y signal.

A localized

stimulation of microtubule organization could affect neuron dendrite/axon migration.
Outside of a potential role in cell polarity and asymmetry, AGS3 may be a general
G-protein signaling regulator. AGS3 can influence the transfer of signal from receptor to
G-protein and AGS3 can regulate the activation state of G-proteins independent of
receptor stimulation. The challenge is to find how AGS3 activity is regulated, when is its
activity needed and under what physiological conditions its activity is required. Current
studies are underway to co-crystalize AGS3-GPR with Ga subunits. These data will
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hopefully map the binding domains of the AGS3-Ga interaction and possibly reveal the
stoichiometry of the interaction. Assessment of AGS3 function in mammals would be
greatly facilitated by generation of AGS3 knockout mice as well as by mapping the
expression of AGS3 through mammalian development. Based on the current interest in
AGS3 and its family members, we can hopefully look forward to answering these very
important questions about this intriguing protein.

162

LIST OF REFERENCES

1.

Sutherland, E. W. "Studies on the mechanism of hormone action." Science. 177:
401-8, 1972.

2.

Bimbaumer, L. and M. RodbelL "Adenyl cyclase in fat cells. II. Honnone
receptors." Journal of Biological Chemistry. 244: 3477-82, 1969.

3.

Orly, J. and M. Schramm. "Coupling of catecholamine receptor from one cell
with adenylate cyclase from another cell by cell fusion." Proceedings of the
National Academy of Sciences of the United States of America. 73: 4410-4, 1976.

4.

Limbird, L. E. and R. J. Lefkowitz. "Resolution of beta-adrenergic receptor
binding and adenyl ate cyclase activity by gel exclusion chromatography." Journal
of Biological Chemlstry. 252: 799-802, 1977.

5.

Rodbell, M., H. M. Krans, S. L. Pohl and L. Bimbaumer. "The glucagon-sensitive
adenyl cyclase system in plasma membranes of rat liver. IV. Effects of
guanylnucleotides on binding of 125I-glucagon." Journal of Biological
Chemistry. 246: 1872-6, 1971.

6.

Ross, E. M. and A. G. Gilman. "Resolution of some components of adenylate
cyclase necessary for catalytic activity." Journal of Biological Chemistry. 252:
6966-9, 1977.

7.

,Ross, E. M., T. Haga, A. C. Howlett, J. Schwarzmeier, L. S. Schleifer and A. G.
Gilman. "Hormone-sensitive adenylate cyclase: resolution and reconstitution of
some components necessary for regulation of the enzyme." Advances in Cyclic
Nucleotide Research. 9: 53-68, 1978.

8.

Northup, J. K., P. C. Stemweis, M. D. Smigel, L. S. Schleifer, E. M. Ross and A.·
G. Gilman. "Purification of the regulatory component of adenylate cyclase."
Proceedings of the National Academy of Sciences of the United States of
America. 77: 6516-20, 1980.

9.

Cassel, D. and T. Pfeuffer. "Mechanism of cholera toxin action: covalent
modification of the guanyl nucleotide-binding protein of the adenylate cyclase
system." Proceedings of the National Academy of Sciences of the United States of
America. 75: 2669-73, 1978.

10.

Katada, T. and M. Ui. "Direct modification of the membrane adenylate cyclase
system by islet-activating protein due to ADP-ribosylation of a membrane
protein." Proceedings of the National Academy of Sciences of the United States
of America. 79: 3129-33, 1982.

163

11.

Hildebrandt, J. D., R. D. Sekura, J. Codina, R. Iyengar, C. R. Manclark "and L.
Bimbaumer. "Stimulation and inhibition of adenylyl cyclases mediated by distinct
regulatory proteins. " Nature. 302: 706-9, 1983.

12.

Bokoch, G. M., T. Katada, J. K. Northup, E. L. Hewlett and A. G. Gilman.
"Identification of the predominant substrate for ADP-ribosylation by islet
activating protein. Journal of Biological Chemistry. 258: 2072-5, 1983.
It

13.

Codina, J., J. Hildebrandt, R. Iyengar, L. Bimbaumer, R. D. Sekura and C. R.
Manclark. "Pertussis toxin substrate, the putative Ni component of adenylyl
cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and
magnesium." Proceedings of the National Academy of Sciences of the United
States of America. 80: 4276-80, 1983.

14.

Neer, E. J., J. M. Lok and L. G. Wolf. "Purification and properties of the
inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase." Journal
of Biological Chemistry. 259: 14222-9, 1984.

15.

Hildebrandt, J. D., J. Codina, R. Risinger and L. Bimbaumer. "Identification of a
gamma subunit associated with the adenylyl cyclase regulatory proteins Ns and
Ni." Journal of Biological Chemistry. 259: 2039-42,1984.

16.

Wheeler, G. L. and M. W. Bitensky. itA light-activated GTPase in vertebrate
photoreceptors: regulation of light-activated cyclic GMP phosphodiesterase."
Proceedings of the National Academy of Sciences of the United States of
America. 74: 4238-42, 1977.

17.

Wheeler, G. L., Y. Matuto and M. W. Bitensky. "Light-activated GTPase in
vertebrate photoreceptors. " Nature. 269: 822-4, 1977.

18.

Kuhn, H., N. Bennett, M. Michel-Villaz and M. Chabre. "Interactions between
photoexcited rhodopsin and GTP-binding protein: kinetic and stoichiometric
analyses from light-scattering changes." Proceedings of the National Academy of
Sciences of the United States of America~ 78: 6873-7, 1981.

19.

Pung, B. K., J. B. Hurley and L. Stryer. "Flow of information in the lighttriggered cyclic nucleotide cascade of vision." Proceedings of the National
Academy of Sciences of the United States of America. 78: 152-6, 1981.

20.

Tanabe, T., T. Nukada, Y. Nishikawa, K. Sugimoto, H. Suzuki, H. Takahashi, M.
Noda, T. Haga, A. Ichiyama and K. Kangawa. "Primary structure of the alphasubunit of transducin and its relationship to ras proteins." Nature. 315: 242-5,
1985.

21.

Medynski, D. C., K. Sullivan, D. Smith, C. Van Dop, F. H. Chang, B. K. Fung, P.
H. Seeburg and H. R. Bourne. "Amino acid sequence of the alpha subunit of
transducin deduced from the cDNA sequence." Proceedings of the National
Academy of Sciences of the United States of America. 82: 4311-5, 1985.
164

d~

22.

Lochrie, M. A., J. B. Hurley and M. I. Simon. "Sequence of the alpha subunit of
photoreceptor G protein: homologies between transducin, ras, and elongation
factors." Science. 228: 96-9, 1985.

23.

Harris, B. A., J. D. Robishaw, S. M. Mumby and A. G. Gilman. "Molecular
cloning of complementary DNA for the alpha subunit of the G protein that
stimulates adenylate cyclase." Science. 229: 1274-7, 1985.

24.

Robishaw, J. D., D. W. Russell, B. A. Harris, M. D. Smigel and A. G. Gilman.
"Deduced primary structure of the alpha subunit of the GTP-binding stimulatory
protein of adenyl ate cyclase." Proceedings of the National Academy of Sciences
of the United States of America. 83: 1251-5, 1986.

25.

Kaziro, Y., H. Itoh, T. Kozasa, M. Nakafuku and T. Satoh. "Structure and
function of signal-transducing GTP-binding proteins." Annual Review of
Biochemistry. 60: 349-400, 1991.

26.

Simon, M. I., M. P. Strathmann and N. Gautam. "Diversity of G proteins in signal
transduction." Science. 252: 802-8, 1991.

27.

N eer, _E. J. "Heterotrimeric G proteins: organizers of transmembrane signals. tt
Cell. 80: 249-57, 1995.

28.

Baltimore, D. "Our genome unveiled." Nature. 409: 814-6, 2001.

29.

Corvol, J. C., J. M. Studler, J. S. Schonn, J. A. Girault and D. Herve. "G
alpha(olf) is necessary for coupling Dl and A2a receptors to adenylyl cyclase in
the striatum." Journal of Neurochemistry. 76: 1585-1588, 2001.

30.

Sternweis, P. C. and A. V. Smrcka. "G proteins in signal transduction: the
regulation of phospholipase C." Ciba Foundation Symposium. 176: 96-106;
discussion 106-11, 1993.

31.

Kozasa, T., X. Jiang, M. J. Hart, P. M. Sternweis, W. D. Singer, A. G. Gilman, G.
Bollag and P. C. Stemweis. "p115 RhoGEF, a GTPase activating protein for
Galpha12 and GalphaI3." Science. 280: 2109-11, 1998.

32.

Strathmann, M. and M. I. Simon. "G protein diversity: a distinct class of alpha
subunits is present in vertebrates and invertebrates." Proce,edings of the National
Academy of Sciences of the United States of America. 87: 9113-7, 1990.

33.

Jansen, G., K. L. Thijssen, P. Werner, M. van der Horst, E. Hazendonk and R. H.
Plasterk. "The complete family of genes encoding G proteins of Caenorhabditis
elegans." Nature Genetics. 21: 414-9, 1999.

34.

McLaughlin, S. K., P. J. McKinnon, A. Robichon, N. Spickofsky and R. F.
Margolskee. "Gustducin and transducin: a tale of two G proteins." Ciba
Foundation Symposium. 179: 186-96; discussion 196-200, 1993.

165

35.

Sternweis, P. C. and J. D. Robishaw. "Isolation of two proteins with high affinity
for guanine nucleotides from membranes of bovine brain." Journal of Biological
Chenristry.259: 13806-13,1984.

36.

McIntire, W. E., J. Dingus, K. L. Schey and J. D. Hildebrandt. "Characterization
of the major bovine brain Go alpha isoforms. Mapping the structural differences
between the alpha subunit isoforms identifies a variable region of the protein
involved in receptor interactions." Journal of Biological Chemistry. 273: 3313541, 1998.

37.

Matsuoka, M., H. Itoh, T. Kozasa and Y. Kaziro. "Sequence analysis of cDNA
and genomic DNA for a putative pertussis toxin-insensitive guanine nucleotidebinding regulatory protein alpha subunit. tt Proceedings of the National Academy
of Sciences of the United States of America. 85: 5384-8, 1988.

38.

Moss, J. and M. Vaughan. "ADP-ribosylation of gu an yl nucleotide-binding
regulatory proteins by bacterial toxins." Advances in Enzymology & Related
Areas of Molecular Biology. 61: 303-79, 1988.

39.

Ho, M. K. C. and Y. H. Wong. "G(z) signaling: emerging divergence from G(i)
signaling [Review]." Oncogene. 20: 1615-1625, 2001.

40.

Clapham, D. E. and E. J. Neer. "New roles for G-protein beta gamma-dimers in
transmembrane signalling. " Nature. 365: 403-6, 1993.

41.

Rasenick, M. M. and M. W. Bitensky. "Partial purification and characterization of
a macromolecule which enhances fluoride activation of adenyl ate cyclase."
Proceedings of the National Academy of Sciences of the United States of
America. 77: 4628-32, 1980.

42.

Florio, V. A. and P. C. Stemweis. "Reconstitution of resolved muscanmc
cholinergic receptors with purified GTP-binding proteins." Journal of Biological
Chemistry. 260: 3477-83, 1985.

43.

Florio, V. A. and P. C. Stemweis. "Mechanisms of muscarinic receptor action on
Go in reconstituted phospholipid vesicles. " Journal of Biological Chemistry. 264:
3909-15, 1989.

44.

Logothetis, D. E., Y. Kurachi, J. Galper, E. J. Neer and D. E. Clapham. "The beta
gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in
heart." Nature. 325: 321-6, 1987.

45.

Tang, W. J. and A. G. Gilman. "Type-specific regulation of adenylyl cyclase by G
protein beta gamma subunits." Science. 254: 1500-3, 1991.

46.

Boyer, J. L., G. L. Waldo and T. K. Harden. "Beta gamma-subunit activation of
G-protein-regulated phospholipase C." Journal of Biological Chemistry. 267:
25451-6, 1992.

166

47.

Camps, M., A. Carozzi, P. Schnabel, A. Scheer, P. J. Parker and P. Gierschik.
"Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta
gamma-subunits. " Nature. 360: 684-6, 1992.

48.

Katz, A., D. Wu and M. I. Simon. "Subunits beta gamma of heterotrimeric G
protein activate beta 2 isoform of phospholipase C." Nature. 360: 686-9, 1992.

49.

Burch, R. M., A. Luini and J. Axelrod. "Phospholipase A2 and phospholipase C
are activated by distinct GTP-binding proteins in response to alpha I-adrenergic
stimulation in FRTL5 thyroid cells." Proceedings of the National Academy of
Sciences of the United States of America. 83: 7201-5, 1986.

50.

Corda, D. and L. D. Kohn. "Role of pertussis toxin sensitive G proteins in the
alpha 1 adrenergic receptor but not in the thyrotropin receptor mediated activation
of membrane phospholipases and iodide fluxes in FRTL-5 thyroid cells."
Biochemical & Biophysical Research Communications. 141: 1000-6, 1986.

51.

Stephens, L., A. Smrcka, F. T. Cooke, T. R. Jackson, P. C. Stemweis and P. T.
Hawkins. "A novel phosphoinositide 3 kinase activity in myeloid-derived cells is
activated by G protein beta gamma subunits." Cell. 77: 83-93, 1994.

52.

Wickman, K. D., J. A. Iniguez-Lluhl, P. A. Davenport, R. Taussig, G. B.
Krapivinsky, M. E. Linder, A. G. Gilman and D. E. Clapham. "Recombinant Gprotein beta gamma-subunits activate the muscarinic-gated atrial potassium
channel." Nature. 368: 255-7,1994.

53.

Whiteway, M., L. Hougan, D. Dignard, L. Bell, G. Saari, F. Grant, P. O'Hara, V.
L. MacKay and D. Y. Thomas. "Function of the STE4 and STE18 genes in
mating pheromone signal transduction in Saccharomyces cerevisiae." Cold Spring
Harbor Symposia on Quantitative Biology. 53: 585-90, 1988.

54.

Kesbeke, F., B. E. Snaar-Jagalska and P. J. Van Haastert. "Signal transduction in
Dictyostelium fgd A mutants with a defective interaction between surface cAMP
receptors and a GTP-binding regulatory protein." Journal of Cell Biology. 107:
521-8, 1988.

55.

Gotta, M. and J. Ahringer. "Distinct roles for G alpha and G beta gamma in
regulating spindle position and orientation in Caenorhabditis elegans embryos."
Nature Cell Biology. 3: 297-300, 2001.

56.

LeVine, H., 3rd. "Structural features of heterotrimeric G-protein-coupled
receptors and their modulatory proteins." Molecular Neurobiology. 19: 111-49,
1999.

57.

Cook, L. A., K. L. Schey, M. D. Wilcox, J. Dingus and J. D. Hildebrandt.
"Heterogeneous processing of a G protein gamma subunit at a site critical for
protein and membrane interactions." Biochemistry. 37: 12280-6, 1998.

167

~1

58.

Londos, C., Y. Salomon, M. C. Lin, J. P. Harwood, M. Schramm, J. Wolff and M.
Rodbell. "5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase
systems in eukaryotic cells." Proceedings of the National Academy of Sciences of
the United States of America. 71: 3087-90, 1974.

59.

Brandt, D. R. and E. M. Ross. "GTPase activity of the stimulatory OTP-binding
regulatory protein of adenylate cyclase, Os. Accumulation and turnover of
enzyme-nucleotide intermediates." Journal of Biological Chemistry. 260: 266-72,
1985.

60.

Brandt, D. R. and E. M. Ross. "Catecholamine-stimulated GTPase cycle. Multiple
sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted
receptor-Os vesicles." Journal of Biological Chemistry. 261: 1656-64, 1986.

61.

Gilman, A. G. "0 proteins: transducers of receptor-generated signals." Annual
Review of Biochemistry. 56: 615-49, 1987.

62 .

Rodbell, M. "0 proteins: out of the cytoskeletal closet." Mount Sinai Journal of
Medicine. 63: 381-6, 1996.

63.

Pedersen, S. E. and E. M. Ross. "Functional reconstitution of beta-adrenergic
receptors and the stimulatory GTP-binding protein of adenylate cyclase. "
Proceedings of the National Academy of Sciences of the United States of
America. 79: 7228-32, 1982.

64.

Hanski, E., P. C. Stemweis, J. K. NorthUp, A. W. Dromerick and A. G. Gilman.
"The regulatory component of adenylate cyclase. Purification and properties of
the turkey erythrocyte protein." Journal of Biological Chemistry. 256: 12911-9,
1981.

65.

Brandt, D. R. and E. M. Ross. "Effect of A13+ plus F- on the catecholaminestimulated OTPase activity of purified and reconstituted Os." Biochemistry. 25:
7036-41, 1986.

66.

Stryer, L. "Molecular design of an amplification cascade in vision." Biopolymers.
24: 29-47, 1985.

67.

Stemweis, P. C., J. K. Northup, M. D. Smigel and A. G. Gilman. "The regulatory
component of adenyl ate cyclase. Purification and properties." Journal of
Biological Chemistry. 256: 11517-26, 1981.

68.

Hanski, E. and A. G. Gilman. "The guanine nucleotide-binding regulatory
component of adenylate cyclase in human erythrocytes." Journal of Cyclic
Nucleotide Research. 8: 323-36, 1982.

69.

Northup, J. K., P. C. Sternweis and A. G. Gilman. "The subunits of the
stimulatory regulatory component of adenylate cyclase. Resolution, activity, and

168

properties of the 35,000-dalton (beta) subunit." Journal of Biological Chemistry.
258: 11361-8, 1983.

~!

70.

Katada, T., G. M. Bokoch, M. D. Smigel, M. Ui and A. G. Gilman. "The
inhibitory guanine nucleotide-binding regulatory component of adenyl ate cyclase.
Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma
cyc- and wild type membranes." Journal of Biological Chemistry. 259: 3586-95,
1984.

71.

Katada, T., J. K. Northup, G. M. Bokoch, M. Ui and A. G. Gilman. "The
inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase.
Subunit dissociation and guanine nucleotide-dependent hormonal inhibition."
Journal of Biological Chemistry. 259: 3578-85,1984.

72.

Levitzki, A. "Beta-adrenergic receptors and their mode of coupling to adenylate
cyclase." Physiological Reviews. 66: 819-54, 1986.

73 .

Benovic, J. L., R. H. Strasser, M. G. Caron and R. J. Lefkowitz. "Beta-adrenergic
receptor kinase: identification of a novel protein kinase that phosphorylates the
agonist-occupied form of the receptor." Proceedings of the National Academy of
Sciences of the United States of America. 83: 2797-801, 1986.

74.

Lohse, M. J., J. L. Benovic, J. Codina, M. G. Caron and R. J. Lefkowitz. "betaArrestin: a protein that regulates beta-adrenergic receptor function." Science. 248:
1547-50, 1990.

75.

Ferguson, S. S., L. S. Barak, J. Zhang and M. G. Caron. "G-protein-coupled
receptor regulation: role of G-protein-coupled receptor kinases and arrestins."
Canadian Journal of Physiology & Pharmacology. 74: 1095-110,1996.

76.

Katada, T., K. Kusakabe, M. Oinuma and M. Ui. "A novel mechanism for the
inhibition of adenylate cyclase via inhibitory GTP-binding proteins. Calmodulindependent inhibition of the cyclase catalyst by the beta gamma-subunits of GTPbinding proteins." Journal of Biological Chemistry. 262: 11897-900, 1987.

77.

Strittmatter, S. M., D. Valenzuela, T. E. Kennedy, E. J. Neer and M. C. Fishman.
"GO is a major growth cone protein subject to regulation by GAP-43." Nature.
344: 836-41, 1990.

78.

Lee, R. H., T. D. Ting, B. S. Lieberman, D. E. Tobias, R. N. Lolley and Y. K. Ho.
"Regulation of retinal cGMP cascade by phosducin in bovine rod photoreceptor
cells. Interaction of phosducin and transducin." Joumal of Biological Chemistry.
267:25104-12,1992.

79.

Arshavsky, V. Y., C. L. Dumke and M. D. Bownds. "Noncatalytic cGMP-binding
sites of amphibian rod cGMP phosphodiesterase control interaction with its
inhibitory gamma-subunits. A putative regulatory mechanism of the rod
photoresponse." Journal of Biological Chemistry. 267: 24501-7,1992.

169

80.

Berstein, G., J. L. Blank, D. Y. Jhon, J. H. Exton, S. G. Rhee and E. M. Ross.
"Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic
regulator." Cell. 70: 411-8, 1992.

81.

Li, S., J. Couet and M. P. Lisanti. "Src tyrosine kinases, Galpha subunits, and HRas share a common membrane-anchored scaffolding protein, caveolin. Caveolin
binding negatively regulates the auto-activation of Src tyrosine kinases." Journal
of Biological Chemistry. 271: 29182-90, 1996.

82.

Okamoto, T., A. Schlegel, P. E. Scherer and M. P. Lisanti. "Caveolins, a family of
scaffolding proteins for organizing "pre as sembled signaling complexes" at the
plasma membrane." Journal of Biological Chemistry. 273: 5419-22, 1998.

83.

Coulter, S. and M. Rodbell. "Heterotrimeric G proteins in synaptoneurosome
membranes are crosslinked by p-phenylenedimaleimide, yielding structures
comparable in size to crosslinked tubulin and F-actin." Proceedings of the
National Academy of Sciences of the United States of America. 89: 5842-6, 1992.

84.

Duzic, E., I. Coupry, S. Downing and S. M. Lanier. "Factors determining the
specificity of signal transduction by guanine nucleotide-binding protein-coupled
receptors. I. Coupling of alpha 2-adrenergic receptor subtypes to distinct Gproteins." Journal of Biological Chemistry. 267: 9844-51, 1992.

85.

Coupry, I., E. Duzic and S. M. Lanier. "Factors determining the specificity of
signal transduction by guanine nucleotide-binding protein-coupled receptors. II.
Preferential coupling of the alpha 2C-adrenergic receptor to the guanine
nucleotide-binding protein, Go." Journal of Biological Chemistry. 267: 9852-7,
1992.

86.

Duzic, E. and S. M. Lanier. "Factors determining the specificity of signal
transduction by guanine nucleotide-binding protein-coupled receptors. ill.
Coupling of alpha 2-adrenergic receptor subtypes in a cell type-specific manner.
Journal of Biological Chemistry. 267: 24045-52, 1992.
It

87.

Sato, M., R. Kataoka, J. Dingus, M. Wilcox, J. D. Hildebrandt and S. M. Lanier.
"Factors determining specificity of signal transduction by G-protein-coupled
receptors. Regulation of signal transfer from receptor to G-protein." Journal of
Biological Chemistry. 270: 15269-76, 1995.

88.

Dohlman, H. G., J. Song, D. Ma, W. E. Courchesne and J. Thorner. "8st2, a
negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae:
expression, localization, and genetic interaction and physical association with
Opal (the G-protein alpha subunit)." Molecular & Cellular Biology. 16: 5194209, 1996.

89.

Koelle, M. R. and H. R. Horvitz. "EGL-IO regulates G protein signaling in the C.
elegans nervous system and shares a conserved domain with many mammalian
proteins." Cell. 84: 115-25, 1996.
170

90.

Mendel, J. B., H. C. Korswagen, K. S. Liu, Y. M. Hajdu-Cronin, M. I. Simon, R.
H. Plasterk and P. W. Sternberg. "Participation of the protein Go in multiple
aspects of behavior in C. elegans." Science. 267: 1652-5, 1995.

91.

Segalat, L., D. A. BIkes and J. M. Kaplan. "Modulation of serotonin-controlled
behaviors by 00 in Caenorhabditis elegans." Science. 267: 1648-51, 1995.

92.

De Vries, L., M. Mousli, A. Wurmser and M. G. Farquhar. "OAIP, a protein that
specifically interacts with the trimeric G protein 0 alpha i3, is a member of a
protein family with a highly conserved core domain." Proceedings of the National
Academy of Sciences of the United States of America. 92: 11916-20, 1995.

93.

Watson, N., M. B. Linder, K. M. Druey, J. H. Kehrl and K. J. Blumer. "RGS
family members: GTPase-activating proteins for heterotrimeric G-protein alphasubunits." Nature. 383: 172-5, 1996.

94.

Berman, D. M. and A. O. Gilman. "Mammalian RGS proteins: barbarians at the
gate." Journal of Biological Chemistry. 273: 1269-72, 1998.

95.

Ross, E. M. and T. M. Wilkie. "GTPase-activating proteins for heterotrimeric G
proteins: regulators of G protein signaling (RGS) and RGS-like proteins." Annual
Review of Biochemistry. 69: 795-827, 2000.

96.

Sterne-Marr, R. and J. L. Benovic. "Regulation of G protein-coupled receptors by
receptor kinases and arrestins." Vitamins & Hormones. 51: 193-234, 1995.

97.

Daaka, Y., L. M. Luttrell and R. J. Lefkowitz. "Switching of the coupling of the
beta2-adrenergic receptor to different G proteins by protein kinase A." Nature.
390: 88-91, 1997.

98.

Tobin, A. B., N. F. Totty, A. B. Sterlin and S. R. Nahorski. "Stimulus-dependent
phosphorylation of G-protein-coupled receptors by casein kinase 1alpha. Journal
of Biological Chemistry. 272: 20844-9, 1997.
It

99.

Budd, D. C., J. E. McDonald and A. B. Tobin. "Phosphorylation and regulation of
a Gq/l1-coupled receptor by casein kinase 1alpha." Journal of Biological
Chemistry. 275: 19667-75, 2000.

100.

Dolph, P. J., R. Ranganathan, N. J. Colley, R. W. Hardy, M. Socolich and C. S.
Zuker. "Arrestin function in inactivation of G protein-coupled receptor rhodopsin
in vivo." Science. 260: 1910-6, 1993.

101.

Krueger, K. M., Y. Daaka, J. A. Pitcher and R. J. Lefkowitz. "The role of
sequestration in G protein-coupled receptor resensitization. Regulation of beta2adrenergic receptor dephosphorylation by vesicular acidification. " Journal of
Biological Chemistry. 272: 5-8, 1997.

171

102.

McLatchie, L. M., N. J. Fraser, M. J. Main, A. Wise, J. Brown, N. Thompson, R.
Solari, M. G. Lee and S. M. Foord. "RAMPs regulate the transport and ligand
specificity of the calcitonin-receptor-like receptor. n Nature. 393: 333-9, 1998.

103.

Lezcano, N., L. Mrzljak, S. Eubanks, R. Levenson, P. Goldman-Rakic and C.
Bergson. "Dual signaling regulated by calcyon, a Dl dopamine receptor
interacting protein." Science. 287: 1660-1664, 2000.

104.

Luebke, A. E., G. P. Dahl, B. A. Roos and I. M. Dickerson. "Identification of a
protein that confers calcitonin gene-related peptide responsiveness to oocytes by
using a cystic fibrosis transmembrane conductance regulator assay." Proceedings
of the National Academy of Sciences of the United States of America. 93: 345560, 1996.

105.

Kim, J. Y., P. V. Haastert and P. N. Devreotes. "Social senses: G-protein-coupled
receptor signaling pathways in Dictyostelium discoideum." Chemistry & Biology.
3: 239-43, 1996.

106.

Chen, M. Y., Y. Long and P. N. Devreotes . "A novel cytosolic regulator,
Pianissimo, is required for chemoattractant receptor and G protein-mediated
activation of the 12 transmembrane domain adenylyl cyclase in Dictyostelium."
Genes & Development. 11: 3218-31, 1997.

107.

Lee, S., C. A. Parent, R. Insall and R. A. Firtel. "A novel Ras-interacting protein
required for chemotaxis and cyclic adenosine monophosphate signal relay in
Dictyostelium." Molecular Biology of the Cell . 10: 2829-45, 1999.

108.

Insall, R. H., J. Borleis and P. N. Devreotes. "The aimless RasGEF is required for
processing of chemotactic signals through G-protein-coupled receptors in
Dictyostelium. n Current Biology. 6: 719-29, 1996.

109.

Hanbauer, I., M. Memo and M. Billingsley. "Role of calmodulin in the regulation
of dopamine receptor function." Advances In Cyclic Nucleotide & Protein
Phosphorylation Research. 17: 521-7, 1984.

110.

Prezeau, L., J. G. Richman, S. W. Edwards and L. E. Limbird. "The zeta isoform
of 14-3-3 proteins interacts with the third intracellular loop of different alpha2adrenergic receptor subtypes." Journal of Biological Chemistry. 274: 13462-9,
1999.

111.

Tang, Y., L. A. Hu, W. E. Miller, N. Ringstad, R. A. Hall, J. A. Pitcher, P.
DeCamilli and R. J. Lefkowitz. "Identification of the endophilins (SH3p4/pS/pI3)
as novel binding partners for the beta1-adrenergic receptor." Proceedings of the
National Academy of Sciences of the United States of America. 96: 12559-64,
1999.

172

~:;::

112.

Smith, F. D., G. S. Oxford and S. L. Milgram. "Association of the D2 dopamine
receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1interacting protein." Journal of Biological Chemistry. 274: 19894-900, 1999.

113.

Wu, G., J. L. Benovic, J. D. Hildebrandt and S. M. Lanier. "Receptor docking
sites for G-protein betagamma subunits. Implications for signal regulation."
Journal of Biological Chemistry. 273: 7197-200, 1998.

114.

Tai, A. W., J. Z. Chuang and C. H. Sung. "Localization of Tctex-1, a cytoplasmic
dynein light chain, to the Golgi apparatus and evidence for dynein complex
heterogeneity. tt Journal of Biological Chemistry. 273: 19639-49, 1998.

115.

Takesono, A., M. J. Cismowski, C. Ribas, M. Bernard, P. Chung, S. Hazard, 3rd,
E. Duzic and S. M. Lanier. "Receptor-independent activators of heterotrimeric Gprotein signaling pathways." Journal of Biological Chemistry. 274: 33202-5,
1999.

116.

Jarvis, S. E., J. M. Magga, A. M. Beedle, J. E. Braun and G. W. Zamponi. fiG
protein modulation of N-type calcium channels is facilitated by physical
interactions between syntaxin 1A and Gbetagamma." Journal of Biological
Chemistry. 275: 6388-94, 2000.

117.

Mochizuki, N., M. Hibi, Y. Kanai and P. A. Insel. "Interaction of the protein
nucleobindin with G alpha i2, as revealed by the yeast two-hybrid system." FEBS
Letters. 373: 155-8, 1995.

118.

Fan, X., L. F. Brass, M. Poncz, F. Spitz, P. Maire and D. R. Manning. "The alpha
subunits of Gz and Gi interact with the eyes absent transcription cofactor Eya2,
preventing its interaction with the six class of homeodomain-containing proteins."
Journal of Biological Chemistry. 275: 32129-34, 2000.

119.

Jordan, J. D., K. D. Carey, P. J. Stork and R. Iyengar. "Modulation of rap activity
by direct interaction of Galpha(o) with Rap1 GTPase-activating protein." Journal
of Biological Chemistry. 274: 21507-10, 1999.

120.

Takai, Y., T. Sasaki and T. Matozaki. "Small GTP-binding proteins [Review]."
Physiological Reviews. 81: 153-208, 2001.

121.

Ueda, T., A. Kikuchi, N. Ohga, J. Yamamoto and Y. Takai. "Purification and
characterization from bovine brain cytosol of a novel regulatory protein inhibiting
the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a
ras p21-like GTP-binding protein." Journal of Biological Chemistry. 265: 937380, 1990.

122.

Berman, D. M., T. M. Wilkie and A. G. Gilman. "GAIP and RGS4 are GTPaseactivating proteins for the Gi subfamily of G protein alpha subunits." Cell. 86:
445-52, 1996.

173

ea

123.

Heximer, S. P., N. Watson, M. E. Linder, K. J. Blumer and J. R. Hepler.
"RGS2/GOS8 is a selective inhibitor of Gqalpha function." Proceedings of the
National Academy of Sciences of the United States of America. 94: 14389-93,
1997.

124.

Glick, J. L., T. E. Meigs, A. Miron and P. J. Casey. "RGSZl, a Gz-selective
regulator of G protein signaling whose action is sensitive to the phosphorylation
state of Gzalpha." Journal of Biological Chemistry. 273: 26008-13, 1998.

125.

Wang, J., A. Ducret, Y. Tu, T. Kozasa, R. Aebersold and E. M. Ross. "RGSZ1, a
Gz-selective RGS protein in brain. Structure, membrane association, regulation by
Galphaz phosphorylation, and relationship to a Gz gtpase-activating protein
subfamily." Journal of Biological Chemistry. 273: 26014-25, 1998.

126.

Saitoh, 0., Y. Kubo, Y. Miyatani, T. Asano and H. Nakata. "RGS8 accelerates Gprotein-mediated modulation of K+ currents." Nature. 390: 525-9, 1997.

127.

Levay, K., J. L. Cabrera, D. K. Satpaev and V. Z. Slepak. "GbetaS prevents the
ROS7-Galphao interaction through binding to a distinct Ggamma-like domain
found in RGS7 and other RGS proteins." Proceedings of the National Academy of
Sciences of the United States of America. 96: 2503-7, 1999.

128.

Snow, B. E., A. M. Krumins, G. M. Brothers, S. F. Lee, M. A. Wall, S. Chung, J.
Mangion, S. Arya, A. G. Gilman and D. P. Siderovski. "A G Protein gamma
subunit-like domain shared between RGS 11 and other RGS proteins specifies
binding to G(beta-5) subunits." Proceedings of the National Academy of Sciences
of the United States of America. 95: 13307-13312, 1998.

129.

Cabrera, J. L., F. de Freitas, D. K. Satpaev and V. Z. Slepak. "Identification of the
Gbeta5-RGS7 protein complex in the retina. " Biochemical & Biophysical
Research Communications. 249: 898-902, 1998.

130.

Siderovski, D. P., M. Diverse-Pierluissi and L. De Vries. "The GoLoco motif: a
Galphai/o binding motif and potential guanine-nucleotide exchange factor."
Trends in Biochemical Sciences. 24: 340-1, 1999.

131.

Cannan, C. V., J. L. Parent, P. W. Day, A. N. Pronin, P. M. Stemweis, P. B.
Wedegaertner, A. G. Gilman, J. L. Benovic and T. Kozasa. "Selective regulation
of Galpha(q/ll) by an RGS domain in the G protein-coupled receptor kinase,
GRK2." Journal of Biological Chemistry. 274: 34483-92,1999.

132.

Usui, H., M. Nishiyama, K. Moroi, T. Shibasaki, J. Zhou, J. Ishida, A. Fukamizu,
T. Haga, S. Sekiya and S. Kimura. "RGS domain in the amino-terminus of G
protein-coupled receptor kinase 2 inhibits Gq-mediated signaling." It1ternational
Journal of Molecular Medicine. 5: 335-40, 2000.

133.

Zeng, L., F. Fagotto, T. Zhang, W. Hsu, T. J. Vasicek, W. L. Perry, J. J. Lee, S.
M. Tilghman, B. M. Gumbiner and F. Costantini. "The mouse Fused locus
174

encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic
axis formation." Cell. 90: 181-92, 1997.

~d!

134.

Siderovski, D. P., B. Strockbine and C. I. Behe. "Whither goest the RGS proteins?
[Review]." Critical Reviews in Biochemistry & Molecular Biology. 34: 215-251,
1999.

135.

Skiba, N. P., J. A. Hopp and V. Y. Arshavsky. "The effector enzyme regulates the
duration of G protein signaling in vertebrate photoreceptors by increasing the
affinity between transducin and RGS protein." Journal of Biological Chemistry.
275: 32716-20,2000.

136.

Roychowdhury, S., N. Wang and M. M. Rasenick. "G protein binding and G
protein activation by nucleotide transfer involve distinct domains on tubulin:
regulation of signal transduction by cytoskeletal elements." Biochemistry. 32:
4955-61, 1993.

137.

Popova, J. S., G. L. Johnson and M. M. Rasenick. "Chimeric G alpha s/G alpha i2
proteins define domains on G alpha s that interact with tubulin for beta-adrenergic
activation of adenylyl cyclase." Journal of Biological Chemistry. 269: 21748-54,
1994.

138.

Nishimoto, I., T. Okamoto, Y. Matsuura, S. Takahashi, Y. Murayama and E.
Ogata. "Alzheimer amyloid protein precursor complexes with brain GTP-binding
protein 0(0)." Nature. 362: 75-9, 1993.

139.

Smine, A., X. Xu, K. Nishiyama, T. Katada, P. Gambetti, S. P. Yadav, X. Wu, Y.
C. Shi, S. Yasuhara, V. Homburger and T. Okamoto. "Regulation of brain Gprotein go by Alzheimer's disease gene presenilin-l." Journal of Biological
Chemistry. 273: 16281-8, 1998.

140.

Kajkowski, E. M., C. F. Lo, X. Ning, S. Walker, H. J. Sofia, W. Wang, W. Edris,
P. Chanda, E. Wagner, S. Vile, K. Ryan, B. McHendry-Rinde, S. C. Smith, A.
Wood, K. J. Rhodes, J. D. Kennedy, J. Bard, J. S. Jacobsen and B. A. Ozenberger.
"B-Amyloid Peptide-induced Apoptosis Regulated by a Novel Protein Containing
a G Protein Activation Module." Journal of Biological Chemistry. 276: 1874818756, 2001.

141.

Sato, M., C. Ribas, J. D. Hildebrandt and S. M. Lanier. "Characterization of a Gprotein activator in the neuroblastoma-glioma cell hybrid NGI08-15." Journal of
Biological Chemistry. 271: 30052-60, 1996.

142.

Cismowski, M. J., A. Takesono, C. Ma, J. S. Lizano, X. Xie, H. Fuemkranz, S. M.
Lanier and E. Duzic. "Genetic screens in yeast to identify mammalian nonreceptor
modulators of G-protein signaling [see comments]." Nature Biotechnology. 17:
878-83, 1999.

175

143.

Cismowski, M. J., C. Ma, C. Ribas, X. Xie, M. Spruyt, J. S. Lizano, S. M. Lanier
and E. Duzic. "Activation of heterotrimeric G-protein signaling by a ras-related
protein. Implications for signal integration." Journal of Biological Chemistry.
275: 23421-4, 2000.

144.

Kemppainen, R. J. and E. N. Behrend. "Dexamethasone rapidly induces a novel
ras superfamily member-related gene in AtT-20 cells." Journal of Biological
Chemistry. 273: 3129-31, 1998.

145.

Fang, M., S. R. Jaffrey, A. Sawa, K. Ye, X. Luo and S. H. Snyder. "Dexras1: a G
protein specifically coupled to neuronal nitric oxide synthase via CAPON."
Neuron. 28: 183-93, 2000.

146.

Lader, E., H. S. Ha, M. O'Neill, K. Artzt and D. Bennett. "tctex-1: a candidate
gene family for a mouse t complex sterility locus." Cell. 58: 969-79, 1989.

147.

King, S. M., J. F. Dillman, 3rd, S. E. Benashski, R. J. Lye, R. S. Patel-King and
K. K. Pfister. "The mouse t-complex-encoded protein Tctex-1 is a light chain of
brain cytoplasmic dynein." Journal of Biological Chemistry. 271: 32281-7, 1996.

148.

Nagano, F., S. Orita, T. Sasaki, A. Naito, G. Sakaguchi, M. Maeda, T. Watanabe,
E. Kominami, Y. Uchiyama and Y. Takai. "Interaction of Doc2 with tctex-I, a
light chain of cytoplasmic dynein. Implication in dynein-dependent vesicle
transport." Journal of Biological Chemistry. 273: 30065-8, 1998.

149.

Campbell, K. S., S. Cooper, M. Dessing, S. Yates and A. Buder. "Interaction of
p59fyn kinase with the dynein light chain, Tctex-1, and colocalization during
cytokinesis." Journal of Immunology. 161: 1728-37,1998.

150.

Tai, A. W.,. J. Z. Chuang, C. Bode, U. Wolfrum and C. H. Sung. "Rhodopsin's
carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic
dynein by binding to the dynein light chain Tctex-1." Cell. 97: 877-87, 1999.

151.

Mochizuki, N., G. Cho, B. Wen and P. A. Insel. "Identification and cDNA
cloning of a novel human mosaic protein, LGN, based on interaction with G alpha
i2." Gene. 181: 39-43, 1996.

152.

Luo, Y. and B. M. Denker. "Interaction of heterotrimeric G protein Galphao with
Purkinje cell protein-2. Evidence for a novel nucleotide exchange factor." Journal
of Biological Chemistry. 274: 10685-8, 1999.

153.

Snow, B. E., L. Antonio, S. Suggs, H. B. Gutstein and D. P. Siderovski.
"Molecular cloning and expression analysis of rat Rgs12 and Rgs14."
Biochemical & Biophysical Research Communications. 233: 770-7, 1997.

154.

Blatch, G. L. and M. LassIe. "The tetratricopeptide repeat: a structural motif
mediating protein-protein interactions." Bioessays. 21: 932-9, 1999.

;:/~

176

155.

Schaefer, M., A. Shevchenko and J. A. Knoblich. "A protein complex containing
inscuteable and the G alpha-binding protein Pins orients asymmetric cell divisions
in Drosophila." Current Biology. 10: 353-362, 2000.

156.

Yu, F. W., X. Morin, Y. Cai, X. H. Yang and W. Chiao "Analysis of partner of
inscuteable, a novel player of Drosophila asymmetric divisions, reveals two
distinct steps in inscuteable apical localization." Cell. 100: 399-409, 2000.

157.

Doe, C. Q. and B. Bowerman. "Asymmetric cell division: fly neuroblast meets
worm zygote [Review]." Current Opinion in Cell Biology. 13: 68-75,2001.

158.

Knoblich, J. A. "Asymmetric cell division during animal development [Review]."
Nature Reviews Molecular Cell Biology. 2: 11-20,2001.

159.

Muller, H. A. J. and E. Wieschaus. "Armadillo, Bazooka, and Stardust-are critical
for earlt stages in formation of the Zonula Adherens and maintenance of the
polarized blastoderm epithelium in Drosophila." Journal of Cell Biology. 134:
149-163, 1996.

160.

Kuchinke, D., F. Grawe and E. Knust. "Control of spindle orientation in
Drosophila by the Par-3-related PDZ-domain protein Bazooka." Current Biology.
8: 1357-65, 1998.

161.

Schober, M., M. Schaefer and J. A. Knoblich. "Bazooka recruits Inscuteable to
orient asymmetric cell divisions in Drosophila neuroblasts." Nature. 402: 548551, 1999.

162.

Wodarz, A., A. Ramrath, U. Kuchinke and E. Knust. "Bazooka provides an apical
cue for Inscuteable localization in Drosophila neuroblasts." Nature. 402: 544-547,
1999.

163.

Kraut, R. and J. A. Camposortega. "Inscuteable, a neural precursor gene of
Drosophila, encodes a candidate for a cytoskeleton adaptor protein. "
Developmental Biology. 174: 65-81, 1996.

164.

Kraut, R., W. Chia, L. Y. Jan, Y. N. Jan and J. A. Knoblich. "Role of Inscuteable
in orientating asymmetric cell divisions in Drosophila." Nature. 383: 50-55, 1996.

165.

Knoblich, J. A., L. Y. Jan and Y. N. Jan. "Asymmetric segregation of Numb and
Prospero during cell division." Nature. 377: 624-7, 1995.

166.

Hirata, J., H. Nakagoshi, Y. Nabeshima and F. Matsuzaki. "Asymmetric
segregation of the homeodomain protein Prospero during Drosophila
development." Nature. 377: 627-30, 1995.

167.

Spana, E. P. and C. Q. Doe. "The prospero transcription factor is asymmetrically
localized to the cell cortex during neuroblast mitosis in Drosophila."
Development. 121: 3187-95, 1995.

~.

177

168.

Shen, C. P., L. Y. Jan and Y. N. Jan. "Miranda is required for the asymmetric
localization of Prospero during mitosis in Drosophila." Cell. 90: 449-58, 1997.

169.

Shen, C. P., J. A. Knoblich, Y. M. Chan, M. M. Jiang, L. Y. Jan and Y. N. Jan.
ttMiranda as a multidomain adapter linking apically localized Inscuteable and
basally localized Staufen and Prospero during asymmetric cell division in
Drosophila." Genes & Development. 12: 1837-46, 1998.

170.

Tio, M., M. Zavortink, X. Yang and W. Chiao "A functional analysis of
inscuteable and its roles during Drosophila asymmetric cell divisions." Journal of
Cell Science. 112: 1541-51, 1999.

171.

Buescher, M., S. L. Yeo, G. Udolph, M. Zavortink, X. Yang, G. Tear and W.
Chiao "Binary sibling neuronal cell fate decisions in the Drosophila embryonic
central nervous system are nonstochastic and require inscuteable-mediated
asymmetry of ganglion mother cells." Genes & Development. 12: 1858-70, 1998.

172.

Knoblich, J. A., L. Y. Jan and Y. N. Jan. "Deletion analysis of the Drosophila
inscuteable protein reveals domains for cortical localization and asymmetric
localization." Current Biology. 9: 155-158, 1999.

173.

Parmentier, M. L., D. Woods, S. Greig, P. G. Phan, A. Radovic, P. Bryant and C.
J. o 'Kane. "Rapsynoidlpartner of inscuteable controls asymmetric division of
larval neuroblasts in Drosophila. " Journal of Neuroscience. 20: 15, 2000.

174.

Park, Y., M. Fujioka, J. B. Jaynes and S. Datta. "Drosophila homeobox gene eve
enhances trol, an activator of neuroblast proliferation in the larval CNS."
Developmental Genetics. 23: 247-57, 1998.

175.

Wodarz, A., A. Ramrath, A. Grimm and E. Knust. "Drosophila atypical protein
kinase C associates with Bazooka and controls polarity of epithelia and
neuroblasts." Journal of Cell Biology. 150: 1361-74, 2000.

176.

Petronczki, M. and J. A. Knoblich. "DmPAR-6 directs epithelial polarity and
asymmetric cell division of neuroblasts in Drosophila." Nature Cell Biology. 3:
43-49, 2001.

177.

Kemphues, K. J., J. R. Priess, D. G. Morton and N. S. Cheng. "Identification of
genes required for cytoplasmic localization in early C. elegans embryos." Cell.
52: 311-20, 1988.

178.

Watts, J. L., B. Etemad-Moghadam, S. Guo, L. Boyd, B. W. Draper, C. C. Mello,
J. R. Priess and K. J. Kemphues. "par-6, a gene involved in the establishment of
asymmetry in early C. elegans embryos, mediates the asymmetric localization of
PAR-3." Development. 122: 3133-40, 1996.

178

179.

Hung, T. J. and K. J. Kemphues. "PAR-6 is a conserved PDZ domain-containing
protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos."
Development. 126: 127-135, 1999.

180.

Tabuse, Y., Y. Izumi, F. Piano, K. J. Kemphues, J. Miwa and S. Ohno. "Atypical
PKC cooperates with Par-3 to establish embryonic polarity in Caenorhabditis
elegans." Development. 125: 3607-3614, 1998.

181.

Izumi, Y., T. Hirose, Y. Tarnai, S. Hirai, Y. Nagashima, T. Fujimoto, Y. Tabuse,
K. J. Kemphues and S. Ohno. "An atypical PKC directly associates and
colocalizes at the epithelial tight junction with ASIP, a mammalian homolog of
caenorhabditus elegans polarity protein par-3." Journal of Cell Biology. 143: 95106, 1998.

182.

Lin, D., A. S. Edwards, J. P. Fawcett, G. Mbamalu, J. D. Scott and T. Pawson. "A
mammalian PAR-3-PAR-6 complex implicated in Cdc42IRacl and aPKC
signalling and cell polarity." Nature Cell Biology. 2: 540-547, 2000.

183.

Qiu, R. G., A. Abo and G. S. Martin. "A human homolog of the C-elegans
polarity determinant Par-6 links Rac and Cdc42 to PKC zeta signaling and cell
transformation." Current Biology. 10: 697-707,2000.

184.

Joberty, G., C. Petersen, L. Gao and I. G. Macara. "The cell-polarity protein Par6
links Par3 and atypical protein kinase C to Cdc42." Nature Cell Biology. 2: 531539, 2000.

185.

Johansson, A. S., M. Driessens and P. Aspenstrom. "The mammalian homologue
of the Caenorhabditis elegans polarity protein PAR-6 is a binding partner for the
Rho GTPases Cdc42 and Racl." Journal of Cell Science. 113: 3267-3275, 2000.

186.

Doe, C. Q. "Cell polarity: the PARty expands." Nature Cell Biology. 3: E7-E9,
2001.

187.

van der Voom, L., M. Gebbink, R. H. Plasterk and H. L. Ploegh.
"Characterization of a G-protein beta-subunit gene from the nematode
Caenorhabditis elegans." Journal of Molecular Biology. 213: 17-26,1990.

188.

Zwaal, R. R., J. Abringer, H. G. van Luenen, A. Rushforth, P. Anderson and R. H.
Plasterk. "G proteins are required for spatial orientation of early cell cleavages in
C. elegans embryos." Cell. 86: 619-29, 1996.

189.

Ramarao, M. K. and J. B. Cohen. "Mechanism of nicotinic acetylcholine receptor
cluster fonnation by rapsyn." Proceedings of the National Academy of Sciences
of the United States of America. 95: 4007-12, 1998.

190.

Fire, A., S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver and C. C. Mello.
"Potent and specific genetic interference by double-stranded RNA in
Caenorhabditis elegans." Nature. 391: 806-11, 1998.

179

~~~

191.

Dingus, J., M. D. Wilcox, R. Kohnken and J. D. Hildebrandt. "Synthesis and use
of biotinylated beta gamma complexes prepared from bovine brain G proteins."
Methods in Enzymology. 237: 457-71, 1994.

192.

Makhlouf, M., S. H. Ashton, J. Hildebrandt, N. Mehta, T. W. Gettys, P. V.
Halushka and J. A. Cook. "Alterations in macrophage G proteins are associated
with endotoxin tolerance." Biochimica et Biophysica Acta. 1312: 163-8, 1996.

193.

Graber, S. G., R. A. Figler and J. C. Garrison. "Expression and purification of
functional G protein alpha subunits using a baculovirus expression system."
Journal of Biological Chemistry. 267: 1271-8, 1992.

194.

Biddlecome, G. H., G. Berstein and E. M. Ross. "Regulation of phospholipase Cbeta! by Gq and ml muscarinic cholinergic receptor. Steady-state balance of
receptor-mediated
activation
and
GTPase-activating
protein-promoted
deactivation." Journal of Biological Chemistry. 271: 7999-8007,1996.

195.

Lambright, D. G., J. Sondek, A. Bohm, N. P. Skiba, H. E. Hamm and P. B. Sigler.
"The 2.0 A crystal structure of a heterotrimeric G protein." Nature. 379: 311-9,
1996.

196.

Gettys, T. W., K. Sheriff-Carter, J. Moomaw, I. L. Taylor and J. R. Raymond.
"Characterization and use of crude alpha-subunit preparations for quantitative
immunoblotting of G proteins." Analytical Biochemistry. 220: 82-91, 1994.

197.

Goldsmith, P., P. S. Backlund, Jr., K. Rossiter, A. Carter, G. Milligan, C. G.
Unson and A. SpiegeL "Purification of heterotrimeric GTP-binding proteins from
brain: identification of a novel fonn of Go." Biochemistry. 27: 7085-90, 1988.

198.

Bernard, M. L., Y. K. Peterson, P. Chung, J. Jourdan and S. M. Lanier. "Selective
interaction of AGS3 with G-proteins and the influence of AGS3 on the activation
state of G-proteins~" Journal of Biological Chemistry. 276: 1585-1593, 2001.

199.

Ross, E. M. and T. Higashijima. "Regulation of G-protein activation by
mastoparans and other cationic peptides." Methods in Enzymology. 237: 26-37,
1994.

200.

Clawges, H. M., K. M. Depree, E. M. Parker and S. G. Graber. "Human 5-HTI
receptor subtypes exhibit distinct G protein coupling behaviors in membranes
from Sf9 cells." Biochemistry. 36: 12930-12938, 1997.

201.

Guthrie, C. and F. G.R. "Guide to yeast genetics and molecular biology." Methods
in Enzymology. 194: 1-932, 1991.

202.

Printen, J. A. and G. F. Sprague, Jr. "Protein-protein interactions in the yeast
pheromone response pathway: Ste5p interacts with all members of the MAP
kinase cascade." Genetics. 138: 609-19, 1994.

180

203.

Breeden, L. and K. Nasmyth. "Regulation of the yeast HO gene." Cold Spring
Harbor Symposia on Quantitative Biology. 50: 643-50, 1985.

204.

Mello, C. and A. Fire. "DNA transformation." Methods in Cell Biology. 48: 45182, 1995.

205.

Benian, G. M., T. L. Tinley, X. Tang and M. Borodovsky. "The Caenorhabditis
elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant
modular protein composed of Ig and signal transduction domains." Journal of Cell
Biology. 132: 835-48, 1996.

206.

Natochin, M., K. G. Gasimov and N. O. Artemyev. "Inhibition of GDP/GTP
exchange on G alpha subunits by proteins containing G-protein regulatory
motifs." Biochemistry. 40: 5322-5328, 2001.

207.

Ponting, C. P. "Raf-like Ras/Rap-binding domains in RGSI2- and still-life-like
signalling proteins." Journal of Molecular Medicine. 77: 695-8, 1999.

208.

Wu, G., M. L. Bernard and S. M. Lanier. "G-protein interaction assays." Methods
in Enzymology. 344: (in press), 2002.

209.

Natochin, M., B. Lester, Y. K. Peterson, M. L. Bernard, S. M. Lanier and N. O.
Artemyev. "AGS3 inhibits GOP dissociation from galpha subunits of the Gi
family and rhodopsin-dependent activation of transducin." Journal of Biological
Chemistry. 275: 40981-5, 2000.

210.

Peterson, Y. K., M. L. Bernard, H. Z. Ma, S. Hazard, S. G. Graber and S. M.
Lanier. "Stabilization of the GDP-bound conformation of Gi alpha by a peptide
derived from the G-protein regulatory motif of AGS3." Journal of Biological
Chemistry. 275: 33193-33196, 2000.

211.

Mochizuki, N., Y. Ohba, E. Kiyokawa, T. Kurata, T. Murakami, T. Ozaki, A.
Kitab atake, K. Nagashima and M. Matsuda. "Activation of the ERKlMAPK
pathway by an isoform of raplGAP associated with G alpha(i)." Nature. 400:
891-4, 1999.

212.

Pizzinat, N., A. Takesono and S. M. Lanier. "Identification of a Truncated Form
of the G-protein Regulator AGS3 in Heart That Lacks the Tetratricopeptide
Repeat Domains." Jo~rnal of Biological Chemistry. 276: 16601-16610, 2001.

213.

De Vries, L., T. Fischer, H. Tronchere, G. M. Brothers, B. Strockbine, D. P.
Siderovski and M. G. Farquhar. "Activator of G protein signaling 3 is a guanine
dissociation inhibitor for Galpha i subunits." Proceedings of the National
Academy of Sciences of the United States of America. 97: 14364-9, 2000.

214.

Meng, J., J. L. Glick, P. Polakis and P. J. Casey. "Functional interaction between
Galpha(z) and RaplGAP suggests a novel form of cellular cross-talk." Journal of
Biological Chemistry. 274: 36663-9, 1999.

181

215.

Snow, B. E., R. A. Hall, A. M. Krumins, G. M. Brothers, D. Bouchard, C. A.
Brothers, S. Chung, J. Mangion, A. G. Gilman, R. J. Lefkowitz and D. P.
Siderovski. "GTPase activating specificity of RGS 12 and binding specificity of an
alternatively spliced PDZ (pSD-9S/DIg/ZO-1) domain." Journal of Biological
Chemistry. 273: 17749-55, 1998.

216.

Gautam, M., P. G. Noakes, J. Mudd, M. Nichol, G. C. Chu, J. R. Sanes and J. P.
Merlie. "Failure of postsynaptic specialization to develop at neuromuscular
junctions of rapsyn-deficient mice [see comments]." Nature. 377: 232-6, 1995.

217.

Glass, D. J. and G. D. Yancopoulos. "Sequential roles of agrin, MuSK and rapsyn
during neuromuscular junction formation." Current Opinion in Neurobiology. 7:
379-84, 1997.

218.

Fuchs, E. and I. Karakesisoglou. "Bridging cytoskeletal intersections." Genes &
Development. 15: 1-14, 2001.

219.

Prokop, A., J. Uhler, J. Roote and M. Bate. "The kakapo mutation affects terminal
arborization and central dendritic sprouting of Drosophila motomeurons." Journal
of Cell Biology. 143: 1283-94, 1998.

220.

Karakesisoglou, I., Y. Yang and E. Fuchs. "An epidermal plakin that integrates
actin and microtubule networks at cellular junctions." Journal of Cell Biology.
149: 195-208,2000.

221.

Prout, M., Z. Damania, J. Soong, D. Fristrom and J. W. Fristrom. "Autosomal
mutations affecting adhesion between wing surfaces in Drosophila melanogaster."
Genetics. 146: 275-85, 1997.

222.

Gao, F. B., J. E. Brenman, L. Y. Jan and Y. N. Jan. "Genes regulating dendritic
outgrowth, branching, and routing in Drosophila." Genes & Development. 13:
2549-61, 1999.

223.

Lee, S., K. L. Harris, P. M. Whitington and P. A. Kolodziej. "short stop is allelic
to kakapo, and encodes rod-like cytoskeletal-associated proteins required for axon
extension." Journal of Neuroscience. 20: 1096-108,2000.

224.

Li, J. and A. Aderem. "MacMARCKS, a novel member of the MARCKS family
of protein kinase C substrates." Cell. 70: 791-801, 1992.

225.

Verghese, G. M., J. D. Johnson, C. Vasulka, D. M. Haupt, D. J. Stumpo and P. J.
Blackshear. "Protein kinase C-mediated phosphorylation and calmodulin binding
of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and
MARCKS-related protein." Journal of Biological Chemistry. 269: 9361-7, 1994.

226.

Vergeres, G. and J. J. Ramsden. "Binding of MARCKS (myristoylated alaninerich C kinase substrate)-related protein (MRP) to vesicular phospholipid
membranes." Biochemical Journal. 330: 5-11,1998.

182

<~

227.

Ramsden, J. J. "MARCKS: a case of molecular exaptation?" International Journal
of Biochemistry & Cell Biology. 32: 475-9,2000.

228.

Chen, J., S. Chang, S. A. Duncan, H. J. Okano, G. Fishell and A. Aderem.
"Disruption of the MacMARCKS gene prevents cranial neural tube closure and
results in anencephaly." Proceedings of the National Academy of Sciences of the
United States of America. 93: 6275-9, 1996.

229.

Chang, S., H. C. Hemmings, Jr. and A. Aderem. "Stimulus-dependent
phosphorylation of MacMARCKS, a protein kinase C substrate, in nerve termini
and PC12 cells." Journal of Biological Chemistry. 271: 1174-8, 1996.

230.

Myat, M. M., S. Chang, E. Rodriguez-Boulan and A. Aderem. "Identification of
the basolateral targeting determinant of a peripheral membrane protein,
MacMARCKS, in polarized cells." Current Biology. 8: 677-83, 1998.

231.

Krull, C. E. and S. A. Koblar. "Motor axon pathfinding in the peripheral nervous
system." Brain Research Bulletin. 53: 479-87, 2000.

232.

Rajagopalan, S., E. Nicolas, V. Vivancos, J. Berger and B. J. Dickson. "Crossing
the midline: roles and regulation of Robo receptors." Neuron. 28: 767-77, 2000.

233.

Kidd, T., C. Russell, C. S. Goodman and G. Tear. "Dosage-sensitive and
complementary functions of roundabout and commissureless control axon
crossing of the CNS midline." Neuron. 20: 25-33, 1998.

234.

Kidd, T., K. Brose, K. J. Mitchell, R. D. Fetter, M. Tessier-Lavigne, C. S.
Goodman and G. Tear. "Roundabout controls axon crossing of the CNS midline
and defines a novel subfamily of evolutionarily conserved guidance receptors."
Cell. 92: 205-15, 1998.

235.

Li, H. S., J. H. Chen, W. Wu, T. Pagaly, L. Zhou, W. Yuan, S. Dupuis, Z. H.
Jiang, W. Nash, C. Gick, D. M. Omitz, J. Y. Wu and Y. Rao. "Vertebrate slit, a
secreted ligand for the transmembrane protein roundabout, is a repellent for
olfactory bulb axons." Cell. 96: 807-18, 1999.

236.

Brose, K. and M. Tessier-Lavigne. "Slit proteins: key regulators of axon
guidance, axonal branching, and cell migration.
Current Opinion In
Neurobiology. 10: 95-102, 2000.
tt

237.

Zallen, J. A., S. A. Kirch and C. I. Bargmann. "Genes required for axon
pathfinding and extension in the C. elegans nerve ring." Development. 126: 367992, 1999.

238.

Kidd, T., K. S. Bland and C. S. Goodman. "Slit is the midline repellent for the
robo receptor in Drosophila." Cell. 96: 785-94, 1999.

183

239.

Rajagopalan, S., V. Vivancos, E. Nicolas and B. J. Dickson. "Selecting a
longitudinal pathway: Robo receptors specify the lateral position ofaxons in the
Drosophila CNS." Cell. 103: 1033-45, 2000.

240.

Hemminki, A. "The molecular basis and clinical aspects of Peutz-Jeghers
syndrome." Cellular & Molecular Life Sciences. 55: 735-50, 1999.

241.

Jenne, D. E., H. Reimann, J. Nezu, W. Friedel, S. Loff, R. Jeschke, O. Muller, W.
Back and M. Zimmer. "Peutz-Jeghers syndrome is caused by mutations in a novel
serine threonine kinase." Nature Genetics. 18: 38-43, 1998.

242.

Watts, J. L., D. G. Morton, J. Bestman and K. J. Kemphues. "The C. elegans par-4
gene encodes a putative serine-threonine kinase required for establishing
embryonic asymmetry." Development. 127: 1467-75,2000.

243.

Morton, D. G., J. M. Roos and K. J. Kemphues. "par-4, a gene required for
cytoplasmic localization and determination of specific cell types in
Caenorhabditis elegans embryogenesis." Genetics. 130: 771-90, 1992.

244.

Ohshiro, T., T. Yagami, C. Zhang and F. Matsuzaki. "Role of cortical tumoUfsuppressor proteins in asymmetric division of Drosophila neuroblast." Nature.
408: 593-6, 2000.

245.

Blaxter, M. "Caenorhabditis elegans is a nematode." Science. 282: 2041-6, 1998.

246.

Montgomery, M. K., S. Xu and A. Fire. "RNA as a target of double-stranded
RNA-mediated genetic interference in Caenorhabditis elegans." Proceedings of
the National Academy of Sciences of the United States of America. 95: 15502-7,
1998.

247.

Sharp, P. A. "RNAi and double-strand RNA." Genes & Development. 13: 139-41,
1999.

248.

Ramarao, M. K., M. J. Bianchetta, J. Lanken and J. B. Cohen. "Role of rapsyn
tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic
acetylcholine receptor clustering." Journal of Biological Chemistry. 276: 74757483,2001.

249.

Druey, K. M., B. M. Sullivan, D. Brown, E. R. Fischer, N. Watson, K. J. Blumer, .
C. R. Gerfen, A. Scheschonka and J. H. Kehrl. "Expression of GTPase-deficient
Gialpha2 results in translocation of cytoplasmic RGS4 to the plasma membrane."
Journal of Biological Chemistry. 273: 18405-10, 1998.

250.

Garrison, T. R., Y. Zhang, M. Pausch, D. Apanovitch, R. Aebersold and H. G.
Dohlman. "Feedback phosphorylation of an RGS protein by MAP kinase in
yeast." Journal of Biological Chemistry. 274: 36387-91, 1999.

184

251.

Murayama, Y . , T. Okamoto, E. Ogata, T. Asano, T. liri, T. Katada, M. Vi, J. H.
Grubb, W. S. Sly and I. Nishimoto. "Distinctive regulation of the functional
linkage between the human cation-independent mannose 6-phosphate receptor
and GTP-binding proteins by insulin-like growth factor II and mannose 6phosphate." Journal of Biological Chemistry. 265: 17456-62, 1990.

252.

Ikezu, T., T. Okamoto, V. Giambarella, T. Yokota and I. Nishimoto. "In vivo
coupling of insulin-like growth factor II1mannose 6-phosphate receptor to
heteromeric G proteins. Distinct roles of cytoplasmic domains and signal
sequestration by the receptor. " Journal of Biological Chemistry. 270: 29224-8,
1995.

253.

Mixon, M. B., E. Lee, D. E. Coleman, A . M . Berghuis, A. G. Gilman and S. R.
Sprang. "Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP
hydrolysis." Science. 270: 954-60, 1995.

185

MICHAEL LABRANCHE BERNARD
Medical University of South Carolina
Department of Pharmacology
171 Ashley Avenue
Charleston, SC 29425
(843) 792-2505 (lab)
(843) 792-2475 (fax)
email: bernarml@musc.edu

Personal Information
Date and Place of Birth

September 4, 1975, New Orleans, LA

Citizenship

US

Marital Status

Married

Address

104 St. Charles Court
Charleston, SC 29407
(843) 769-6204

Education
Undergraduate Training

1993-1997
Emory University, GA
B.S. (Biology), B.S. (Chemistry)

Graduate Training

1997-2001
Department of Pharmacology
Medical University of South Carolina
Ph.D. (Molecular and Cellular Biology and Pathobiology)
1998-2005
Medical Scientist Training Program
Medical University of South Carolina
M.D./Ph.D

Research Experience
1/98-7/01 Graduate Student, Department of Pharmacology,
Medical University of South Carolina, SC
Topic: "Structural and Functional Characterization of the
Activator ofG-protein Signaling 3 (AGS3)"
Advisor: Dr. Stephen M. Lanier

186

Honors and Awards

1997
1998
1999
2000
2000

Phi Beta Kappa
MUSC student research day 1st place, 1st year poster
division
ASPET Graduate Student Travel Award
ASPET Graduate Student Best Paper Award
MUSC student research day 1st place, 3rd year
poster division

Research Presentations

1998-2000
1998-2000
1998-2000
1998-2001
1999
1999
2000
2000

MUSC Molecular and Cellular Biology
Seminar Series
MUSC Pharmacology Seminar Series
MUSC Student Research Day
MUSC MSTP Research Day
Gordon Research Conference in Molecular
Pharmacology, CA
ASPEr, Washington D.C.
ASPET, MA
Gordon Research Conference in Molecular
Pharmacology, CA

Pu blications

Takesono, A., Cismowski, MJ., Ribas, C., Bernard, M.L., Chung, P., Hazard, S. III,
Duzic, E. and Lanier, S.M. Receptor-independent activators of heterotrimeric Gprotein signaling pathways. Journal of Biological Chemistry. 274(47): 33202-5,
1999.
Peterson, Y.K., Bernard, M.L., Ma, H., Hazard, S. III, Graber, S.G. and Lanier, S.M.
Stabilization of the GDP-bound conformation of Gialpha by a peptide derived
from the G-protein regulatory motif of AGS3. Journal of Biological Chemistry.
275(43): 33193-6,2000.
Natochin, M., Lester, B., Peterson, Y.K., Bernard, M.L., Lanier, S.M., and Artemyev,
N.D. AGS3 inhibits GDP dissociation from Galpha subunits of the Gi family and
rhodopsin-dependent activation of transducin. Journal of Biological Chemistry.
275(52): 40981-5,2000.
Bernard, M.lI., Peterson, Y.K., Chung, P., Jourdan, 1. and Lanier, S.M. Selective
interaction of AGS3 with G-proteins and the influence of AGS3 on the activation
state of G-proteins. Journal of Biological Chemistry. 276(2): 1585-93, 2001.

187

